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INTRODUCTION AND 

















Multicellular organisms are made up out of smaller building blocks 
called cells. In 1847, Schleiden and Schwann concluded that 
cells are the common building blocks of tissues, both in plants 
as well as in animals1. Rapid developments in the field of cell 
biology in the mid-20th century enabled investigators to culture 
metazoan cells outside of the living organism. Cell culturing in vit-
ro - which literally means “on glass” - was performed on glass or 
polystyrene, while these materials have a stiffness that exceeds 
the physiological stiffness range found in the body by orders of 
magnitude (Figure 1).
Most cells cultured in vitro are anchorage dependent, which 
means that they need to adhere to be able to survive and carry 
out their function. However, the chemical and physical proper-
ties of the substrate the cells adhere to can have profound ef-
fects on cell behavior. Mechano-biologists are at the interface 
of engineering and biology, and focus on the effect physical 
properties and other mechanical forces have on the cell. Phys-
ical properties include ligand density3, rheology4, topographic 
changes5 and stiffness6–8. Mechanical forces include (but are not 
limited to) tension9,10, compression11, shear stress12, and strain13. 
How cells sense these mechanical forces is called mechano-
sensing, while the conversion of mechanical signals into a bio-
chemical response is called mechanotransduction. Mechanical 
forces can influence tissue development, cell behavior, as well 
as the progression and outcome of diseases14. As such, cellular 
mechanosensing and mechanotransduction play pivotal roles 
in a wide range of  intricate biological and (patho)physiologi-
cal processes2,15. In this thesis we will mainly focus on the effect 
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Young’s modulus (stiness) in kPa
Figure 1. The biophysical range in tissue goes from 50 Pa up to 100 kPa (excluding mineralized bone). 
















1of stiffness (or elastic modulus) on the phenotypical properties and gene expression profiles of macrophages and fibroblasts in 
wound repair, fibrosis and the foreign body reaction16–18. 
TENSEGRITY
Several methods and models have been developed to better 
understand the effect of mechanical forces on cell biology7,19,20. 
In the late 90’s of the past century Donald E. Ingber adopted 
the tensegrity model (first introduced by Buckminster Fuller in the 
field of architecture) to better understand cellular mechanosens-
ing21,22. Ingber’s tensegrity model states that the cell cytoskeleton 
is in a continuous state of isometric tension and therefore sta-
bilizes the cells’ morphology. Changes in isometric tension, for 
example due to changes in substrate stiffness17, can have pro-
found effects on the cells’ morphology23–25 and behavior26,27. For 
instance, fibroblasts mimic the stiffness of their underlying sub-
strate in order to reduce intercellular isometric tension17 and this 
stiffness mimicking leads to a decrease in cell size on softer sub-
strates. Decrease in cell size is accompanied by a loss of alpha 
smooth muscle actin, which means fibroblasts lose their contrac-
tile phenotype28,29.
Ingber posit tensegrity as the best fitting model for cellular struc-
ture based on the observation that cells flatten on a solid  stiff 
surface but become spherical when non-adherent (Figure 2), 
as observed after trypsin treatment21,22,30. Most scientists study-
ing mechanobiology have adopted tensegrity as the best fitting 
model for cellular mechanosensing11,22,30. 
THE CYTOSKELETON, FOCAL ADHESIONS AND INTEGRINS
Mechanotransduction signals are transduced via changes in the 
cytoskeleton - a complex network of interlinking filaments con-
sisting of actin and tubulin - and these changes directly regu-
late cell morphology and movement. In terms of tensegrity the 
actin filaments exert a constant inward-force creating tension 
between the cell membrane and the nucleus, while constant 
compression is created by tubulin and specialized anchoring 















1 balance (or equilibrium) between this compression and tension is the basis of cellular tensegrity11,22,30.
 
Cells are surrounded in vivo by a fibrous mixture of extracellular 
molecules that provides mechanical and biochemical support, 
also known as the extracellular matrix (ECM). The ECM is largely 
deposited by a specific subset of cells of mesenchymal origin 
called fibroblasts, and consists of fibrous proteins (e.g. collagen, 
fibronectin), polysaccharides (glycosaminoglycans, hyaluronic 
acid) and water. 
In adherent cells, focal adhesions tether the ECM that surrounds 
and supports cells to the cytoskeleton via integrins. Integrins are 
heterodimers consisting of a wide variety of α- and β-subunit 
combinations, and expression of each subunit is highly depend-
ent on ECM type. Although we will not focus on integrins in de-
tail, it is important to understand the basic principles of cellular 
adhesion to the ECM via these calcium-dependent receptors to 
understand general mechanosensing.
Integrins reside at the cell-ECM interface and exert external forc-
es onto linker proteins in focal adhesion complexes. Talin and 
paxillin, being the most abundant linker proteins in focal adhe-
Non-adherent cells
Very low elastic modulus (stiness)
low isometric tension
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Figure 2. Differences in isometric tension based on cellular adherence. Non-adherent cells become 
rounded, while adherent cells become flat and spread more. Differences in elastic modulus (Young’s 
modulus or stiffness) lead to a similar effect in most cells: the lower the stiffness, the more rounded 















1sion complexes, recruit focal adhesion kinase (FAK) and vinculin. Phosphorylation of α-actinin by FAK leads to α-actinin and vincu-
lin adhesion and crosslinks and tethers actomyosin (F-actin and 
non-muscle myosin II complex) stress fibers to the cytoplasmic 
membrane via focal adhesion sites31. Adaptor protein p130Cas 
and the membrane-associated tyrosine kinase Src regulate in-
tegrin clustering in a stiffness-dependent manner (Figure 3). Re-
cently, an SH3 (Src kinase homolog 3) domain in αII-spectrins, 
a family member of α-actinin, has been linked to initial integrin 
clustering and cell spreading as well32. In Chapter 5 we studied 
the effect of stiffness on spectrins in fibroblasts. In Chapter 2 we 
report on the effect of stiffness on cell morphology and size us-
ing hydrogels that were coated with ECM molecules via a novel 
cross-link procedure. Furthermore, we studied in the same setting 
the effect of stiffness on vinculin, a mechanosensing protein in 
focal adhesions19,20.
STIFFNESS AND CELL DEVELOPMENT
Stiffness plays an import role in cell development and differentia-
tion33. In a seminal study by Engler et al., mesenchymal stem cells 
cultured on soft (1 kPa), intermediate (12 kPa) or stiff (>20 kPa) 
substrates obtained different morphologies and differentiated 
into functionally different cell types due to stiffness alone8. Soft 
substrates led to differentiation into an adipogenic phenotype, 
intermediate stiffness induced a myogenic phenotype while a 
stiff (rigid) substrate could induce an osteogenic phenotype8,34,35. 
Many different cell types have been studied for their mechano-
sensitivity, and it has even been speculated that all prokaryot-
ic and eukaryotic cells offer some form of mechanosensing due 
to  the presence of mechanosensitive ion channels36. Indeed, 
changes in differentiation state, proliferation31, migration37,38 and 
morphology17,23,28 have been observed in a wide variety of cells 
due to changes in substrate stiffness leading to changes in inter-
cellular isometric tension17.
Mechanosensing describes how cells feel the physical proper-
ties of their surroundings. Consecutively these mechanical signals 
can be converted into biochemical activity, a process called 















1 translocation (e.g. Yes-associated protein, YAP) can be induced via mechanotransduction pathways, thereby inducing cell dif-
ferentiation and/or proliferation15,42–45. These data suggest that 
chemical and mechanical signaling cues are equally important 
in cell differentiation and cellular response. 
THE EXTRACELLULAR MATRIX: WOUND REPAIR
In non-pathological conditions, fibroblasts are involved in tissue 
homeostasis and ECM remodeling, effectively balancing ECM 














Figure 3. Integrins and focal adhesions in cell-substrate adherence. Integrins are membrane span-
ning calcium-dependent adhesion receptors, which link the ECM to the intracellular cytoskeleton 















1to trauma, platelets and polymorphonuclear neutrophils (PMNs) extravasate from locally damaged blood vessels and infiltrate 
the area of the insult. During the coagulation phase platelets co-
agulate with fibrin to form the hemostatic plug at the wound 
site, and start to release transforming growth factor β1 (TGFβ1) 
and platelet derived growth factor (PDGF).  TGFβ1 is an impor-
tant driver of fibrosis and much effort has been put into limiting 
the effects of TGFβ1. Although PMNs are the most abundant in-
flammatory cells during early inflammation (24 h) they are re-
placed by macrophages at the late inflammatory phase (48 h). 
Macrophages and PMNs play an important role in cellular debris 
phagocytosis and remodeling of damaged tissue and newly syn-
thesized ECM. Influx of T-cells and mast cells leads to secretion of 
large quantities of the M2 inducing cytokines IL4 and IL13. These 
cytokines induce native marcophages and blood derived mac-
rophage to differentiate towards an anti-inflammatory (wound 
healing) M2 phenotype.  Later we will see that these M2 inducing 
cytokines also induce macrophage multinucleation.
As fibroblasts are attracted to the wound site, they differentiate 
into myofibroblasts under the influence of TGFβ1. Myofibroblasts 
are profibrotic cells with a highly contractile phenotype. In vivo, 
fibroblasts and myofibroblasts are in direct and continuous con-
tact with the ECM, and mechanical force plays an important 
role in fibroblast to myofibroblast differentiation and activation 
of latent TGFβ1.
As fibroblasts differentiate into myofibroblasts, an equilibrium shift 
occurs towards ECM production. More collagen type I is pro-
duced and at the same time this collagen type I is modified and 
cross-linked, which leads to an attenuation of collagen degrada-
tion. Myofibroblasts sense the cross-linked collagen and further 
contract the collagen fiber network to close the wound, which 
leads to tissue stiffening. In normal wound healing collagens are 
remodeled in the weeks after wound closure, which leads to a 
decrease in myofibroblasts, and subsequently shifts the ECM pro-
















1 FIBROSISFibrosis is defined as the accumulation of excessive fibrous con-
nective tissue due to an aberrant and dysregulated wound heal-
ing response46,47. Myofibroblasts, key players in fibrosis, are usually 
positive for α-smooth muscle actin (ACTA2) and have an ac-
quired capacity to synthesize collagen I, the main component 
of the fibrotic ECM. A forward feedback loop exists in fibrosis in 
which the stiffened ECM is both a cause and consequence of 
(myo)fibroblasts activation.
Where in normal wound healing collagen synthesis is attenuat-
ed after wound closure, an imbalance in collagen synthesis and 
degradation exists during fibrosis, and the fibrillary collagens are 
extensively cross-linked, further attenuating degradation. Fibrosis 
leads to an increased tissue stiffening, replacing healthy tissue 
with excessive scar formation. While most tissues in vivo range 
between 0.1 and 20 kPa, fibrotic tissues can reach up to 100 kPa, 
which can have profound effects on all cells found in the dam-
aged tissue, both mesenchymal as well as hematopoetic. 
Fibroblast function is largely dependent on ascorbic acid - which 
has it name derived from scurvy (ascorbic = anti scorbutic agent), 
as it regulates collagen deposition. In Chapter 7 we further eluci-
dated the synergistic/cofounding role of ascorbic acid on fibro-
blasts function and myofibroblast formation.
FOREIGN BODY RESPONSE AND THE FIBROUS CAPSULE
Biomaterials are used on a daily basis in the clinic, e.g. for cos-
metic purposes, reconstructive surgery, tissue engineering, and 
implantation of sensors48. Our body is tuned in such a way that it 
will elicit a material-dependent inflammatory response to most 
foreign body objects. This response is called the foreign body 
response (FBR)49. During the FBR macrophages remain at the im-
plant surface, and can elicit macrophage fusion, resulting in mult-
inucleated giant cells50. During the remodeling phase fibroblasts 
form a fibrous capsule (or foreign body granuloma) around the 
biomaterial, while macrophages mainly reside at the biomateri-
al interface. Macrophages are captured between the dense fi-















1giant cells (FBGCs) are formed
51,52. Not much is known about the 
role and function of these FBGCs, but they can reside for over a 
decade at the implant surface, and microscopic cracks in the 
biomaterials have been observed under FBGCs.
In the past decade, research focused onto limiting the FBR and 
formation of the fibrous capsule, mainly by modulating the topog-
raphy and surface chemistry of the biomaterial53–56. During fibrous 
capsule formation excess collagen type I deposition, cross-link-
ing and contraction by (myo)fibroblasts introduces changes in 
the physiological stiffness, which might cause a forward feed-
back loop, thereby influencing cell behavior. On the other hand, 
implanted biomaterials themselves often introduce non-physio-
logical stiffness and we know from both in vivo and in vitro studies 
that this non-physiological stiffness can regulate and orchestrate 
cell signaling and cell response, ultimately modulating cell fate. 
We wondered whether changes in stiffness, as found in wound 
healing, fibrosis and the FBR, might influence macrophage polar-
ization and behavior, much like it influences fibroblast behavior.
Macrophages play an important role during the FBR in a variety of 
ways. For instance, macrophages secrete cytokines and growth 
factors which directly alter fibroblast function. Moreover, mac-
rophages can infiltrate and, depending on biomaterial proper-
ties, degrade the biomaterial by phagocytosis and/or secretion 
of matrix metalloproteinases and/or other enzymes. 
As our understanding of biomaterials and mechanobiology pro-
gresses it becomes more and more evident that in order to reg-
ulate the FBR, we need to regulate three pillars; the first pillar 
being the state of the cell of interest, the second is (to control 
release of) soluble factors (growth factors, cytokines, chemok-
ines) and the third encompasses the properties (both chemical 
and mechanical) of the direct (micro)environment of the cell. 
For the third pillar we need to modulate and tightly control the 
properties of the biomaterial (e.g. the structure, organization, to-















1 AIM OF THIS THESISAlthough many different forces are exerted on cells in vivo, the 
aim of this thesis is to identify how cells respond to changes in sub-
strate stiffness in a wound healing / fibrotic / foreign body setting, 
without convolution of stiffness, surface chemistry and ECM den-
sity. Every organ in the body has a different approximate stiffness 
(Figure 1) which can be measured with different techniques, e.g. 
by atomic force microscopy. The physiological range of healthy 
organs ranges from 0.1 to 20 kPa and cells in these organs re-
spond to changes in stress and strain due to stiffness changes. 
These changes can directly influence cell morphology and be-
havior. To put things in perspective: most in vitro studies thus far 
have been performed on polystyrene (PS) with an approximate 
stiffness 100,000 times higher compared to dermal tissue. Yet for 
decades’ researchers expected (and still expect!) cells adhered 
to a stiff substrate to respond in a native way to cytokines and 
growth factors, and make direct comparisons with the in vivo sit-
uation. In this thesis we aimed to develop a novel system to study 
the effect of substrate stiffness on the cells regulating wound re-
pair, fibrosis and the FBR: the fibroblasts and macrophages.
DESIGN AND RATIONALE
In Chapter 2 we developed a reliable, robust and reproducible 
hydrogel system for in vitro cell culture using polyacrylamide 
(PAAm) which can be used to study 2D mechanosensing path-
ways. We used 3,4-dihydroxy-L-phenylalanine (L-DOPA) as a 
novel cross-linker to adhere ECM components to the otherwise 
inert polyacrylamide hydrogels to enable cell cultures. L-DOPA 
outperforms sulfo-SANPAH cross-linking (the golden standard) of 
ECM to PAAm in every way. ECM functionalization was more ho-
mogeneous, stable and more efficient. Furthermore, L-DOPA is 
more economical and can quite easily be applied by even basic 
laboratories, as it does not need fancy equipment or chemistry 
knowledge. To test our model, we used fibroblasts and observed 
effects similar to studies performed on either sulfo-SANPAH coat-
ed PAAMs or PDMS. Cell size and the number of vinculin-rich fo-
















1In Chapter 3 we used our newly developed PAAm in vitro cultur-ing system to study the effect of stiffness on macrophage polari-
zation when cultured on collagen type I. 
In Chapter 4 we investigated the effect of stiffness in combination 
with fibronectin coating on the formation of macrophage-de-
rived foreign body multinuclear giant cells.
In Chapter 5 we investigated the CD44 pathway regarding stiff-
ness-based macrophage fusion.
In Chapter 6 we studied the role of spectrins in wound healing 
and mechanosensing in the key wound healing cell, the fibro-
blast.
In Chapter 7 we studied the effect of ascorbic acid on fibroblast 
behavior and myofibroblast formation.
Concluding remarks, discussion and future prospects are pre-
sented in Chapter 8, where an overview linking all studies can be 
found.
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Cells acquire mechanical information from their surrounding and 
convert this into biochemical activity. The concept and mech-
anism behind this cellular mechanosensing and mechanotrans-
duction are often studied by means of two-dimensional hydrogels. 
Polyacrylamide hydrogels (PAAMs) offer chemical, mechanical, 
and optical advantages but due to their inert surface do not 
allow protein and cell adherence. Several cross-linkers have 
been used to functionalize the surface of PAAMs with extracel-
lular matrix (ECM) proteins to enable cell culture. However, the 
most commonly used cross-linkers are either unstable, expensive, 
or laborious and often show heterogeneous coating or require 
PAAM modification. Here, we introduce 3,4-dihydroxy-l-phenyl 
alanine (L-DOPA) as a novel cross-linker that can functionalize 
PAAMs with ECM without the above-mentioned disadvantages. 
A homogenous collagen type I and fibronectin coating was ob-
served after L-DOPA functionalization. Fibroblasts responded to 
differences in PAAMs’ stiffness; morphology, cell area, and pro-
tein localization were all affected as expected, in accordance 
with literature where other cross-linkers were used. In conclusion, 
L-DOPA can be used as a crosslinker between PAAMs and ECM 
and represents a novel, straightforward, nonlaborious, and ro-






























Cells sense and respond to external mechanical signals from their 
environment and convert this mechanical stimulus into biochem-
ical activity, a process known as mechanosensing and mecha-
notransduction1. Indeed, cells actively sense their environment 
by applying forces to the surrounding substrate at the site of ad-
hesion2. An increase in substrate stiffness directly influences cell 
morphology as stiffer materials lead to more cell spreading3. Cells 
also migrate more easily on and toward stiffer materials, a phe-
nomenon called durotaxis4,5. Furthermore, cells generally prolifer-
ate faster on a stiff substrate6,and substrate stiffness affects stem 
cell lineage differentiation7,8. 
To study the effect of substrate stiffness on cells in vitro, poly-
acrylamide hydrogels (PAAMs) have been used for years as elas-
tomers with a pretunable stiffness5,9–11. PAAMs offer chemical, op-
tical, and mechanical advantages. PAAMs are translucent and 
nonfluorescent, which enables their use in immunohistochemistry 
and fluorescence microscopy. PAAMs also show linear deforma-
tion in response to mechanical load and show rapid and com-
plete recovery after release10. Furthermore, PAAMs offer linear 
elasticity independent of applied strain12, enabling the verifica-
tion of PAAMs elastic moduli by fitting force retraction curves 
obtained with an atomic force microscope (AFM) with a linear 
Hertz model13,14. Extremely low moduli mimickin organ stiffness in 
vivo (<5 kPa)15 can be obtained by varying the ratio between 
acrylamide and bisacrylamide without introducing changes in 
the surface chemistry.
Despite excellent optical, chemical, and mechanical properties, 
PAAMs are biologically inert and require surface functionaliza-
tion to facilitate cell adhesion. In the past, a variety of cross-link-
ers have been used to couple protein to the surface of PAAMs. 
Sulfo-SANPAH (sulfosuccinimidyl 6-(4’-azido-2’-nitrophenylamino)
hexanoate), a chemical cross-linker and golden standard as of 
today, is used to functionalize the surface of PAAMs with extra-
cellular matrix (ECM) proteins or  peptides for cell adherence. 




























nitrophenyl azide and can bind protein through an aminereac-
tive N-hydroxysuccinimide ester. Sulfo-SANPAH is an  expensive 
reagent that due to its poor solubility, limited stability, and short 
shelf life can show variations in crosslinking, which leads to het-
erogeneous ECM coating15,16. This results in poor, heterogeneous, 
aberrant, or no adhesion of cells.
Other used cross-linkers are dependent on polyacrylamide mix-
ture modifications10,16: 1-ethyl-3-(3-dimethylaminopropyl) carbo-
diimide hydrochloride can only couple protein to PAAMs when 
acrylic acid is incorporated into the hydrogel because it depends 
on a free carboxylic acid group to form a stable amide bond. An-
other used cross-linker, 6-acrylaminohexylaminohexanoic acid 
N-succinimidyl ester (N6) needs to be incorporated directly into 
PAAMs and these modifications may influence hydrogel stiffness, 
stability and integrity. The synthesis of N6 is another limitation as 
it can only be formed through a multistep chemical reaction, 
which is hard to implement for most biologically oriented labo-
ratories. Alternatives such as polydimethylsiloxane (PDMS) are a 
less desirable choice for studying cell mechanosensing due to 
nonlinear mechanical behavior17. 
Clearly, the need for a straightforward protocol to function-
alize PAAMs for cell culture to study mechanosensing and 
mechanotransduction in vitro remains. In this article, 3,4-dihy-
droxy-l-phenylalanine (L-DOPA), the dopamine precursor and 
key compound in mussel byssus adhesion18–20, is proposed to sub-
stitute said cross-linkers to couple ECM proteins to unmodified 
PAAMs with different substrate stiffness. L-DOPA is a nontoxic 
compound, which is extensively used in the clinic for the treat-
ment of Parkinson’s disease and dopamine-responsive dystonia 
and is considered biocompatible. As shown by Lee et al., L-DO-
PA can bind to various materials such as steel, titanium, polysty-
rene, and PDMS21. L-DOPA has also been used as a cell-adhesion 
molecule in serum-free cell cultures as discussed by Wan-Geun 
La et al.22 
 
L-DOPA is more economic in use compared to sulfo-SANPAH 




























bined the excellent optical, chemical and mechanical proper-
ties of PAAMs with the remarkable binding properties of L-DOPA 
to functionalize PAAMs for cell culture and briefly compare our 
functionalization method with sulfo-SANPAH.
 
Using this method, we offer a novel, easy, and robust in vitro 
model to study the effect of substrate stiffness on the biology of 
cells. We validated our model by studying the effect of substrate 
stiffness on human fetal fibroblasts using the following charac-
teristics: cell adherence, cell area, the incorporation of alpha 
smooth muscle actin (aSMA) into stress fibers, the localization of 
vinculin in focal adhesions, and the translocation of Yes associat-
ed protein (YAP) into the nucleus.
MATERIALS & METHODS
PREPARATION OF PAAMS
PAAMs were prepared between a chemically modified glass 
plate and a glass coverslip, a slight modification of a method 
first described by Pelham and Wang10. The glass plate was steri-
lized in an autoclave, followed by immersion in 99.9% ethanol for 
15 min. To prevent PAAM adhesion to the underlying glass plate, 
it was incubated with dichlorodimethylsilane (8034520; Merck, 
Darmstadt, Germany) for 5min, wiped clean and washed gently 
with sterile water afterward. Glass coverslips (Ø 15mm; VWR, Am-
sterdam, The Netherlands) were, to covalently link PAAMs, pre-
treated for 3 min with a freshly prepared solution of 99.9% etha-
nol containing 0.5% (v/v) 3-(trimethoxysilyl)propyl methacrylate 
(M6514; Sigma, St. Louis, MO) and 0.3% (v/v) glacial acetic acid. 
After incubation, the mixture was carefully aspirated and cover-
slips were washed twice with 99.9% ethanol to remove residual 
reagents.
PAAMs with mechanical properties mimicking in vivo tissue stiff-
ness were prepared by varying the ratio between 40% acryla-
mide solution (#161-0140; BioRad, Veenendaal, The Nether-
lands) and 2% bisacrylamide solution (#161-0142; Bio-Rad) in 
10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer 




























erization catalyst N,N,N,N-tetramethylethylenediamine (TEMED, 
#161-0800; BioRad) was added to the mixture in a final concen-
tration of 0.15%. This solution was deoxygenated under argon for 
30min. Without deoxygenation, large variations in hydrogel stiff-
ness, homogeneity, and polymerization speed were observed. 
After deoxygenation, the (bis)acrylamide solution was gently 
mixed with ammonium persulfate (APS; A3678, Sigma-Aldrich; Ta-
ble 1). APS addition was quickly followed by pipetting the polym-
erizing solution onto the glass plate and had to be done in rapid 
succession, placing a coverslip on top. PAAMs covalently linked 
to the glass coverslips were left to polymerize for 15–30min before 
carefully flipping them with a needle and tweezers and placed 
into 24-well culture well plates. 
 
To cease the polymerization process and remove leftover acryla-
mide and bisacrylamide monomers, the PAAMs were washed 
twice with phosphate buffered saline (PBS) and stored in PBS in 
the fridge until further use. Hydrogel surface creasing of soft gels 
was prevented by adapting acrylamide and bisacrylamide con-
centrations as described by Saha et al23.
ATOMIC FORCE MICROSCOPY
The mechanical properties of the PAAMs were measured us-
ing a Bruker BioScope Catalyst AFM (Bruker UK Limited, Coven-
try, United Kingdom) in contact in fluid mode in PBS. Triangular 
silicon nitride cantilevers (NP10; Bruker UK Limited) with nominal 
spring constants of 0.06 N/m were used. Cantilever spring con-
stants were determined and calibrated on glass at the begin-
ning of each experiment. The stiffness of each PAAM was meas-




























assure homogeneity and assessed by 20 indentations per loca-
tion. The stiffness was validated by repeated measurements per 
day (triple hydrogels) and by repeated experiments at different 
days (n = 3) to validate reproducibility. The Young’s modulus 
was obtained retrospectively by fitting obtained force retrac-
tion curves with a linear Hertz model13,14.
L-DOPA TO FUNCTIONALIZE THE SURFACE OF PAAMS
The catecholamine L-DOPA (D9628; Sigma-Aldrich) was used 
to functionalize the surface of PAAMs. L-DOPA was dissolved in 
10mM Tris buffer (pH 10) at a final concentration of 2 mg/mL un-
less otherwise specified and left to dissolve for 30 min in the dark. 
After dissolving, the L-DOPA solution was sterilized through a 0.20 
µm surfactant-free cellulose acetate filter, and PAAMs were in-
cubated with 250 mL of L-DOPA for 30 min in the dark, followed 
by two washes with PBS to remove any residual unbound L-DOPA. 
L-DOPA coated hydrogels were functionalized with 250 mL of ei-
ther a 20 µg/mL fibronectin (F1141; Sigma-Aldrich) or a 40 µg/mL 
rat-tail tendon collagen type I (354249; BD Bioscience, San Jose, 
CA) solution in PBS at 37C for 2h, unless stated otherwise. After 
incubation, gels were washed with PBS to remove any unbound 
ECM components. During optimization experiments, the time and 
concentration of both L-DOPA and collagen I were varied to de-
termine L-DOPA and collagen I binding dynamics. A schematic 
representation of L-DOPA as a cross-linker in our PAAM model is 
depicted in Figure 1.
FIG. 1. Schematic representation of the PAAM–L-DOPA–ECM construct. A glass coverslip with co-
valently attached PAAM is coated with L-DOPA, after which the PAAM is functionalized with ECM 
proteins (collagen I, fibronectin). ECM, extracellular matrix; L-DOPA, 3,4-dihydroxy-l-phenylalanine; 
PAAM, polyacrylamide hydrogel.





























To compare our method with sulfo-SANPAH, we coated PAAMs 
with either sulfo-SANPAH or L-DOPA (2 mg/mL L-DOPA in 10 mM 
Tris buffer and filtered before use, as described in previous para-
graph) before collagen I functionalization. In brief, PAAMs were 
overlaid with 200 mL of a 0.5mg/mL (1mM) sulfo-SANPAH in 50mM 
HEPES solution and incubated under a 365 nm UV lamp for 5min, 
as described by Pelham and Wang10,24. Next, PAAMs were washed 
three times with 50mM HEPES and incubated with collagen type 
I for 2h at 37C.
IMMUNOFLUORESCENCE AND QUANTIFICATION OF ECM 
COATING ON PAAMS
To visualize collagen type I and fibronectin bound to the surface 
of the PAAMs through L-DOPA or sulfo-SANPAH, gels were incu-
bated for 30 min with (1) 10% goat serum or (2) 10% donkey se-
rum followed by incubation with either (1) mouse monoclonal 
antibody to collagen type I (ab90395; Abcam, Cambridge, Unit-
ed Kingdom; 1:5000 in PBS) or (2) rabbit polyclonal antibody to 
fibronectin (ab2413; Abcam; 1:1000 in PBS) for 2 h. Gels were 
washed with PBS and incubated with (1) goat-anti-mouse IRDye 
800 CW (610– 132-121: Rockland, Limerick, PA) or (2) donkey-an-
ti-rabbit IRDye 680 CW (926-68073; Rockland; both 1:500 in PBS) 
for 1 h followed by three washes with PBS. ECM coating was vis-
ualized at infrared wavelength (780 nm for collagen I, 680 nm for 
fibronectin) using the Odyssey Infrared Imaging System (LI-COR, 
Lincoln, NE). Collagen I and fibronectin staining were quantified 
using the supplied LI-COR image studio software for Windows, 
version 4.0.21.
CELL CULTURE
To determine cell adhesion, human dermal fetal fibroblasts (WS1, 
CRL-1502; ATCC, Teddington, United Kingdom) were pretreated 
with 10 µg/mL mitomycin C (M4287; Sigma-Aldrich) for 2 h. Mito-
mycin C forms cross-links between the DNA strands and therefore 
inhibits DNA synthesis and proliferation. Fibroblasts were seeded 
on L-DOPA/collagen type I-functionalized PAAMs with a density 
of 1000 cells/cm2 to avoid confluent cell–cell contact and cul-




























Waltham, MA) supplemented with 10% filtered heat-inactivated 
fetal calf serum (SV3016) (Thermo Scientific, Waltham, MA), 1% 
penicillin/streptomycin, and 1% l-glutamine (both from Sigma-
Aldrich) under 20% O2 and 5% CO2 at 37C. For cell adherence, 
fibroblasts were cultured for 24 h on plain PAAMs, PAAMs coated 
with only collagen type I or PAAMs functionalized with L-DOPA 
and collagen type I. For immunofluorescence detection of cell 
area and protein (trans)location, fibroblasts were cultured on 
PAAMs functionalized with L-DOPA/collagen type I. After either 
24 h (cell adhesion) or 48 h (cell area, protein [trans]location), 
fetal fibroblasts were washed twice with PBS and fixated with 2% 
paraformaldehyde (PFA) at 4C for 15 min.
CELL ADHESION AND AREA
To assess cell adherence, PFA-fixated cells cultured for 24 hours 
on functionalized gels were incubated with 4,6-diamidino-2-phe-
nylindole (DAPI; D9542; Sigma-Aldrich) for nuclear staining (1:5000 
in PBS). To assess cell area, fibroblasts cultured on either L-DOPA–
collagen I or L-DOPA–fibronectin functionalized PAAMs were fix-
ated after 48 h. Next cells were stained with DAPI (1:5000 in PBS) 
and phalloidin tetramethylrhodamine B isothiocyanate (phalloi-
din-TRITC; P1951; Sigma-Aldrich; 1:1000 in PBS; F-actin staining) 
for 10 min, followed by three washes with PBS supplemented with 
0.5% Tween-20. Slides were mounted in Citifluor (Agar Scientific, 
Essex, United Kingdom). Images for cell adherence and cell area 
were obtained with a TissueFAXS equipped with a Pixelfly cam-
era and a 10x objective. For cell adherence, 36 field of views 
(FOVs) and for cell area 25 FOVs were acquired per stiffness and 
these images were automatically stitched together by the Tis-
sueGnostics TissueFAXS software. Both cell adherence and cell 
area experiments were repeated four times and analyzed using 
the Leica NuanceFX software. To analyze the cell area, stitched 
images were converted to spectral cubes to unmix fluorescence 
background from phalloidin staining. Using the threshold seg-
mentation function, cell area was measured in pixels. Each cell 
was checked and manually corrected using the draw/erase 
function if necessary. At least 100 cells were measured per hy-
drogel. By using the TissueFAXS provided scale bar, the measured 




























IMMUNOFLUORESCENT STAINING FOR F-ACTIN, VINCULIN, AND 
YAP IN FETAL FIBROBLASTS ON PAAMS
To visualize aSMA, vinculin, and YAP, PFA-fixated fibroblast were 
permeabilized with 0.5% Triton X-100 (108643; Merck) for 10 min 
and incubated with 10% goat serum for 1 h. Next, fibroblasts were 
incubated for 2 h at room temperature (RT) with (1) mouse mon-
oclonal to aSMA (Clone 1A4; DAKO, Glosstrup, Denmark; 1:100), 
(2) mouse monoclonal to vinculin (hVIN-1; Sigma-Aldrich; 1:1000), 
or (3) rabbit polyclonal to YAP (sc-15407; Santa Cruz, Dallas, TX; 
1:1000) in PBS containing 2.2% bovine serum albumin (BSA). After 
three washes with PBS, fibroblasts were incubated with biotinylat-
ed (1) IgG2a-specific goat-anti-mouse (1080-08; SouthernBiotech, 
Birmingham, AL; 1:250), (2) IgG1-specific goat-anti-mouse–biotin 
(1070-08; SouthernBiotech; 1:250), or (3) polyclonal goat-anti-
rabbit–biotin (E0432; DAKO, Glosstrup, Denmark; 1:250), diluted 
in PBS containing 2.2% BSA for 1 h at RT. Cells were washed three 
times with PBS and incubated with streptavidin-CY5 (Invitrogen, 
Grand Island, NY; 1:250) in PBS containing DAPI (1:5000) for 30 
min. After three washes with PBS, slides were mounted in Citifluor 
(Agar Scientific).  aSMA, vinculin, and YAP were visualized using 
a Leica DMI 6000 equipped SP8 confocal microscope using a 40x 
oil objective. Overlays of confocal z-stacks were created using 
ImageJ with the FIJI image processing package.25
STATISTICS
All data are represented as mean – standard error of the mean. 
All experiments were analyzed using GraphPad Prism, version 6 
(GraphPad Software, La Jolla, CA) either by one-way or two-way 
ANOVA, followed by Bonferroni post hoc analysis. Values of p < 
0.05 were considered to be statistically significant.
RESULTS
CHARACTERIZATION OF PAAMS FUNCTIONALIZED WITH L-DOPA 
We obtained PAAMs with mechanical properties that match 
the physiological stiffness of different tissues by varying the ratio 
between acrylamide and bisacrylamide (Fig. 2). A key step to 
obtain PAAM stability, homogeneity, and reproducibility is de-
oxygenation: we obtained excellent results when we used the 




























solutions. Our PAAMs derived from mixtures mimicking the in vivo 
stiffness (Young’s modulus between 2 and 92 kPa) showed a high 
reproducibility with low variation (Fig. 2)
FIG. 2. Stiffness of PAAM hydrogels. Mechanical properties of PAAMs were obtained by atomic force 
microscopy in contact in fluid mode in phosphate buffered saline with triangular silicon nitride can-
tilevers. Data shown represent three experiments conducted separately, each consisting of triple 
hydrogels. Each hydrogel was measured at three different topographic locations to validate PAAM 
homogeneity.








































































































FIG. 3. POLYACRYLAMIDE SURFACE FUNCTIONALIZATION WITH COLLAGEN TYPE I USING L-DOPA. 
Collagen I functionalization was visualized using the LI-COR Odyssey infrared imaging system. Com-
puted pseudocolored images of collagen I coating of PAAMs are shown left of the quantification 
graphs. L-DOPA shows (A) time- and (B) concentration-dependent functionalization of PAAMs. (C) 
At the optimal L-DOPA concentration (2 mg/mL in 10 mM Tris), collagen I adhered in a time and 
(D) concentration-dependent manner to the L-DOPA-functionalized PAAMs. (E) Without L-DOPA 
functionalization, collagen I did not adhere to the inert PAAMs (grey bars). L-DOPA–collagen I func-
tionalization showed no significant differences between hydrogels of different stiffness (black bars). 
(F) L-DOPA (black bars) shows a significant enhancement in collagen I adherence compared to sul-
fo-SANPAH (white bars). Statistics were performed by two-way ANOVA with Bonferroni post hoc test. 
***Significant difference between hydrogels functionalized with L-DOPA and collagen I or collagen 
I alone, p-value <0.0001. ###Significant difference between functionalization with collagen I using 
either L-DOPA (black bars) or sulfo-SANPAH (white bars), p-value <0.0001. sulfo-SANPAH, sulfosuccin-
imidyl 6-(4¢-azido-2¢-nitrophenylamino)hexanoate.
FIG. 4. FIBROBLAST CELL AREA AND CELL ADHERENCE ON PAAMS WITH PHYSIOLOGICAL STIFFNESS 
FUNCTIONALIZED WITH L-DOPA AND ECM. 
(A) Fibroblast cell adherence to plain PAAMs, PAAMs functionalized with only collagen I, or PAAMs 
functionalized with L-DOPA and collagen I. Cell adherence on plain PAAMs or PAAMs with only 
collagen I showed less than 3% cell adherence compared to L-DOPA and collagen I functionalized 
PAAMs.(B)Cell area as analyzed after F-actin staining with phalloidin. Cells showed marked differ-
ences in cell area, depending on PAAM stiffness (n = 3 for both experiments). (C) Fluorescence 
images depicting changes in cell area due to substrate stiffness on collagen I-functionalized PAAMs, 
original magnification 100·. (D) Quantification of L-DOPA–fibronectin-functionalized PAAMs using the 
LI-COR Odyssey infrared imaging system. Computed pseudocolored images of fibronectin coating 
of PAAMs are shown left of the quantification graph. (E) Cell area on L-DOPA–
fibronectin-functionalized PAAMs. (A) ***Significant differences between PAAM alone and PAAM 
functionalized with LDOPA and collagen I ( p < 0.001). ###Significant differences between PAAM 
coated with only collagen I and PAAM functionalized with L-DOPA and collagen I ( p < 0.001). (B) 
***Significant differences in cell area between 2 and ‡12 kPa, p-value <0.001. $$$Significant differ-
ence in cell area between 4 and ‡12 kPa, p-value <0.001 (D) ***Significant difference in coating be-
tween L-DOPA-FN-functionalized and FN-functionalized hydrogels, p-value <0.001.(E) ***Significant 
difference in cell area between 2 and ‡12 kPa, p-value <0.001. $$$Significant different between 4 
and ‡26 kPa, p-value <0.001. **Significant difference between 2 and 4 kPa, p-value <0.01. *Signifi-
cant difference between 4 and 12 kPa, and between 12 and 92 kPa, p-value <0.05. FN: fibronectin. 
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*** *** *** *** *** ***
### ### ### ### ### ###
Next, we functionalized PAAMs with collagen type I using the 
catecholamine L-DOPA. Because directly quantifying L-DOPA 
adherence to thePAAM surface is difficult, we have indirectly 
measured L-DOPA through collagen I adherence using the high-
ly sensitive LI-COR Odyssey Infrared Imaging System. Coating of 
PAAM with collagen type I, using L-DOPA as a cross-linker, is time 
and concentration dependent (Fig. 3A, B). We observed com-
plete and homogenous collagen type I coating of PAAMs after 
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L-DOPA concentration (2 mg/mL; Fig. 3B). Collagen I adhered in 
a fast and efficient manner to L-DOPA; no detectable increase in 
collagen type I adherence at the surface of L-DOPA functional-
ized hydrogels was detected after 30min of collagen incubation 
(Fig. 3C). 
When L-DOPA is used at the optimal concentration of 2mg/mL in 
10mM Tris, collagen is the limiting factor in collagen surface den-
sity (Fig. 3D). PAAMs coated with L-DOPA and functionalized with 
collagen I showed no significant differences in collagen density 
between hydrogels with different degrees of stiffness (Fig. 3E). 
Without L-DOPA treatment, collagen type I could not bind to the 
PAAMs (Fig. 3E). Furthermore, we see a marked improvement in 
collagen I functionalization when comparing L-DOPA with sulfo-
SANPAH (Fig. 3F). Note that sulfo- SANPAH not only shows less col-
lagen I adherence compared to L-DOPA but also shows a more 
heterogeneous collagen I coating. Adhesion of ECM to L-DOPA-
functionalized PAAMs was also validated with fibronectin (Fig. 
4D) where similar results as collagen I were obtained (Fig. 3E).
EFFECT OF SUBSTRATE STIFFNESS ON CELL ADHERENCE AND 
CELL SPREADING
To validate our method, human fetal fibroblasts preincubated 
with mitomycin C were seeded onto plain PAAMs, PAAMs with 
collagen type I, or PAAMs functionalized with L-DOPA and col-
lagen type I, and cultured for 24 h. Cells hardly adhered to un-
coated or collagen-coated PAAMs (without L-DOPA). Compared 
to L-DOPA/collagen I-functionalized hydrogels, uncoated and 
collagen-coated PAAMs showed less than 3% cell adherence. 
In contrast, cells adhered homogenously to PAAMs functional-
ized with L-DOPA/collagen, and no significant differences in cell 
densities were observed between hydrogels of different stiffness 
(Fig. 4A). Although the quantification of cell densities between 
hydrogels with different stiffness revealed no differences in ad-
hesion, significant differences were observed in cell area. Cells 
cultured for 48 h on PAAMs functionalized with either L-DOPA/
collagen (Fig. 4B) or L-DOPA/fibronectin (Fig. 4E) showed a sub-
strate stiffness-dependent increase in cell area. Figure 4C shows 




























L-DOPA–collagen I functionalized PAAMs with different stiffness, 
clearly demonstrating substrate stiffness dependent changes in 
cell area.
EFFECT OF SUBSTRATE STIFFNESS ON ASMA
Incorporation of aSMA into stress fibers is a well-known myofibro-
blast marker and is involved in, for example, cell motility, struc-
ture, integrity and contraction. Changes in cell morphology, 
directed by substrate stiffness, have a direct effect on aSMA lo-
calization and organization. The formation of aSMA stress fibers in 
fibroblasts, directed by substrate stiffness, was tested in our L-DO-
PA/collagen I functionalized PAAMs model. Along with changes 
in cell area, fetal fibroblasts incorporated, as expected, aSMA 
into stress fibers at a stiffness of 12 kPa and higher (Fig. 5). At low-
er stiffness (2 and 4 kPa), aSMA dissociated from the stress fibers 
and was retained in the cytoplasm (Fig. 5).
EFFECT OF SUBSTRATE STIFFNESS ON VINCULIN LOCALIZATION
As the substrate stiffness has a direct effect on cellular spread-
ing, we next validated our PAAMs with respect to the formation 
of focal adhesions. Vinculin, a key component in focal adhe-
sions, plays an important role in cell–cell and cell–matrix inter-
actions.1,26,27 Vinculin-containing focal adhesions extend if cells 
sense higher stiffness and promotes cell spreading by mechani-
cally coupling integrins to the cytoskeleton28–30. Singular focal 
adhesions also act as mechanosensors; the elongation of focal 
adhesions depends on the force generated by the cell on the 
substrate and substrate rigidity26,31–34. At lower stiffness values, 
matching physiological organ stiffness (<12 kPa), a marked de-
crease in focal adhesion size was observed (Fig. 5), which was 
accompanied by an increase in cytoplasmic vinculin staining (4 
FIG. 5. STAINING OF THREE PROTEINS KNOWN TO BE INVOLVED IN CELLULAR MECHANOSENSING IN 
FIBROBLASTS. 
(A)Alpha smooth muscle actin (aSMA) stress fibers dissociated from stress fibers on lower substrate 
stiffness of 2 and 4 kPa. On substrate stiffness of 12 kPa and higher, stress fibers are formed (arrow). 
(B) Vinculin dissociated from focal adhesions at the lower substrate stiffness of 2 and 4 kPa. Mature 
focal adhesions only formed on substrate stiffness of 12 kPa and higher (arrow). (C) Yes-associated 
protein (YAP) was sequestered to the cytoplasm at the lowest substrate stiffness (2 kPa), but translo-







































































kPa) or loss of vinculin (2 kPa). In contrast, at higher stiffness we 
observed an increase in vinculin in focal adhesions and an in-
crease in focal adhesion size.
EFFECT OF SUBSTRATE STIFFNESS ON YAP TRANSLOCATION
Cells can convert physical and mechanical signals obtained 
from their environment into biochemical signals. YAP, one of the 
main effectors of the Hippo tumor suppressor pathway, has been 
identified as a mechanosensing protein35,36. When cells encoun-
ter a stiff matrix, YAP translocates to the nucleus and regulates 
gene transcription35,36. In our model, YAP remained cytoplasmic 
on 2 kPa gels but translocated to the nucleus on 4 kPa gels and 
stiffer (Fig. 5), which validates our model as this has also been 
shown by Dupont et al.35
DISCUSSION
In this article, we propose L-DOPA18–20 as a novel covalent linker 
that can functionalize the surface of PAAMs with ECM proteins. 
In the last decade, some researchers have shifted away from 
PAAMs, mainly due to its inert surface properties and problems 
with homogenous ECM coating when using the bifunctional 
cross-linker sulfo-SANPAH. In contrast, alternatives such as PDMS 
are less favorable for in vitro stiffness-based studies as they show
nonlinear mechanical behavior17,37. Biological alternatives in the 
form of collagen, fibronectin, or Matrigel hydrogels fail to ob-
tain a stiffness higher than 1 kPa unless crosslinked38 and/or do 
not offer a similar surface chemistry and ECM density between 
gels of different stiffness, thereby convoluting stiffness and 
surface topography. PAAMs, however, offer linear mechanical 
behavior, and gels with physiological stiffness (between 1 and 
100 kPa) can easily be prepared by simply varying the acryl–bi-
sacrylamide ratio.
 
Polyacrylamide also offers a direct positive correlation between 
cell spreading and bulk substrate stiffness, whereas cell spread-
ing on PDMS is mainly influenced by the stiffness (and thickness) 
of the silica-like layer overlaying the cross-linked or plasma-treat-
ed PDMS surface39. Due to their polymer nature, all PAAMs have 




























ble 1 were at least 100 mm in thickness, keeping in mind that a 
minimum threshold of 20 mm is necessary to ensure that cells only 
‘‘feel’’ the gel and not the substrate (glass) below7,40. Although 
polyacrylamide gels are more suitable for studying the effect of 
substrate stiffness on cell mechanosensing, PDMS or other silicon 
derivatives might be more useful for wrinkling assays or surface 
modification studies41.
One drawback of PAAMs, hydrogel creasing, is a common
but poorly defined problem in extremely soft PAAM hydrogels at-
tached to stiff substrates (e.g., glass coverslips). Creasing can be 
caused by a combination of too low levels of the bisacrylamide 
cross-linker, osmotic pressure, and swelling23,42–44. As cells can en-
ter and elongate along creases, creasing can directly influence 
cell morphology and behavior23. It is, therefore, of importance to 
avoid hydrogel creasing at all times when studying the effect of 
substrate stiffness on cellular behavior. Here, we prepared PAAMs 
based on the article by Saha et al.23, to ensure that no creases 
are formed in the gels. In brief, this means that bisacrylamide was 
never lowered below 0.028 wt% as this leads to PAAM instability 
and creases during swelling23. 
In this article, we identified L-DOPA, the main molecular compo-
nent in mussel byssus adhesion,18,19,45 as a novel covalent linker to 
functionalize the inert surface of PAAMs with ECM, without intro-
ducing differences in collagen I or fibronectin density between 
gels with different Young’s moduli. We directly compared L-DO-
PA with sulfo-SANPAH functionalization and reveal a significant 
increase in collagen I adherence to L-DOPA-coated PAAMs. L-
DOPA has been used to coat a large variety of substrates, both 
organic and inorganic46. To our knowledge, this is the first time 
that L-DOPA is used to coat PAAM hydrogels to functionalize 
them with ECM components for cell culture. 
The exact mechanism of L-DOPA adherence to PAAMs is un-
known, although both Schiff base reactions and Michaels ad-
ditions have been proposed.21 It is also known that L-DOPA can 
autooxidate at alkaline pH forming dopaquinone19,47–50. Dopaqui-




























which can form covalent bonds with amine and thiol groups in 
proteins19.  
Furthermore, dopaquinone can self-polymerize forming poly-do-
paquinone sheets that form multiple strong covalent and nonco-
valent bonds with a multitude of different organic and inorganic 
substrates19. Indeed, Lee et al. describe covalent interactions of 
oxidated dopaquinone with organic amine-coated surfaces at 
alkaline pH (pH 10)19. Although the exact binding mechanism re-
mains elusive, ECM coating on PAAMs was homogeneous, lead-
ing to homogeneous cell attachment across all functionalized 
PAAMs.
Fibroblasts pretreated with mitomycin C (to inhibit prolifera-
tion) adhered homogeneously on the PAAMs and showed sim-
ilar cell densities between soft and stiff substrates, confirming 
similarity in surface chemistry and coating between gels of dif-
ferent substrate stiffness. Although cells showed no differenc-
es in adhesion, substrate stiffness induced marked responses 
in protein localization and cell area, indicating that the cells 
‘‘sense’’ the stiffness of their underlying substrate below the 
L-DOPA and ECM layer. Solon et al. showed similar results with 
fibroblasts on PAAMs which were functionalized with sulfo-SAN-
PAH51. In both our own results and Solon’s article, fibroblasts 
have a more rounded smaller morphology and lack a clearly 
defined F-actin cytoskeleton on low substrate stiffness (2 and 4 
kPa), whereas at higher stiffness (12 kPa) cells spread more easily 
and show a neatly arranged cytoskeleton. 
 
When comparing focal adhesion sizes to a similar study conduct-
ed by Goffin et al.52 on a PDMS substrate (in which the lowest 
substrate stiffness was 9.6 kPa), we obtained similar but more ex-
tended results. As observed by Goffin et al., focal adhesion size 
decreases sharply below 12 kPa. We observed no focal adhe-
sions in the lowest substrate stiffness (2 kPa) and detected mainly 
cytoplasmic vinculin at 4 kPa. These results could not be obtained 
with PDMS, as its stiffness cannot be modulated below 5 kPa, 
thus omitting critical physiological stiffness data points38. Fibro-




























ing their environment for mechanical cues and responding to 
changes in substrate stiffness by adapting their internal stiffness 
to match the stiffness of the surrounding substrate51. In fibroblasts, 
higher substrate stiffness can lead to more internal tension, high 
contraction, and formation of aSMA stress fibers51,53. One way to 
match the internal stiffness to the softer surrounding substrate is 
by remodeling the cytoskeleton, which in turn leads to a smaller 
cell area and less intracellular tension. aSMA stress fibers and fo-
cal adhesions increase due to enhanced intracellular isometric 
tension54 and focal adhesions quickly disassociate after loss of 
intracellular tension55–59. On lower stiffness hydrogels, fibroblasts 
have less internal tension, are less contractile, and disassemble 
aSMA stress fibers53.
In our experiments, incorporation of aSMA in stress fibers and 
vinculin-positive focal adhesions was only observed at stiffness 
higher than 4 kPa, matching results from other groups3,52. Last, to 
validate our system, we studied YAP localization. YAP is involved 
in mechanosensitive translocation to the nucleus and is only re-
tained in the cytoplasm if internal tension is low. Similar to results 
obtained by Dupont et al., YAP retained in the cytoplasm only 
on the lowest substrate stiffness. On higher stiffness (4 kPa and 
higher), YAP translocated to the nucleus, where it can interact 
with transcription factors and modulate differentiation and pro-
liferation35.
CONCLUSIONS
We conclude that L-DOPA is a nontoxic and biocompatible22 
cross-linker that can be used to more easily, more homogeneous-
ly, and more efficiently functionalize PAAMs with ECM compo-
nents when compared to sulfo-SANPAH. With this straightforward 
in vitro model, the effect of substrate stiffness on cell mechano-
sensing and mechanotransduction can be studied, without the 
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Cells are able to sense the stiffness of the substrate they are at-
tached to. In tissue repair and in fibrotic tissues an accumulation 
of collagen is seen, resulting in tissue stiffening. Macrophages 
and fibroblasts play important roles in both processes. Although 
the effect of tissue stiffening on fibroblast biology is investigated 
thoroughly, hardly anything is known about the activation sta-
tus of macrophages as a function of substrate stiffness. There-
fore, human primary macrophages were cultured on (1) colla-
gen-coated hydrogels with a stiffness ranging from 4-92 kPa or (2) 
collagen-coated glass with a stiffness > 10 MPa, and subsequent-
ly subjected to a combination of lipopolysaccharides/interfer-
on-gamma or the interleukins IL4/IL13 to polarize macrophages 
to the M1 or M2 polarization state, respectively. We found that 
the polarization of macrophages was not affected by stiffness, as 
revealed by gene expression levels of M1 and M2 markers, mor-
phology, or protein staining of CD40 and CD209. We conclude 
that the activation and polarization status of macrophages is not 
influenced by tissue stiffness and that there is no negative feed-























Macrophages are driving forces in wound healing and fibro-
sis. These cells, which are derived from monocytes, can display 
different phenotypes, depending on the chemical stimuli pre-
sent in the local micro-environment (Brown et al., 2014). Mac-
rophages show a highly dynamic plasticity: they exhibit different 
activation states and can switch from one polarization state to 
another (Ploeger et al., 2012 and Stout et al., 2005). The most 
well-known are the M1 and M2 polarization states, also known as 
pro-inflammatory and anti-inflammatory macrophages, respec-
tively. Macrophages exposed to lipopolysaccharides (LPS) and/
or interferon-gamma (IFNγ) display a M1 phenotype, whereas 
macrophages exposed to the interleukins IL4 and/or IL13 display 
a M2 phenotype. Although this is a rather simplistic classification 
of macrophage heterogeneity, as these two states are the ex-
tremes of a wide spectrum of overlapping activation types (Col-
in et al., 2014, Gordon, 2003, Mosser and Edwards, 2008, Murray 
and Wynn, 2011), it is still a useful in vitro concept.
During the first onset of wound healing, macrophages become 
pro-inflammatory (M1 phenotype) and are associated with tissue 
injury and inflammation. These M1 macrophages are involved in 
tissue degradation whereas tissue repair is associated with an-
ti-inflammatory (M2) macrophages (Brown et al., 2014, Gordon 
and Martinez, 2010, Mahdavian Delavary et al., 2011, Wynn and 
Vannella, 2016). M2 macrophages can instruct invading fibro-
blasts to proliferate and to produce extracellular matrix (ECM) 
(Nikolic-Paterson et al., 2014 and Ploeger et al., 2013). During this 
wound healing phase (proliferation phase) fibroblasts become 
activated, differentiate into myofibroblasts and produce new 
collagenous ECM, which makes the tissue stiffer. Therefore, mac-
rophages encounter different tissue stiffness: the physiological 
normal tissue stiffness range varies from 0,5 kPa (blood) to 15 kPa 
(muscle) in normal tissue and is temporary elevated during the 






















In normal wound healing, newly formed ECM will be remodeled 
and fibroblasts and myofibroblasts leave the wound site or go 
into apoptosis. In contrast, in fibrosis fibroblasts and myofibro-
blasts stay and continue to produce ECM that remains deposit-
ed. Therefore, one of the hallmarks of fibrosis is the pathological 
accumulation of collagen (mainly collagen type I), resulting in 
a local stiffening of the affected tissue, which can go up to 100 
kPa. Detailed knowledge is available about the effect of tissue 
stiffness on fibroblast biology (Hinz, 2000, Lech and Anders 2013, 
Liu et al., 2010, Schroer and Merryman, 2015, Yong et al., 2015). 
Matrix stiffening even promotes the formation of new myofibro-
blasts, which results in a negative feedback loop (matrix stiffen-
ing promotes matrix synthesis) (Liu et al., 2010). 
Although much is known about the role of macrophages in wound 
healing and fibrosis (Braga et al., 2015, Mahdavian Delavary et 
al., 2011, Nikolic-Paterson et al., 2014, Wynn and Vannella, 2016), 
and the chemical stimuli that induce the different polarization 
states (Mosser and Edwards, 2008, Vogel et al., 2014), remarkably 
little has been reported with regard to the effect of matrix stiff-
ness on macrophage polarization (reviewed in McWhorter et al., 
2015). In fact, the effect of substrate rigidity on macrophage ac-
tivation is still under debate (McWhorter et al., 2015). Since matrix 
stiffness is enhanced in normal wound healing and in fibrosis (Cox 
and Erler, 2011, Goffin et al., 2006, Liu et al., 2010), we wondered 
whether these biomechanical changes have an influence on 
the polarization capacity of macrophages.
An elegant system to study the effect of substrate stiffness on 
cells in vitro is the use of polyacrylamide hydrogels (PAAMs) with 
a pre-tunable stiffness (Engler et al., 2004). We have recently 
introduced the use of L-DOPA as a superior covalent linker to 
functionalize the otherwise inert PAAM hydrogel surface with 
extracellular matrix proteins such as collagen type I (Wouters et 
al., 2016). In the current paper, we investigated if stiffness, rang-
ing from 4-92 kPa, by itself induce polarization of primary human 
macrophages towards a M1 or M2 phenotype. Furthermore, we 
investigated whether primary human macrophages are able to 





















IL13 when cultured on collagen-coated hydrogels with a stiffness 
ranging from 4-92 kPa; collagen-coated glass (> 10 MPa) was 
used as control. We found that macrophage polarization does 
not seem to be affected by matrix stiffness. 
MATERIAL AND METHODS
PREPARATION OF POLYACRYLAMIDE HYDROGELS, FUNCTIONALIZA-
TION WITH L-DOPA AND COLLAGEN TYPE I 
PAAMs were prepared between a chemically modified glass 
plate and a glass coverslip as described previously (Wouters et 
al., 2016). Briefly, the glass plate was sterilized and incubated with 
dichlorodimethylsilane (Merck, Darmstadt, Germany, 8034520) 
for 5 minutes and washed with sterile water. Glass coverslips 
(VWR, Amsterdam, Netherlands) were pre-treated for 3 minutes 
with a freshly prepared solution of 99.1% ethanol containing 0.5% 
(v/v) 3-(trimethoxysilyl)propyl methacrylate (Sigma, St. Louis, USA, 
M6514) and 0.3% (v/v) glacial acetic acid. After incubation, the 
glass coverslips were washed twice with 99.9% ethanol.
The different stiffness of the PAAMs were obtained by varying the ra-
tio of 40% acrylamide solution (BioRad, Veenendaal, Netherlands, 
#161-0140) and 2% bisacrylamide solution (BioRad, Veenendaal, 
Netherlands, #161-0142) in 10 mM x 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid buffer (HEPES, Sigma, St. Louis, USA, 
H0887) as described previously. To catalyze polymerization 
0.15 % N,N,N’,N’-tetramethylethylenediamine (TEMED, BioRad, 
Veenendaal, Netherlands, #161-0800) was added. The solution 
was deoxygenated under argon for 30 minutes and ammonium 
persulfate (APS, Sigma, St. Louis, USA, A3678) was added to the 
solution, to initiate polymerization. From this solution (1) 10 μl or 
(2) 40 μl was pipetted onto the glass plate followed by placing 
(1) 10 mm Ø or (2) 20 mm Ø coverslip on top. PAAMs were left 
to polymerize for 15 minutes. After polymerization, the coverslips 
were turned and placed in a (1) 48 or (2) 12 wells culture plate 
followed by washing with PBS.
L-DOPA (Sigma, St. Louis, USA, D9628) was used to functionalize 





















tration of 2 mg/ml in 10 mM Tris buffer (pH10) and left to dissolve 
in the dark for 30 minutes. After dissolving, the L-DOPA solution 
was filter sterilized and PAAMs were incubated with 250 µg/cm2 
L-DOPA for 30 minutes in the dark. After incubation with L-DOPA 
the gels were washed with PBS and functionalized with 5 µg/cm2 
rat-tail tendon collagen type I (BD BioScience, San Jose, USA, 
354249) in PBS for 2 hours at 37°C. After incubation the gels were 
washed with PBS and left overnight in Minimum Essential Medium 
(MEM) α (ThermoFisher Scientific, Waltham, USA) without addi-
tives at 37°C.
ISOLATION OF CD14+ CELLS
Human peripheral blood mononuclear cells (PBMCs) from 
healthy donors were isolated from buffy coats (Sanquin, Gronin-
gen, the Netherlands) by density-gradient centrifugation. CD14+ 
cells were isolated with immunomagnetic bead separation using 
CD14 Microbeads (Miltenyi Biotec B.V., Leiden, the Netherlands) 
as described previously (Ploeger et al., 2013). After isolation, 
CD14+ cells were counted with a Coulter Counter and gently 
resuspended in culture medium consisting of Essential Medium 
(MEM) α (ThermoFisher Scientific, Waltham, USA) supplemented 
with 1% penicillin/streptomycin (Sigma-Aldrich, St. Louis, USA), 
10% HyClone FetalClone I Serum (FCI) (GE Healthcare, Utah, USA) 
and 10 ng/ml recombinant human M-CSF (R&D Systems, Minne-
apolis, USA). 
Macrophage cell culture and polarization with M1 or M2 stimuli 
Immediately after isolation and counting, the cell suspension was 
plated with a density of 300,000 cells/cm2 onto PAAMs with dif-
ferent stiffness coated with L-DOPA and functionalized with col-
lagen type I. As control, cells were seeded on glass coverslips 
coated with L-DOPA and collagen type I, which are further treat-
ed the same as cells cultured on PAAMs. Cells were cultured at 
37 °C under 5% CO2 and after 3 days non-adhered cells were 
removed by replacing the media supplemented with M-CSF with 
stimulation media. Stimulation media consisted of MEMα with 1% 
penicillin/streptomycin and 10% FCI supplemented with either (1) 
1 µg/ml LPS (Sigma-Aldrich, St. Louis, USA) + 10 ng/ml IFNγ (Pepro-
tech, Rocky Hill, USA) (classical stimuli), (2) 2 ng/ml IL4 + 2 ng/ml 





















additive (no stimulation = control) at 37 °C for 24 h. Macrophag-
es cultured on different PAAMs and controls were characterized 
by means of morphology, qRT-PCR and by immunofluorescence 
stainings before stimulation (pre-stimulation; after 3 days of cell 
culture with M-CSF) and after 24 h of stimulation.
RNA ISOLATION, CDNA SYNTHESIS AND QRT-PCR
Total RNA was isolated from the cells using the RNeasy Kit (Qiagen 
Inc., CA, USA) in accordance to manufacturer’s protocol. RNA 
concentration and purity were determined by UV spectropho-
tometry (NanoDrop Technologies, Wilmington, NC). For qRT-PCR 
analysis, total RNA was reverse transcribed using the First Strand 
cDNA synthesis kit (Fermentas UAB, Lithuania) in accordance to 
manufacturer’s protocol. Quantification of gene expression was 
performed using qRT-PCR analysis in a final reaction volume of 10 
μl, consisting of 1x SYBR Green Supermix (Roche, Basel, Switser-
land), 6 μM forward primer, 6 μM reverse primer (Table 1) and 5 
ng cDNA. Reactions were performed at 95 °C for 10 min followed 
by, 95 °C for 15 sec, 60 °C for 60 sec, for 40 cycles in a ViiA™ 
7 Real-Time PCR System (Applied Biosystems, CA, USA). Analysis 
of the data was performed using ViiA 7™ Real-Time PCR System 
Software v1.1 (Applied Biosystems, CA, USA).
Target gene Forward sequence Reverse sequence 
CCL18 ATGGCCCTCTGCTCCTGT AATCTGCCAGGAGGTATAGACG 
CCL5 CGCTGTCATCCTCATTGCTA GCACTTGCCACTGGTGTAGA 
CD14 AGCTAAAGCACTTCCAGAGC AGTTGTGGCTGAGGTCTAGG 
CD1B GAAGTTGCATCTCCCAGTGAA GGTAAAGGACGAGGTCTGGA 
CD209 GCTCGTCGTAATCAAAAGTGC CCAGGTGAAGCGGTTACTTC 
CD40 GGTCTCACCTCGCTATGGTT  CAGTGGGTGGTTCTGGATG  
CD68 GTCCACCTCGACCTGCTCT CACTGGGGCAGGAGAAACT 
CLEC10A AGGGTTTCAAGCAGGAACG AGGTGTGCCTTCTGCGTAGT 
IL1B TACCTGTCCTGCGTGTTGAA TCTTTGGGTAATTTTTGGGATCT 
IL6 ACTTGCCTGGTGAAAATCAT CAGGAACTGGATCAGGACTT 
MRC1 ACACCAAAACCTGAGCCAAC CCACCCATCTTCAGTAACTGGT 





















 IMMUNOFLUORESCENCE STAININGS ON PRE- OR STIMULATED MAC-
ROPHAGES CULTURED ON DIFFERENT STIFFNESS
Pre- and stimulated macrophages (day 3 and 4 of culture) were 
washed twice with PBS and fixed in 2% PFA at room tempera-
ture for 10 min. Fixed pre-stimulated cells (day 3) were incubat-
ed overnight at 4°C with monoclonal mouse-anti-human CD68 
(M0718, Dako, Glosstrup, Denmark) (1:50) diluted in 1% bovine 
serum albumin (BSA) (Sanquin, Amsterdam, the Netherlands)/ 2% 
normal goat serum (NGS) (Brunschwig Chemie, Amsterdam, the 
Netherlands)/ 0,5% Triton-X100 (Merck, Darmstadt, Germany)/ 
PBS. 
After overnight incubation, cells were washed with PBS and in-
cubated with biotinylated goat-anti-mouse IgG (H+L) (1031-08, 
SouthernBiotech, Alabama, USA) (1:100) diluted in 1% BSA/ PBS 
for 2 h at room temperature (RT). Cells were washed and incubat-
ed with streptavidin CY3 (Invitrogen, Grand Island, USA) (1:100) in 
PBS for 1 h at RT, which was followed by washing and incubation 
with DAPI (1:5000) in PBS for 5 min at RT. After three washes with 
PBS, slides were mounted in Citifluor (Agar Scientific, Essex, UK).
To visualize M1 or M2 macrophage phenotypes, macrophages 
were stained for either CD40 (M1) or CD209 (M2). Stimulated 
macrophages, fixed at day 4, were incubated with (1) polyclonal 
rabbit-anti-human CD40 (ab13545, Abcam Cambridge, UK) 
(1:100) or (2) monoclonal mouse-anti-human CD209 (SC-74589, 
Santa Cruz Biotechnology, Inc., Heidelberg, Germany) (1:100) 
both diluted in PBS containing 1% BSA and 2% NGS for 1 h at 
RT. After three washes with PBS, cells were incubated with bioti-
nylated (1) polyclonal goat-anti-rabbit immunoglobulins (E0432, 
Dako, Glosstrup, Denmark) (1:100) or (2) goat-anti-mouse IgG 
(H+L) (1:100) diluted in 1% BSA/ PBS for 1 h at RT. The cells were 
washed with PBS and incubated with streptavidine-CY5 (Invitro-
gen, Grand Island, USA) (1:250) in PBS containing DAPI (1:5000) 
for 1 h at RT. Subsequently, the cells were washed three times 
with PBS, mounted in Citifluor and examined by immunofluores-
cent microscopy using a Leica DMRA microscope equipped with 
a Leica DFC350FX digital camera and Leica Application Suite 
(LAS) software (all Leica Microsystems, Wetzlar, Germany) and 






















For quantification, cells stained for either CD40 (M1) or CD209 
(M2) were imaged using the TissueGnostics TissueFAXS micro-
scope equipped with a Pixelfly camera. TissueQuest was set to 
analyze fluorescent staining based on single cell nuclear identifi-
cation via the DAPI master marker. 
Next fluorescence of either CD40 or CD209 staining outside the 
nucleus was measured. To correct for differences in background 
fluorescence between hydrogels of different stiffness we calcu-
lated the range of intensity. The range of intensity is defined as 
the absolute difference between background fluorescence and 
the staining. The fluorescent range of intensity was analyzed us-
ing the TissueGnostics provided TissueQuest software. 
Six fields of views were stitched together and analyzed using the 
TissueGnostics TissueQuest software, and this was repeated six 
times. Results were visualized in a dot plot scattergram and in-
dividual gates were placed to differentiate between high and 
low expressing cells. Expression gates were set based on 8 bit 
RGB values in the range from 0 to 255. For CD40, gates were set 
at 0-60 (low) and 61-255. For CD209, gates were set at 0-40 (low) 
and 41-255 (high).
STATISTICS
All data are represented as means ± standard error of the mean 
of at least three independent experiments and were analyzed 
by Graph-Pad Prism Version 5 for Macintosh (GraphPad Soft-
ware, Inc., La Jolla, CA, USA) either by one-way ANOVA followed 
by Tukey’s post hoc analysis, or by two-way ANOVA followed by 
Bonferroni post hoc analysis. Values of P < 0.05 were considered 






















MORPHOLOGY AND DIFFERENTIATION OF MONOCYTES TOWARDS 
MACROPHAGES CULTURED ON DIFFERENT STIFFNESS 
CD14+ monocytes were seeded on 4, 12, 26 and 92 kPA gels 
functionalized with collagen type I. Cells adhered similar on all 
gels; after three days of incubation with M-CSF (to induce differ-
entiation of monocytes into macrophages) cells had a compa-
rable morphology irrespective of stiffness. A mixture of rounded, 
spindle-shaped and “pancake”-shaped cells were seen (Fig 1A), 
which indicates that, from a morphological point of view, the 
starting point before differentiation into M1 and M2 subtypes was 
similar. Adhered monocytes differentiated towards macrophages 
irrespective of stiffness, which is shown by a high gene expression 
level of CD68 (general macrophage marker) compared to ref-
erence gene tyrosine 3-monooxygenase/tryptophan 5-monoox-
ygenase activation protein, zeta polypeptide (YWHAZ), positive 
CD68 protein levels (Fig 1C) and a low gene expression of CD14 
(commonly used to identify monocytes) (Fig 1B). 
DIFFERENT STIFFNESS DOES NOT INDUCE POLARIZATION OF PRE-STIM-
ULATED MACROPHAGES TOWARDS M1 OR M2 
Macrophages cultured for three days with M-CSF (pre-stimula-
tion) on collagen type I-coated PAAMs with different stiffness 
showed similar levels of the pro-inflammatory genes that are typi-
cal for M1 macrophages, namely TNF receptor superfamily mem-
ber 5 (CD40), interleukin 1 beta (IL1B) and chemokine (C-C motif) 
ligand 5 (CCL5) (Fig 2A). Comparable gene levels were found 
in the control situation (macrophages cultured on glass coated 
with collagen type I). As was the case with the M1 markers, the 
M2 macrophage markers Dendritic Cell-Specific ICAM-3-Grab-
bing Non-Integrin 1 (CD209), CD1B and mannose receptor C 
type 1 (MRC1) showed similar gene expression levels compared 
to the control (Fig 2B). This indicates that different stiffness did not 
spontaneously induce M1 or M2 polarization of macrophages in 




























































































4 kPa 92 kPa100 µm 100 µm
100 µm 100 µm
Fig. 1
Fig 1. Morphology and differentiation of monocytes towards macrophages cultured on different 
stiffness. Monocytes cultured for 3 days with M-CSF showed on low (4 kPa) and high (92 kPa) stiffness 
a mixture of rounded, spindle-shaped and “pancake”-shaped cells (A). Adherent cells are mac-
rophages as shown by a high expression of general macrophage marker CD68, a low expression of 
monocyte marker CD14 (B) and positive CD68 protein staining (C). No significant differences in gene 
expression and protein levels were observed between the various substrates. Data were analyzed 
using one-way ANOVA followed by Tukey’s post-hoc test. Gene expression analysis n=4. CD68 pro-





















MORPHOLOGY OF MACROPHAGES AFTER M1 OR M2 STIMULATION 
IS NOT INFLUENCED BY DIFFERENT STIFFNESS
Macrophages cultured on 4, 12, 26 and 92 kPa were polarized 
towards M1 or M2 after 24 h stimulation with LPS/IFNγ or IL4/IL13, 
respectively. On all stiffness, M1 macrophages showed a den-
dritic and rounded morphology, while M2 macrophages and un-
stimulated macrophages still showed spindle-shaped and round-
ed cells. Pictures of macrophage morphology cultured on the 
different stiffness are shown in figure 3. The overall morphology 
pointed towards the direction that stimulation with LPS/IFNγ re-
sulted in M1 macrophages irrespective of stiffness, whereas no 
conclusion can be drawn with respect to stimulation with IL4/






















































































































































Fig 2. Different stiffness does not induce polarization of pre-stimulated macrophages towards M1 
or M2. Stiffness alone did not directly skew macrophages towards a M1 or a M2 phenotype. This is 
shown by similar gene levels between different stiffness of M1 markers CD40, IL1B, CCL5 (A) and M2 
markers CD209, CD1B, MRC1 (B). Data were analyzed using one-way ANOVA followed by Tukey’s 





















POLARIZATION OF MACROPHAGES IS NOT INFLUENCED BY DIFFER-
ENT STIFFNESS 
After stimulation with LPS/IFNγ, the M1 marker genes CD40, IL1B, 
CCL5, IL6 and CD14 are upregulated on all stiffness compared to 
IL4/IL13 (M2) stimulated and unstimulated macrophages (Fig 4A). 
It is of importance to notice that although macrophages indeed 
Fig. 3
Fig 3. Morphology of macrophages after M1 or M2 stimulation is not influenced by different stiffness.
After 24 h of stimulation with LPS/IFNγ, M1 macrophages showed a dendritic and rounded morphol-






















polarized towards M1 macrophages, no positive or negative (in-
verse) relationship was seen with respect to gene expression as 
a function of increased stiffness (Fig 4A). This was also the case 
with respect to the percentage CD40-positive cells (Fig 4B-C): it 
is shown that on all stiffness M1 macrophages are strong CD40 
positive compared to M2 and unstimulated macrophages.
Upon IL4/IL13 stimulation, macrophages polarized into M2 mac-
rophages on all stiffness as shown by a high gene expression of 
the M2 markers CD209, CD1B, MRC1, CLEC10A and CCL18 (Fig 
5A) compared to LPS/IFNγ or unstimulated macrophages. Stiff-
ness had no influence on M2 polarization, as shown by the lack of 
statistical differences in gene expression levels of the measured 
M2 genes (Fig 5A). Also no positive or negative correlation with 
stiffness was seen in the percentage CD209-positive cells after 
IL4/IL13 stimulation. Although M2 macrophages are highly posi-
tive for CD209 compared to M1 and unstimulated macrophages, 
no correlation can be seen with regard to increased stiffness. 
 
Unstimulated macrophages did not show phenotypical differ-
ences on PAAMs of various stiffness, as no significant differences 
were seen in all previously mentioned markers, either on mRNA 
level or on protein level (Figs. 4-5). Therefore, stiffness by itself 
did not induce macrophage polarization. Further of interest, the 
control macrophages, which were cultured on collagen type 
I-coated glass cover slips under the same culture conditions, 
show gene expression levels that were comparable with M1, M2 
or unstimulated macrophages on PAAMs, despite the fact that 
the stiffness of glass is orders of magnitudes higher.
All these data show that stiffness does not seem to influence 
macrophage polarization in a positive or negative way. 
DISCUSSION
Our study is, to the best of our knowledge, the first to investigate 
the anti- and pro-inflammatory properties of primary human 
macrophages on a physiological substrate (collagen type I) at 
a physiological stiffness range (4-92 kPa). We have stimulated 
the macrophages with chemical stimuli that macrophages 





































































































































































































































































































































































































12 kPa 26 kPa 92 kPa4 kPa
12 kPa 26 kPa 92 kPa4 kPa
12 kPa 26 kPa 92 kPa4 kPa
Fig. 4
Fig 4. Polarization of macrophages towards a M1 phenotype is not influenced by different stiffness. 
All LPS/IFNγ stimulated macrophages differentiated towards M1 macrophages irrespective of stiff-
ness. M1 macrophages showed significant higher gene levels of pro-inflammatory genes CD40, 
IL1B, CCL5 and IL6 compared to M2 and unstimulated macrophages (A). However, no difference in 
gene expression of CD40, IL1B, CCL5, IL6, and CD14 between stiffness (4 kPa to 92 kPa) was seen in 
M1 polarized macrophages (A). LPS/IFNγ-stimulated macrophages significantly upregulated CD40 
protein levels on all stiffness compared to IL4/IL13-stimulated (M2) and unstimulated macrophag-
es (B, C). Furthermore, unstimulated macrophages showed no polarization towards either M1 or 
M2 macrophages. ** p< 0.01, Difference between LPS/IFNγ-stimulated macrophages (M1) with IL4/
IL13-stimulated (M2) and unstimulated macrophages, *** p<0.001. Gene expression analysis data 
were analyzed using two-way ANOVA followed by Bonferroni’s post-hoc test, n=4. Protein data were 
analyzed using TissueFAXS software and one-way ANOVA followed by Tukey’s post-hoc test using six 















































































































































































































































































































































































































12 kPa 26 kPa 92 kPa4 kPa
12 kPa 26 kPa 92 kPa4 kPa
12 kPa 26 kPa 92 kPa4 kPa
Fig. 5
Fig 5. Polarization of macrophages towards a M2 phenotype is not influenced by different stiffness.
All IL4/IL13-stimulated macrophages differentiated irrespective of stiffness towards M2 macrophages 
as shown by the significant upregulation of the M2 genes CD209, CD1B, MRC1, CLEC10A and CCL18 
compared to M1 macrophages and unstimulated macrophages (A). Stiffness has no influence on 
M2 polarization as shown by comparable gene expression levels of all M2 markers between dif-
ferent stiffness (A). IL4/IL13-stimulated macrophages significantly upregulated CD209 protein lev-
els on all stiffness compared to LPS/IFNγ (M1) and unstimulated macrophages (B, C). Unstimulated 
macrophages showed no polarization towards M2 macrophages. *p< 0.05, Difference between 
IL4/IL13-stimulated macrophages (M2) with LPS/IFNγ-stimulated (M1) and unstimulated macrophag-
es, ** p< 0.01, *** p<0.001. Gene expression analysis data were analyzed using two-way ANOVA 
followed by Bonferroni’s post-hoc test, n=4. Protein data were analyzed using TissueFAXS software 
and one-way ANOVA followed by Tukey’s post-test using six fields of view repeated six times. CD209 





















IL13). Under these conditions, we did not observe differences 
in M1 polarization in relation to stiffness when treated with LPS/
IFNγ, nor did we see differences in M2 polarization when treated 
with IL4/IL13. Neither did we see differences in M1 and M2 mark-
ers in unstimulated macrophages. In fact, also gene expression 
of macrophages subjected to a stiffness > 10 MPa that is orders 
of magnitudes higher than seen in vivo showed comparable 
gene expression levels when compared to hydrogels with a stiff-
ness < 100 kPa. This was the case irrespective whether the mac-
rophages were subjected to LPS/IFNγ and IL4/IL13, or left un-
stimulated. Evidently, substrate stiffness does not seem to have 
an effect on macrophage polarization. 
The effect of stiffness on the inflammatory behavior of human 
macrophages has been investigated in only two other studies. 
Irwin et al. (2008) used the human THP-1 monocytic cell line that 
they activated by means of phorbol myristate acetate (PMA); hy-
drogels with a stiffness of 1.4, 6.0, 9.9 and 348 kPa were used that 
were coated with a peptide containing the Arg-Gly-Asp (RGD) 
motif. No effect was seen for TNFα secretion, whereas IL8 demon-
strated a biphasic response (low at 1.4, 6.0 and 348 kPa, a 2 to 3 
fold increase on 9.9 kPa). Patel et al. (2012) cultured PMA-stimu-
lated human U937 macrophages cell line on PAAMs with a stiff-
ness range of 0.3 to 76.8 kPa, and found a slight decrease in TNFα 
production as a function of stiffness. But both datasets cannot be 
compared with our data, as we used primary cells (not cell lines), 
and we used M1 and M2 stimuli (not PMA). 
Finally, two studies reported the inflammatory behavior of pri-
mary mouse macrophages in relation to stiffness. Previtera and 
Sengupta (2016) differentiated mouse bone marrow monocytes 
to macrophages, subjected them to LPS, and cultured them on 
collagen-coated PAAMs with a stiffness ranging from 0.3 to 230 
kPa. TNFα, NO, and IL1β production was only increased when 
cells were cultured on gels with a stiffness higher than 120 kPa, 
whereas IL6 production started to increase at 47 kPa. Blakney et 
al. (2012) showed, in a similar experimental setup, an increase of 
IL1β, IL6 and IL10 expression at 840 kPa compared to 130 kPa; no 





















pared with our data, as mouse macrophages are phenotypically 
completely different from human macrophages (Martinez et al., 
2013), and gels with a higher stiffness (> 92 kPa), outside the phys-
iological range, were used.
It has been reported that environmental factors influence the 
polarization state of tissue-resident macrophages (Avraham-Da-
vidi et al., 2013, Gosselin et al., 2014, Lavin et al., 2014, Okabe 
and Medzhitov, 2014): the tissue determines macrophage iden-
tity and educates arriving monocytes (Swirski et al., 2016). Inter-
estingly, all the reported factors are of a chemical nature; so far, 
tissue elasticity has not been mentioned in this context. Our data 
clearly recapitulates that substrate stiffness does not affect the 
polarization state of macrophages, but that soluble factors are 
the driving force. However, this does not mean that macrophag-
es are not mechanosensitive. In fact, stiffness can increase the 
attachment of macrophages (Nemir et al., 2010), the shape of 
macrophages can change from rounded to flattened (Fereol 
et al., 2006), phagocytosis is enhanced (Fereol et al., 2006 and 
Scheraga et al., 2016), and the motility is increased (Hind et al., 
2015 and Labernadie et al., 2014). But our data indicate that 
macrophages, when present in a collagen-rich environment in 
a stiffness range as observed in normal tissue and fibrotic tissues 
do not change polarization status as a function of stiffness: it are 
the soluble factors that play a dominant role. Indeed, we have 
previously shown that soluble factors play an orchestrating role 
in the initial priming and later (re)polarization processes of mac-
rophages, while the type (chemistry) of ECM molecules (colla-
gen or fibronectin) is of secondary importance. We can now add 
the elastic properties of the ECM to this list as well. This is in strong 
contrast to the situation seen with fibroblasts: here, tissue stiffen-
ing is sufficient to generate a self-sustaining fibrotic process by 
virtue of activation of fibroblasts via a feedback loop (Liu et al., 
2010). 
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ABSTRACT
Macrophage fusion and subsequent foreign body cell (FBGC) 
formation, important phenomena in the foreign body reaction 
towards implanted biomaterials, are not well understood. By 
using fibronectin-coated polyacryalamide hydrogels (PAAMs) 
of different stiffness (4-92 kPa) we investigated for the first time 
whether stiffness is involved in the formation of FBGC. Human 
CD14+ monocytes pre-stimulated with M-CSF for 3 days on 4, 12, 
26 and 92 kPa PAAMs showed already small multinucleated cells 
on 12 and 26 kPa hydrogels, whereas only mononucleated mac-
rophages were observed at lower (4 kPa) and higher (92 kPa) 
stiffness. Macrophages that were subsequently left unstimulated 
or stimulated with IL4/IL13 for 24 h, showed large FBGC on 12 kPa 
and 26 kPa hydrogels, whereas only small multinucleated cells 
were seen on 92 kPa hydrogels and no multinucleated cells on 4 
kPa hydrogels. IL4/IL13 had only a promoting role: at 12 kPa gels 
FBGC with more nuclei were observed, whereas similar amounts 
of FBGC and nuclei per giant cell were observed at 26 kPa gels. 
We have measured in addition some of the mediators that have 
been reported to be important in macrophage fusion: CD36, 
CD44, dendritic cell-specific transmembrane protein DCSTAMP, 
lymphocyte co-stimulator B7H1, E-cadherin, P2X7 receptor, DNAX 
activation protein 12, and the matrix metalloproteinases 9 and 
14. No relationship was found between FBGC frequencies and 
the level of these mediators. In conclusion, the data show that 
stiffness plays an important role in the formation of FBGC, and 


























Implantation of a biomaterial provokes an inflammatory reaction 
called the foreign body reaction (FBR) [1-4]. Implantation initiates 
a wound healing response, and proteins such as albumin, fibrin-
ogen, vitronectin and fibronectin attach to the biomaterial and 
form a provisional matrix [5,6]. Macrophages migrate towards 
the implantation site, interact with the provisional matrix and try 
to invade and degrade the biomaterial by phagocytosis and/or 
the secretion of proteinases [2,7,8]. In the FBR, M2 macrophag-
es (the wound healing macrophage phenotype induced by the 
cytokines IL4/IL13 produced by T helper 2 lymphocytes) stimulate 
(myo)fibroblast proliferation and extracellular matrix deposition, 
which at the end leads to fibrosis or a fibrotic capsule around the 
biomaterial [6,9-11].
A distinctive feature of the FBR is the formation of foreign body 
giant cells (FBGC), which occurs through fusion of macrophages. 
FBGC can contain over one hundred randomly distributed nu-
clei embedded in a plethora of cytoplasm [2,12,13]. Before mac-
rophages are able to fuse and form FBGC, the cells have to be-
come fusion-competent. Adhesion to a substratum, chemotaxis 
and soluble stimuli are crucial for macrophage fusion [14]. During 
the formation of FBGC, macrophages express specific adhesion 
molecules that interact with the provisional matrix and/or extra-
cellular matrix (ECM) proteins. It has been shown that β1 and 
β2 integrins are required to mediate IL4-induced macrophage 
adhesion and fusion [15], and that the classic fibronectin recep-
tor, α5β1 integrin, is strongly expressed during this process [16]. 
Additionally, biomaterial characteristics such as chemical com-
position and surface roughness may affect the formation and 
function of FBGC [17-22]. 
 It has been shown that IL4/IL13 induces, besides M2 macrophage 
polarization, macrophage fusion and FBGC formation both in vit-
ro and in vivo [20,23,24]. Much effort has been directed to unrav-
el the role of cytokines, the composition of the provisional matrix 
and the biomaterial properties with regard to macrophage fu-
sion and FBCG formation. However, so far no studies determined 

























studies carried out so far have used materials that are much (of-
ten magnitudes) stiffer than normal tissues. Hence, in the current 
paper we investigated the role of stiffness on the formation of 
FBGC. We used hydrogels with a stiffness of 4, 12, 26 and 92 kPa 
coated with plasma-derived fibronectin. We used fibronectin, as 
this is one of the major components of the provisional matrix [5,6]. 
Experiments were carried out with blood-derived human mono-
cytes that were differentiated into macrophages by means of 
macrophage colony-stimulating factor (M-CSF), which were sub-
sequently treated with or without the combination IL4/IL13. Much 
to our surprise, we observed already after 72 hours of pre-stimu-
lation with M-CSF macrophage fusion and small multinucleated 
cells on 12 and 26 kPa hydrogels, while only mononuclear cells 
were seen on 4 and 92 kPa hydrogels. An increase in FBGC was 
observed after IL4/IL13 stimulation that was also substrate stiff-
ness-dependent, starting at 12 kPa, with an optimum at 26 kPa, 
and much less FBGC at 92 kPa hydrogels. Lower (4 kPa) stiffness 
showed no FBGC formation. This indicates a crucial role for stiff-
ness in macrophage fusion and the formation of FBGC.
MATERIAL AND METHODS
PREPARATION OF POLYACRYLAMIDE HYDROGELS (PAAMS)
PAAMs were prepared between a chemically modified glass 
coverslip and glass plate as described in our recent publication 
[25]. In brief, glass coverslips (VWR, Amsterdam, Netherlands) 
were pre-treated for 3 minutes with a freshly prepared solution 
consisting of 99.1% (v/v) ethanol, 0.5% (v/v) 3-(trimethoxysilyl)
propyl methacrylate (Sigma-Aldrich, St. Louis, USA, M6514) and 
0.3% (v/v) glacial acetic acid to facilitate covalent adhesion of 
the polymerizing PAAM solutions. After incubation, the glass cov-
erslips were washed twice with 99.9% ethanol. The glass plate 
was sterilized by immersion in 99.9% ethanol followed by chemi-
cal modification with dichlorodimethylsilane (Merck, Darmstadt, 
Germany, 8034520) on top during 5 minutes. Subsequently the 
glass plate was washed with sterile water. 
The varying degrees of stiffness of the PAAMs were obtained by 
varying the ratio between 40% acrylamide (BioRad, Veenendaal, 

























Veenendaal, Netherlands, #161-0142) as described previously 
[25]. Solutions were diluted in 10 mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid buffer (HEPES Sigma-Aldrich, St. Louis, 
USA, H0887). To catalyze PAAM polymerization 0.15%  N,N,N’,N’-te-
tramethylethylenediamine (TEMED, BioRad, Veenendaal, Neth-
erlands, #161-0800, final concentration) was added. The solution 
was deoxygenated under argon for 30 minutes and 10% ammo-
nium persulfate (Sigma-Aldrich, St. Louis, USA, A3678) was added 
to initiate polymerization. The polymerizing solution was pipetted 
onto the modified glass plate followed by placing a modified 
coverslip on top. PAAMs were left to polymerize for 15 minutes. 
Coverslips with adherent PAAMs were flipped with tweezers, 
placed in either a 12 or 48 wells culture plate and washed twice 
with PBS.
PAAM FUNCTIONALIZATION WITH L-DOPA AND FIBRONECTIN
In order to functionalize the surface of the PAAMs, 3,4-dihy-
droxy-L-phenylalanine (L-DOPA; Sigma-Aldrich, St. Louis, USA, 
D9628) was used as described in our previous paper [25]. In brief, 
L-DOPA was reconstituted in 10 mM Tris buffer (pH 10) to a fi-
nal concentration of 2 mg/ml and left to dissolve for 30 minutes 
in the dark in continuous motion. The L-DOPA solution was filter 
sterilized (0.20 µm) and PAAMs were incubated with 250 µg/cm2 
L-DOPA for 30 minutes in the dark. Subsequently, PAAMs were 
washed twice with PBS and functionalized with 2.5 µg/cm2 plas-
ma-derived fibronectin (Sigma-Aldrich, St. Louis, USA, F1141) in 
PBS for 2 hours at 37°C. After incubation, gels were washed with 
PBS and left overnight in Minimum Essential Medium Alpha Mod-
ification (MEMα) (ThermoFisher Scientific, Waltham, USA) without 
additives at 37°C until the isolated CD14+ cell could be seeded.
ISOLATION OF CD14+ CELLS
To obtain a >99% pure CD14+ cell population, CD14+ cells were 
isolated by immuno-magnetic bead separation using CD14 Mi-
crobeads (Miltenyi Biotec, Leiden, Netherlands) as described 
previously [26]. In brief, human peripheral blood mononuclear 
cells (PBMCs) were isolated from buffy coats (Sanquin, Gronin-
gen, Netherlands) from four healthy donors by LymphoPrep 

























counted with a Coulter Counter (Beckman Coulter, Brea, USA) 
before immuno-magnetic bead separation. In brief, 20 μl of 
CD14 Microbeads and 80 μl isolation buffer, consisting of phos-
phate buffered saline (PBS), 0.5% fetal bovine serum (FBS; Life 
Technologies Europe, Bleiswijk, Netherlands) and 2 mM EDTA 
(Merck, Darmstadt, Germany) were added per 1 × 107 PBMCs 
and cells were incubated on ice for 30 min. Cells were washed 
with isolation buffer and the suspension containing CD14 labeled 
cells was centrifuged at 300 × g at 4°C for 10 min to remove any 
unbound CD14 beads. The cell pellet was resuspended in de-
gassed isolation buffer and the CD14+ cells were separated with 
an LS column (Miltenyi Biotec, Leiden, Netherlands) placed on a 
column adapter in a magnetic field. After carefully washing with 
degassed isolation buffer the LS column was removed from the 
magnetic field and the CD14+ cells were quickly flushed from the 
column using a plunger.
The obtained CD14+ cells were counted using a Coulter Counter 
and gently resuspended in culture medium consisting of MEMα 
(ThermoFisher Scientific, Waltham, USA) supplemented with 1% 
penicillin/streptomycin (Sigma-Aldrich, St. Louis, USA) and 10% 
HyClone FetalClone I Serum (FCI) (GE Healthcare, Utah, USA).
MACROPHAGE CELL-ON-GEL CULTURE AND INDUCTION OF GIANT 
CELL FORMATION
CD14+ positive cells isolated in the previous paragraph were 
plated at a density of 300,000 cells/cm2 onto PAAMs with vary-
ing degrees of stiffness functionalized with fibronectin. Cells were 
cultured in culture medium (see above) supplemented with 10 
ng/ml recombinant human M-CSF (R&D Systems, Minneapolis, 
USA) at 37°C under 5% CO2. After 3 days of M-CSF treatment all 
non-adherent cells were removed by gently replacing the me-
dia with culture medium without M-CSF. This culture medium was 
either supplemented with 2 ng/ml IL4 + 2 ng/ml IL13 (both R&D, 
Minneapolis, USA) to induce giant cell formation, or without IL4/
IL13 (no stimulation) to study the effect of substrate stiffness on 
giant cell formation, for 24 hours. 

























on the different PAAMs were characterized by morphology, qRT-
PCR and by immunofluorescent stainings/quantification.   
RNA ISOLATION, CDNA SYNTHESIS AND QRT-PCR
To obtain total RNA the RNeasy Kit (Qiagen, Hilden, Germany) 
was used in accordance to the manufacturer’s protocol. After 
isolation RNA concentration and purity were determined by UV 
spectrophotometry (NanoDrop Technologies, Wilmington, NC, 
USA). For gene expression analysis, total RNA was reverse tran-
scribed using the First Strand cDNA synthesis kit (Fermentas UAB, 
Lithuania) using random hexamer primers in accordance to the 
manufacturer’s protocol. Gene expression quantification was 
performed using qRT-PCR analysis in a final reaction volume of 10 
μl, consisting of 1x SYBR Green Supermix (Roche, Basel, Switzer-
land), 6 μM forward primer, 6 μM reverse primer (Table 1) and 5 
ng cDNA. Reactions were performed at 95°C for 10 min followed 
by: 95°C for 15 sec, 60°C for 60 sec, total of 40 cycles in a ViiA™ 
7 Real-Time PCR System (Applied Biosystems, CA, USA). Analysis 
of the data was performed using ViiA 7™ Real-Time PCR System 
Software v1.3 (Applied Biosystems, CA, USA).
IMMUNOFLUORESCENT STAININGS FOR PHALLOIDIN CD44 AND DC-
STAMP ON MACROPHAGES AND GIANT CELLS
PHALLOIDIN  
Pre- and stimulated macrophages (day 3 and 4 of culture) were 
washed twice with PBS and fixed in 2% PFA at room tempera-
ture for 10 min. To visualize the outer rim of both single nuclei 
and giant cells, cells were stained with the F-actin binding toxic 
phalloidin and counterstained with DAPI to visualize the nuclei. 
Phalloidin was pre-labeled with a TRITC fluorescent label (P1951, 
Sigma-Aldrich, St. Louis, USA). Whole wells were imaged using 
the TissueGnostics TissueFAXS equipped with a Plan-Neofluar 10x 
lens and a pixelfly camera. FBGC formation was quantified by 
counting the amount of nuclei per FBGC in 4 FOVs, and this was 
repeated for 5 times. Fusion index was grouped into 3-5, 6-10, 11-

























CD44 AND DC-STAMP 
To visualize the membrane markers CD44 and DC-STAMP, PFA-fix-
ated macrophages/FBGC cultured on hydrogels were incubat-
ed with 10% goat serum for 1 h.  Cells were incubated over-
night at 4°C with either (1) mouse monoclonal to CD44 (M7082, 
DAKO, Glosstrup, Denmark; 1:100) or (2) mouse monoclonal to 
DC-STAMP (MAB7824, R&D Systems, Minneapolis, USA, 1:1000) in 
PBS containing 2.2% bovine serum albumin (BSA). The next day 
cells were washed three times with PBS and incubated with bi-
otinylated goat-anti-mouse IgG(H+L) (1031-08, SouthernBiotech, 

























h at RT. In the last step, cells were washed three times with PBS 
and incubated with streptavidin-Alexa647 (S32357, ThermoFisher 
Scientific, Waltham, USA 1:1000) in DAPI (1:5000 in PBS) for 30 min. 
After three washes with PBS, slides were mounted in Citifluor (Agar 
Scientific, Essex, UK). Both CD44 and DC-STAMP were visualized 
using a Leica DM4000b fluorescence microscope equipped with 
a Leica DFC3000 G digital camera and Leica Application Suite 
(LAS) software (Leica Microsystems, Wetzlar, Germany) using a 
20x objective. Overlays were made using the FIJI ImageJ soft-
ware.
STATISTICS
All data are represented as means ± standard error of the mean 
of at least three independent experiments and were analyzed 
by Graph-Pad Prism Graph-Pad Prism Version 7 for Macintosh 
(GraphPadSoftware, Inc., La Jolla, CA, USA) either by one-way 
ANOVA followed by Tukey’s post hoc analysis, or by two-way 
ANOVA followed by Bonferroni post hoc analysis. Values of P < 
0.05 were considered to be statistically significant.
RESULTS
MACROPHAGE DIFFERENTIATION AND MORPHOLOGY AFTER 
PRE-STIMULATION WITH M-CSF
To assess the effect of stiffness on macrophage morphology and 
differentiation, human CD14+ monocytes isolated from buffy 
coats from four healthy donors were seeded on 4, 12, 26 and 
92 kPa PAAMs functionalized with fibronectin and pre-stimulated 
with M-CSF for 3 days to induce macrophage differentiation. On 
all stiffness a mixture of rounded, “pan-cake” and spindle-shaped 
macrophages were observed by bright-field microscopy, and 
by visualizing F-actin filaments with TRITC-labeled phalloidin (Fig. 
1A). As expected, stimulation with M-CSF differentiated mono-
cytes into macrophages irrespective of stiffness, which is shown 
by a high gene expression level of CD68 relative to the reference 
gene tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta polypeptide (YWHAZ) (Fig. 1B).
To our surprise, small multinucleated cells (maximum 3 nuclei) 

























on 12 kPa and 26 kPa hydrogels (Fig. 1A). In contrast, no multi-
nucleated cells were observed on 4 kPa or 92 kPa PAAMs. This 
indicates that a stiffness value as observed in fibrotic tissues and 
fibrotic capsules can induce macrophage fusion in the absence 
of cytokines such as IL4 or IL13.
M2 POLARIZATION AND FBGC FORMATION
M2 macrophage polarization and FBGC formation can both be 
induced by stimulating the cells with IL4/IL13 [23,24]. Therefore, 
CD68+ macrophages formed after pre-stimulation with M-CSF 
were subjected to IL4/IL13; culture medium without IL4/IL13 was 
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Fig. 1. Morphology of differentiated macrophages.
Macrophages pre-stimulated with M-CSF for 3 days show on 4 kPa, 12 kPa, 26 kPa and 92 kPa stiffness 
a mixture of rounded, “pancake”- and spindle-shaped cells as shown in bright-field pictures and by 
visualization of F-actin filaments with phalloidin (A). Small-nucleated cells were observed at 12 kPa 
and 26 kPa gels (arrowheads). Adherent monocytes differentiated towards macrophages as shown 
by a high expression of the general macrophage marker CD68 relative to the control gene YWHAZ 






























































































































































































































































































Fig. 2. M2 polarization and foreign body giant cell formation. 
IL4/IL13-stimulated macrophages differentiated, irrespective of stiffness, towards M2 macrophages 
as shown by the significant upregulation of the M2 genes MRC1, CD209, and CD1B compared to 
unstimulated macrophages (A). Pre-stimulation with M-CSF induced a M2-”like” macrophage phe-
notype as shown by the comparable high gene expression of IL1R2 in all macrophages (A). Large 
FBGC (arrows) were observed on 12 kPa and 26 kPa in unstimulated macrophages (stiffness-induced 
fusion) and IL4/IL13-stimulated macrophages (B). Only small FBGC (arrowheads) were observed at 
92 kPa , whereas no fusion occurs on 4 kPa gels (B). (C) Quantification of FBGC (fusion index) on the 
different stiffness and stimulations. * p< 0.05, Difference between unstimulated macrophages and 
IL4/IL13-stimulated (M2) macrophages, ** p<0.01, *** p<0.001. Gene expression analysis data were 
analyzed using two-way ANOVA followed by Bonferroni’s post-hoc test, n=4. F-actin filaments are 

























After 24 h of stimulation with IL4/IL13 the macrophages adopt-
ed, as expected, a M2 phenotype, as reflected by an upregu-
lated gene expression of the M2 markers mannose receptor C 
type 1(MRC1), CD209 and CD1B compared to non-treated mac-
rophages (Fig. 2A). It should be stressed that pre-stimulation with 
M-CSF already induced, as reported previously [26,27], on all stiff-
ness a more or less “M2-like” phenotype, as shown by a compa-
rably high gene expression level of interleukin 1 receptor, type II 
(IL1R2) in non-treated macrophages (Fig. 2A).
The direct influence of stiffness on FBGC formation is shown by 
macrophages that were left unstimulated (i.e. cultured without 
IL4/IL13). We already showed that during pre-stimulation, small 
multinucleated cells were formed on 12 and 26 kPa gels (Fig. 1A). 
When the macrophages were subsequently left unstimulated for 
24 hours, we observed a marked increase in both the number 
of FBGC, as well as the size of the FBGC (containing >5 to 50+ 
random distributed nuclei and extensively spread cytoplasm) on 
12 and 26 kPa gels (Fig. 2B). In contrast, only small multinucleat-
ed cells (maximum 3 nuclei) were seen on 92 kPa gels (Fig. 2B), 
whereas   no FBGC were seen on 4 kPa gels. Similar observations 
were made with macrophages stimulated with IL4/IL13: on 12 and 
26 kPa gels large FBGC were seen, which was in contrast to small 
multinucleated cells on 92 kPa PAAMs (Fig. 2B) and no FBGC on 
4 kPa gels. IL4/IL13 stimulation induced FBGC with more nuclei on 
12 kPa PAAMs compared to FBGC formed by non-treated mac-
rophages (Fig. 2C), whereas similar amounts of giant cells and 
nuclei were observed on 26 kPa (Fig. 2C).
These results show that stiffness has an important role in inducing 


























FUSION MEDIATORS INVOLVED IN STIFFNESS OR/ AND IL4/IL13 IN-
DUCED FBGC FORMATION 
Mediators reported to be important in IL4/IL13-induced mac-
rophage fusion are CD44, dendritic cell-specific transmembrane 
protein (DCSTAMP), CD36, lymphocyte co-stimulator B7H1, 
E-cadherin (CDH1), P2X7 receptor (P2RX7), DNAX activation pro-
tein 12 (DAP12), matrix metalloproteinase 9 (MMP9) and MMP14 
[28-38]. We have measured the mRNA levels of the respective 
genes in macrophages exposed to IL4/IL13, as well as control 
macrophages (not exposed to IL4/IL13). No differences were 
observed in CD44, DCSTAMP, CD36, CDH1, P2RX7, MMP9 and 



































































































































































































































Fig. 3. Fusion mediators involved in stiffness and/or IL4/IL13-induced FBGC formation.
Gene expression levels of known fusion mediators, CD44, DCSTAMP, CD36, B7H1, CDH1, P2RX7, 
DAP12, MMP9 and MMP14 in unstimulated (stiffness-induced fusion) macrophages and IL4/IL13-stim-
ulated (cytokine-inuced fusion) macrophages.  ** p< 0.01, Difference between unstimulated mac-
rophages and IL4/IL13-stimulated macrophages. # p<0.05 Difference in gene expression between 
the different stiffness in unstimulated macrophages or in IL4/IL13-stimulated macrophages, ### p< 
0.001. Gene expression analysis data were analyzed using two-way ANOVA followed by Bonferroni’s 

























on 4, 12, 26 and 92 kPa hydrogels. B7H1 and DAP12 showed high-
er expression levels on 4 kPa compared to 26 and 92 kPa (both 
for B7H1 and DAP12) and 12 kPa (for DAP12 only). Since many 
more (and larger) FBGC were formed on 12 and 26 kPa, none 
of the genes show a correlation with FBGC formation. The same 
can be said for macrophages that were not exposed to IL4/IL13: 
mRNA levels of CD44, DCSTAMP, B7H1, CDH1 and MMP9 were 
not different between cells cultured on 4, 12, 26 and 92 kPa hy-
drogels. In fact, CD36, P2RX7, DAP12 and MMP14 are more highly 
expressed on 4 kPa hydrogels compared to 12 and/or 26 kPa, but 
no multinucleated cells are seen on 4 kPa gels, compared to an 
abundance of large FBGC on 12 and 26 kPa. Although IL4/IL13 in-
duced higher expression levels of B7H1 on 12 kPa gels compared 
to non-stimulated macrophages (and can thus be correlated to 
the increased FBGC formation of IL4/IL13 stimulated macrophag-
es on 12 kPa), the same was seen for 4 and 92 kPa (i.e. in condi-
tions were FBGC formation was absent and minor, respectively) 
or 26 kPa (i.e. in a condition were FBGC formation was equally 
abundant between non-stimulated or IL4/IL13 stimulated mac-
rophages).
Finally, we stained for the membrane proteins CD44 and DC-
STAMP to further validate that these proteins cannot be consid-
ered as specific fusion-related markers (Figs 4, 5). Indeed, CD44 
was present on all non-stimulated and IL4/IL13-stimulated mac-
rophages and FBGC, irrespective of gel stiffness (Fig. 4). Even a 
high protein expression of CD44 is observed at a stiffness of 4 kPa, 
a stiffness that prohibits fusion of macrophages. Similarly, single 
macrophages and FBGC were highly positive for DC-STAMP pro-
tein on all stiffness and stimulations (Fig. 5): no obvious differenc-



























B IL4/IL13 stim. macrophages
4 kPa 12 kPa 26 kPa 92 kPa







100 µm 100 µm 100 µm 100 µm
100 µm 100 µm 100 µm 100 µm
Fig. 4. Protein expression of CD44 in macrophages and FBGC. 
Unstimulated macrophages and IL4/IL13-stimulated macrophages on all stiffness showed high pro-
tein expression of CD44, as well as stiffness-induced and IL4/IL13-induced FBGC. CD44 protein ex-
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Fig. 5. Protein expression of DC-STAMP in macrophages and FBGC.
All macrophages (unstimulated or IL4/IL13-stimulated) on all stiffness show a high protein expression 
of DC-STAMP, as well as stiffness-induced and IL4/IL13-induced FBGC. DC-STAMP protein expression 


























Biomaterials display a wide variety of different characteristics 
such as stiffness, chemical composition, or surface roughness, 
which all can influence the course and nature of the FBR. The 
FBR can generally be divided into three phases: the onset phase, 
the progression phase and the resolution phase. The onset phase 
starts directly after implantation of the biomaterial were proteins 
(such as fibronectin) adsorb to the biomaterial and an acute in-
flammation reaction occurs, consisting of infiltrating leukocytes 
and macrophages. In the progression phase a transition from 
acute to chronic inflammation can be observed, which include 
macrophages and the formation of FBGC. These cells secrete 
factors that attract and activate fibroblasts, which in their turn 
secrete extracellular matrix proteins for the formation of a fibrotic 
capsule around the biomaterial. In the resolution phase, which 
is still hardly understood, macrophages and FBGC often persist 
during the entire life-time of an implant. 
In this study we investigated the role of stiffness in the range 4-92 
kPa on the fusion of macrophages and the formation of FBGC 
in a fibronectin-rich environment. To the best of our knowledge 
this is the first time that stiffness is used as a parameter to study 
macrophage fusion. We used freshly isolated CD14+ human 
monocytes and differentiated the cells towards macrophag-
es by M-CSF stimulation on fibronectin-coated 4, 12, 26 and 92 
kPa PAAMs. We observed small multinucleated cells on 12 and 
26 kPa hydrogels, whereas only mononucleated macrophag-
es were observed at lower (4 kPa) and higher (92 kPa) stiffness. 
This already shows that certain stiffness values can induce mac-
rophage fusion.
Macrophages were subsequently left unstimulated or were stimu-
lated with IL4/IL13, cytokines that are known to induce the forma-
tion of FBGC [23,24,39-41]. After 24 hours, in both cultures, large 
FBGC are observed on 12 kPa and 26 kPa hydrogels, whereas 
only small multinucleated cells were seen on 92 kPa hydrogels 

























IL4/IL13 stimulation induced FBGC with more nuclei compared 
to the unstimulated macrophages. However, similar amounts of 
FBGC and nuclei per giant cell were observed at 26 kPa gels be-
tween stimulated and unstimulated cultures. This demonstrates 
that stiffness plays an important role in the formation of FBGC 
with only a facilitating role for IL4/IL13. 
Several studies identified crucial fusion mediators during the for-
mation of FBGC. Here we investigated several of these known 
fusion-mediators and explored their involvement in stiffness-in-
duced FBGC formation. The cell-surface glycoprotein CD44 has 
been reported to be involved in the onset of macrophage fusion 
[42]. CD44 enables cell-cell adhesion/fusion of macrophage by 
binding to a yet unknown ligand; blocking this binding prevents 
the formation of multinucleated cells [42]. Our results show that 
CD44 gene expression was equal in macrophages in all condi-
tions and stiffness. CD44 protein expression was present on all 
macrophages, even on macrophages cultured at 4 kPa where 
no fusion occurs.  We conclude that the cells cultured on 4 kPa 
gels fail to express the putative binding partner of CD44, whereas 
it is expressed on macrophages cultured on 12, 26 and 92 kPa 
gels.
DC-STAMP is shown to be crucial for macrophage fusion and 
FBGC formation. DC-STAMP deficient macrophages are not able 
to fuse or become multinucleated cells, both in vivo and in vitro 
[29,31,34]. Here we show that gene expression levels and pro-
tein expression of DC-STAMP is prominently present in all different 
conditions (Figs. 3 and 5). In fact, single macrophages and FBGC 
were both highly positive for DC-STAMP protein on all stiffness 
and treatments (Fig. 5). Gene expression levels of DCSTAMP were 
upregulated in macrophages stimulated with IL4/IL13 compared 
to non-treated macrophages at all stiffness. However, the higher 
levels of DCSTAMP do not seem to be associated with the gen-
erally increased FBGC formation of IL4/IL13 treated cells, as no 
differences in gene expression were observed between non-fus-
ing macrophages at 4 kPa and fusing macrophages at 12-92 kPa 
gels. It is known that DC-STAMP must interact with a ligand in or-

























ligand is unknown. We hypothesize that this ligand is not present 
on macrophages cultured on 4 kPa gels.
DAP12 is considered to be required for FBGC formation in an indi-
rect way: it is not directly involved in fusion but rather necessary 
for the upregulation of the fusion mediators CDH1, DCSTAMP and 
MMP9, and therefore crucial in the fusion process [14,30]. Here 
we show that a high DAP12 gene expression is observed in all 
stimulated and non-stimulated macrophages, although DAP12 is 
upregulated in macrophages cultured on 4 kPa hydrogels com-
pared to macrophages cultured on 12, 26 and 92 kPa. We did 
not find a relationship between mRNA levels of DAP12 with CDH1, 
DCSTAMP and MMP9.
It has been reported that CDH1 has a role in cell-cell adhesion by 
macrophage fusion and that it is upregulated within hours after 
stimulation with IL4 and IL13 [14,32]. However, we observed only 
low mRNA levels, even after 24 hours of stimulation, and these 
levels did not correlate with fusion frequencies. In our experimen-
tal setting fusion of macrophages seems to be E-cadherin inde-
pendent. 
MMP9 and MMP14 are proteases involved in migration. It has 
been described that blocking of MMP9 reduces the formation 
of FBGC [36]. On the other hand, Jones et al. reported that ad-
dition of IL4 to macrophage cultures decreased MMP9 levels on 
the majority of their tested surfaces [44]. MMP14 acts in an indi-
rect manner in the fusion process: it forms a complex with CD44, 
co-localizes with the actin cytoskeleton and activates Rac1 in 
the lamellipodia, which in turn is crucial for macrophage migra-
tion and fusion [45-47]. In our results both MMP9 and MMP14 show 
a high expression in macrophages on all stiffness and this was 
independent of IL4/IL13 stimulation. Furthermore, nor relationship 
was found between MMP9 and MMP14 mRNA levels and fusion 
frequencies.
CD36 is localized within the lamellipodia and participates in fu-
sion in a heterotypic manner after initial cell-cell contact has 

























formation, it is not upregulated after IL4 stimulation, which sug-
gest that fusion-competent macrophages only increase a part 
of the required fusion mediators [14]. Indeed, we observed no 
differences in gene expression of CD36 in unstimulated and IL4/
IL13 stimulated macrophages and FBGC on all stiffness.
McNally et al. [35] showed a strong upregulation of B7H1 only 
in fusion-competent macrophages and FBGC, and consider it 
an important FBGC marker. We observed an up-regulated gene 
expression after IL4/IL13 stimulation, however this upregulation 
is also highly present in macrophages cultured on 4 kPa hydro-
gels were no macrophage fusion occurs. These macrophages 
even show a significant upregulation of B7H1 compared to mac-
rophages cultured on 12, 26 and 92 kPa were FBGC formation 
did occur. In contrast, unstimulated macrophages showed no 
upregulation of B7H1 on all stiffness, whereas on 12, 26 and 92 
kPa FBGC were observed. In our experimental setting, B7H1 does 
not seem to be restricted to fusion-competent cells.
P2X7 receptor, a member of the family of P2X purinergic recep-
tors, triggers the formation of membrane pores after activation 
by extracellular ATP [14,33,37]. Activation of P2X7 receptor is as-
sociated with increased macrophage fusion and the formation of 
FBGC, however the P2X7 receptor is not a requirement for fusion 
[37]. Here, no differences in gene expression levels were seen be-
tween unstimulated an IL4/IL13-induced FBGC, with the excep-
tion for unstimulated macrophages on 4 kPa hydrogels that show 
an upregulated P2X7 receptor. Since unstimulated macrophag-
es on 4 kPa do not show FBGC formation, the presence of P2X7 
alone is not sufficient the stimulate fusion.
Overall, our results show that stiffness has a major impact on the 
fusion of macrophages, and that stiffness-induced fusion can 
occur in the absence of IL4/IL13. Fibrotic capsules surrounding 
biomaterials exhibit a stiffness that falls in the range in which we 
observed enhanced fusion rates, and it is therefore not a surprise 
that FBGC are often present in such capsules. Lower stiffness, seen 
in normal tissues, did not induce macrophage fusion. The role 

























but it is likely that their reactions at the surface of a biomaterial 
play an important role in directing biological responses. Specific 
modulation of certain aspects of the foreign body reaction will 
be required to achieve the desired performance of biomaterials 
[Anderson 2008]. The stiffness of the biomaterial and its surround-
ings should be taken into consideration in such interventions. It is 
also obvious that our knowledge on the molecules that facilitate 
the fusion process of macrophages is still fragmentary, as we did 
not found a relationship between the extent of FBGC formation 
and the presence of molecules reported to be important in the 
fusion process. 
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Macrophage multinucleation plays an important role in the on-
set of the foreign body reaction and can be induced in vitro by 
means of IL4 and IL131,2. The level of macrophage multinuclea-
tion is dependent on the presence of certain cytokines1–4, cell-
cell and cell-biomaterial interactions5–7. Inability of macrophages 
to phagocytose non-degradable biomaterials results in a chronic 
inflammatory response and an extended foreign body reaction. 
Fibrotic encapsulation by tissue-resident fibroblasts and mac-
rophage multinucleation into foreign body giant cells are hall-
marks of this response.
Although a plethora of material surface characteristics have 
been studied for their capability to induce giant cell formation7,8 
the role of biomaterial surface stiffness has so far been neglected. 
In our recent (unpublished) research, we observed an extracellu-
lar matrix (ECM) and stiffness-dependent effect on macrophage 
multinucleation. In this mini-review, we describe in depth the 
CD44-RAC1 pathway, to elucidate the role of this pathway in the 
mechano-regulated fusion of macrophages.
THE CYTOSKELETON DURING MACROPHAGE MULTINUCLEATION
The cytoskeleton is of paramount importance for normal mac-
rophage behavior: cell spreading9, movement10,11, phagocyto-
sis12 and even macrophage-to-macrophage fusion13,14 can only 
be achieved with an active and intact cytoskeleton. CD44, de-
scribed in literature as a macrophage multinucleation marker, 
directly regulates the macrophage cytoskeleton through RAC1. 
The cytoskeleton, as described before in this thesis, plays an im-
portant role in mechanosensing in mammalian cells.
CD44
CD44, a cell-surface glycoprotein involved in cell-cell and cell-
ECM interactions, is proposed as a candidate protein in ECM 
and stiffness-induced multinucleation. CD44 is expressed by most 
mammalian cell types and was first classified as the receptor for 
hyaluronic acid15–17, although it can also interact with other lig-
ands including osteopontin (OPN, produced by e.g. osteoblasts), 




























our interest as MMPs18,19, fibronectin7 and CD44 are described 
in the literature as crucial factors for macrophage multinucle-
ation20–22. CD44 can interact with fibronectin (specifically the 
COOH terminus)23, which might explain the increased multinu-
cleation observed when culturing macrophages on fibronec-
tin-functionalized hydrogels (Chapter 4), when compared to col-
lagen type I functionalized hydrogels (Chapter 3).
In at least three independent studies, CD44 upregulation was 
observed during macrophage multinucleation15,20,21. More spe-
cifically, translocation of the CD44 intracellular domain (CD44-
ICD), after cleavage by y-secretase, induced macrophage 
multinucleation. Inhibition of y-secretase cleavage by a specific 
inhibitor, DAPT, resulted in an attenuation of macrophage multi-
nucleation. This attenuation could be reversed by retroviral over-
expression of the CD44-ICD21. Overexpression of the full CD44 
receptor or the transmembrane and intracellular domain did 
not induce any macrophage multinucleation, as this does not 
increase the CD44-ICD form21. This means that the ICD of CD44 is 
necessary for macrophage fusion. We however, did not observe 
any differences in CD44 receptor expression between cells cul-
tured on hydrogels with different stiffness, while we did observe 
large differences in multinucleation. All cells stained CD44-posi-
tive, independent of surface stiffness, as was the case for mRNA 
levels of CD44 (Figure 2).
CD44 AND RAC1
Macrophages are known for extensively modulating their cy-
toskeleton during both phagocytosis10,12 and multinucleation13. 
Multinucleation and phagocytosis can happen both simultane-
ously and independently. 
Inhibitors of F-actin polymerization can also directly attenuate 
and inhibit macrophage fusion13,14, further outlining a role for the 
cytoskeleton in multinucleation. CD44 might play a pivotal role in 
these cytoskeletal reorganizations as it can regulate, via TIAM1, 
RAC1 (Ras-related C3 botulinum toxin substrate 1). RAC1 is a plei-
otropic GTPase which belongs to the RAS superfamily of small 




























a diverse array of cellular events, including cell growth, cytoskel-
etal reorganization, and the activation of protein kinases. RAC1 
has also been described in actin reorganization events, includ-
ing formation of lamellipodia, filopodia and membrane ruffling 
via downstream effector proteins9,25–29 (Figure 1). Interestingly, 
the formation of lamellipodia is also observed just before mac-
rophage fusion29, and RAC1 has been described as a regulator 
of macrophage multinucleation18,29,30. 
We hypothesized that CD44 might act as a mechano-sensor and 
that stiffness would lead to a significant CD44 upregulation dur-
ing fusion, which in turn contributes to RAC1 upregulation. This 
RAC1 regulation could in turn regulate actin dynamics, which 
leads to more multinucleation (Figure 1). However, we did not 
observe any differences in CD44 on both gene expression anal-



















Figure 1. CD44 regulates the actin cytoskeleton through RAC1 and its downstream effector genes. 
CD44 directly regulates stress fiber formation, membrane ruffling, lamellipodia and filopodia forma-
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Macrophage fusion is accompanied by actin reorganization13,14, 
which is under direct regulation of Rho GTPases. Rho GTPases act 
as molecular switches in signal transduction cascades by cycling 
between inactive GDP-bound and active GTP-bound states. Rho 
GTPases regulate cell shape, adherence and motility by regulat-
ing and reorganizing the actin cytoskeleton. RAC1 is a member 
of the Rho GTPase family. Although we observed actin reorgan-
izational events in multinuclear giant cells (MGCs) (Chapter 3: 
Figure 2), we did not observe any differences in actin organiza-
tion in single cell macrophages cultured on soft (~4 kPa) or in-
creasingly stiffer (12, 26, 92 kPa) substrates. Although we did not 
observe any significant differences in CD44 expression between 
different stiffness, we still wondered whether gene expression lev-
els of effector proteins downstream of CD44 were differently reg-
ulated.
Figure 2: Gene expression analysis of CD44 of macrophages/giant cells cultured on hydrogels of 
different stiffness, relative to YWHAZ.  Hydrogels of different stiffness functionalized with L-DOPA and 




























DOWNSTREAM EFFECTOR GENE ARFIP2 (POR 1)
ADP-Ribosylation Factor Interacting Protein 2 (ARFIP2 or POR1) 
is reported to be involved in membrane ruffling25 and cytoskel-
etal reorganization26, and is observed both before and during 
macrophage fusion. POR1 is under the direct control of RAC125, 
which in turn is regulated by CD44 upon activation16. Membrane 
ruffling is also often observed in a different multinucleation pro-
cess during osteoclast formation. The exact role of membrane 
ruffling is still unclear, but is often described as being the onset 
of lamellipodia formation to induce cell movement. We did not 
observe any differences in POR1 gene expression between gels 
of different stiffness (Figure 3).
ARP2/3: THE ACTIN FILAMENT NUCLEATION SITES
The Actin-Related Proteins 2/3 (ARP2/3) are major components 
of the actin cytoskeleton. Both proteins closely resemble the 
monomeric structure of actin and serve as actin filament nucle-
ation sites. ARP2/3 is located at the inner surface of the plasma 
membrane and is essential to cell shape and motility10. ARP2/3 is 
described as necessary for the formation of new actin bundles 
and lamellipodia actin assemblies. Although we did observe dif-
ferences between different stiffness, we could not directly link 
high gene expression to increased macrophage multinucleation. 
Higher stiffness (between 12 and 92 kPa) seemed to favor lower 
ARP2/3 gene expression levels while 4 kPa and control (Glass + 
DOPA + fibronectin) seemed to favor higher expression levels. 
PAK1: REGULATOR OF RAC1 AND CDC42
P21 Activated Kinase (PAK1) is part of the family of serine/threo-
nine p21-activated kinases. PAK1 is a critical effector that under 
direct regulation of both RAC1 and Cdc42, and is involved in 
reorganization of the actin cytoskeleton. PAK1 can induce Lim 
Kinase (LIMK), which can in turn phosphorylate and inactivate 
Cofilin. Unphosphorylated (activated) Cofilin can depolymerize 
actin bundles. Deactivation of Cofilin by LIMK leads to actin sta-
bilization, and together with ARP2/3 can lead to protrusions and 
lamellipodia formation, which are observed just before mac-
rophage fusion16,29. Although low stiffness (4kPa) and high stiff-










































































































































































































































































































































































































































































































Figure 3: Gene expression analysis of downstream effector proteins of CD44. : All genes were ana-
lyzed relative to YWHAZ gene expression.  Hydrogels of different stiffness were compared to glass 
functionalized with L-DOPA and fibronectin
levels independent of stimulation, no relationship was found be-
tween mRNA levels of PKA1 and the frequency of macrophage 
multinucleation. 
CDC42
Cell Division Control protein 42 homolog (CDC42) is part of the 
small GTPases of the Rho family, which makes it a pleiotropic 
protein involved in many cellular events including morphology, 
migration, endocytosis and cell cycle progression. Rho GTPas-
es play a key role in actin dynamics – both in assembly and re-
organization – and stand at the basis of cell adhesion, spread-
ing and migration. CDC42 has also been linked to macrophage 
chemotaxis28. Activated CDC42 is known to regulate PAK1 and 
is involved in formation of filopodia9. We observed no differenc-
es between hydrogels of different stiffness, although controls cul-
tured on functionalzed glass had higher gene expression levels.
RhoA
Ras Homology Family Member A is a member of the Rho family 
of small GTPases which, as described above, function as a mo-
lecular switch in actin dynamics. RhoA regulates actin polymer-




























stress fiber formation in mesenchymal cells31,32. We observed 
no differences in RhoA gene expression between hydrogels of 
different stiffness.
ROCK
Rho-associated Kinase 1 (ROCK) belongs to the serine/threo-
nine kinase family and is a downstream effector of the small GT-
Pase RhoA. ROCK1 is a regulator of the actomyosin cytoskeleton 
which is necessary for the generation of contractile force. ROCK 
has often been linked to mechanosensing as it directly regulates 
actin to non-muscle myosin  II interactions33–35, and can regu-
late LIMK. We observed no differences in ROCK gene expression 
between hydrogels of different stiffness.
CONCLUSION
We hypothesized that CD44 might play an important role in stiff-
ness-dependent macrophage fusion. However, we did not ob-
serve any difference in CD44 gene and protein expression be-
tween macrophages cultured on different stiffness. Furthermore, 
we performed transcription analysis on effector genes down-
stream of CD44-Rac1. Although we did observe differences in 
mRNA levels of some of the effector genes, these differences 
could not be directly linked to macrophage multinucleation, as 
there was no relation between mRNA levels and macrophage 
fusion efficiency. Although in theory CD44 ligand density (fi-
bronectin) could also contribute, this seems unlikely, as we did 
not observe differences in fibronectin density between hydrogels 
of different stiffness36. Another possibility is that CD44-ICD was 
cleaved by y-secretase on 12 and 26 kPa, and not on 4 and 92 
kPa, meaning an optimum was reached here. Unfortunately, we 
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C H A P T E R 6
αII-SPECTRIN AND βI I -SPECTRIN 





























Mechanosensing of fibroblasts plays a key role in the develop-
ment of fibrosis. So far, no effective treatments are available to 
treat this devastating disorder. Spectrins regulate cell morpholo-
gy and are potential mechanosensors in a variety of non-eryth-
roid cells, but hardly anything is known about the role of spectrins 
in fibroblasts. We investigated whether αII- and βII-spectrins are 
required for the phenotypic properties of adult human dermal 
(myo)fibroblasts. Knockdown of αII- or βII-spectrin in fibroblasts 
did not affect cell adhesion, cell size and YAP nuclear/cytosolic 
localization. We further investigated whether αII- and βII-spec-
trins play a role in the phenotypical switch from fibroblasts to 
myofibroblasts under the influence of the pro-fibrotic cytokine 
TGFβ1. Knockdown of spectrins did not affect myofibroblast for-
mation, nor did we observe changes in the organization of αSMA 
stress fibers. Focal adhesion assembly was unaffected by spec-
trin deficiency, as was collagen type I mRNA expression and pro-
tein deposition. Wound closure was unaffected as well, showing 
that important functional properties of myofibroblasts are un-
changed without αII- or βII-spectrin. In fact, fibroblasts stimulat-
ed with TGFβ1 resulted in significantly lower endogenous mRNA 
levels of αII- and βII-spectrin. Taken together, despite the diverse 
roles of spectrins in a variety of other cells, they do not seem to 






















Chronic organ injury often results in the development of fibro-
sis: an excessive production, post-translational modification, and 
stiffening of extracellular matrix (ECM) components (Rockey et 
al., 2015). Pathological stiffening of the ECM creates a pro-fibrot-
ic feedback loop (Parker et al., 2014), but how mechanical cues 
are transduced to change cell function and fate, remain incom-
pletely understood. Driving the fibrotic response are activated 
fibroblasts or pericytes that acquire the myofibroblast pheno-
type, which is characterized by a well-developed endoplasmic 
reticulum and an extensive contractile actomyosin cytoskeleton 
(Klingberg et al., 2013). Decades of research have been devot-
ed to the contractile apparatus in the regulation of the myofibro-
blast phenotype. More recently, structural proteins belonging to 
the spectrin family were found to act as functional adaptors be-
tween the actomyosin cytoskeleton and the plasma membrane, 
and are thought to regulate transduction of mechanical signals 
(Liem, 2016; Stankewich et al., 2011). 
Spectrins form a major component of the cytoskeleton at the 
membrane-cytoskeleton interface (Bennett, 1990a; Sormunen, 
1993), and play an important role in maintaining cellular integri-
ty (Bennett and Baines, 2001). Spectrins form tetrameric flexible 
heterodimers, which contain two alpha and two beta subunits 
(Dubreuil et al., 1989; MacDonald and Cummings, 2004) and have 
been evolutionary conserved in species as different as echino-
derms (Fishkind et al., 1987), Sophophora (Bennett, 1990a; Deng 
et al., 1995; Dubreuil et al., 1987, 1990), birds (Wasenius et al., 
1989), and humans (Bennett, 1990b; Leto et al., 1988; Sevinc and 
Fung, 2011). They were first discovered in metazoan erythrocytes 
where they support the membrane cytoskeleton (Bennett, 1990a, 
1990b; Bennett and Baines, 2001). In erythrocytes two different 
spectrin genes are found, SPTA1 (αI-spectrin) and SPTB1 (βI-spec-
trin). Both subtypes are uniquely expressed in erythrocytes and 
thus not found in other cell types (Wasenius et al., 1989). More re-
cently, other spectrin proteins were identified in non-erythrocyte 
cells (Bennett, 1990a; Dubreuil et al., 1990; Moon and McMahon, 





















αII-spectrin polypeptide that are generated through alternative 
splicing. In addition, non-erythrocyte β-spectrins are encoded 
by four similar genes: SPTBN1 (βII-spectrin), SPTBN2 (βIII-spectrin), 
SPTBN4 (βIV-spectrin) and SPTBN5 (bV-spectrin (βHeavy)). Here, 
we focus on αII-spectrin and βII-spectrin, since they have been 
reported to provide mechanical stability and maintaining cell in-
tegrity, plasma membrane stability and morphology—key fea-
tures of cellular mechanosensing (Bialkowska, 2005; Machnicka 
et al., 2012; Metral et al., 2009; Stankewich et al., 2011). Further-
more, αII-spectrin and βII-spectrin regulate cell adhesion (Metral 
et al., 2009) and cell spreading (Bialkowska, 2005; Meriläinen et 
al., 1993; Stankewich et al., 2011) and contain domains which 
function in protein sorting, vesicle trafficking and endocytosis (Bi-
alkowska, 2005; Devarajan et al., 1997; Kamal et al., 1998).
The functional domain in the αII-spectrin subunit is the high-
ly conserved Src Homology 3 (SH3) domain (Musacchio et al., 
1992), which initiates Rac activation during cell adhesion and 
spreading (Bialkowska, 2005). In addition, αII-spectrin contains a 
calmodulin binding site (Bennett, 1990a; Dubreuil et al., 1987), 
which might be involved in cell contraction and migration. Fur-
thermore, αII-spectrin is reported to be involved in regulation of 
actin dynamics (Bialkowska, 2005) and βII-spectrin is involved in 
TGFβ1 signaling, where it functions as a SMAD adaptor protein 
(Baek et al., 2011; Kitisin et al., 2007; Tang et al., 2003) . Addition-
ally, spectrins associate with, as well as regulate, Yes-associated 
protein 1 (YAP) (Fletcher et al., 2015; Wong et al., 2015). YAP acts 
as a transcriptional regulator of genes involved in proliferation 
and suppression of apoptotic genes and is regulated by both 
Hippo and  TGFβ1 signaling (Liu et al., 2015; Piersma et al., 2015). 
YAP is a phosphoprotein involved in mechanotransduction (Cal-
vo et al., 2013; Dupont et al., 2011; Janmey et al., 2013). Wheth-
er spectrins play a role in the myofibroblast phenotypical switch 
remains unknown. Here we studied the role of αII-spectrin and 
βII-spectrin in stiffness-induced cell spreading and adhesion, YAP 
translocation and wound closure with human dermal fibroblasts. 
Furthermore, we examined the role of αII-spectrin and βII-spec-























Reagents were as follows: human plasma fibronectin (20 µg/mL, 
F1056; Sigma-Aldrich, Munich, Germany), human recombinant 
TGFβ1 (10 ng/mL, 100-21C; Peprotech, London, UK), αII-spectrin 
siRNA (25 ng/cm2, EHU093741, Sigma, St. Louis, MO), βII-spectrin 
siRNA (25 ng/cm2, EHU081451, Sigma-Aldrich), Renilla luciferase 
siRNA (25 ng/cm2, EHURLUC, Sigma-Aldrich), Alexa647 labe-
led-streptavidin (8 µg/mL, S32357; Thermo Fisher Scientific, Lands-
meer, the Netherlands), TRITC labeled-Phalloidin (100 nM, P1951; 
Sigma-Aldrich). Antibodies used: mouse anti-αII-spectrin (2 µg/
mL, sc-376849; Santa Cruz, Dallas, USA), mouse anti-βII-spectrin 
(2 µg/mL, sc-376487; Santa Cruz), mouse anti-αSMA (0.28 µg/mL, 
M0851; DAKO, Glostrup, Denmark), mouse anti-collagen type I (1 
µg/mL, ab90395; Abcam, Cambridge, UK), mouse anti-vinculin 
(9.3 µg/mL, V9131; Sigma-Aldrich).
CELL MANIPULATIONS
Before the onset of experiments, normal adult human dermal 
fibroblasts (CC-2511, nHDF-Ad-Der, Lonza, Basel, Switzerland) 
were propagated in DMEM (12-604F; Lonza, Basel, Switzerland) 
supplemented with 2 mM L-glutamine, 50 U/L penicillin/strepto-
mycin, and 10% FCS. For protein knockdown experiments, cells 
were seeded at 15.000 cells/cm2 and transfected with siRNA 
using Lipofectamine RNAiMax reagent (Thermo Fischer Scientif-
ic) and incubated for 72 h in DMEM supplemented with 1.5 mM 
L-glutamine, 38 U/L penicillin/streptomycin, and 7.5% FCS. siRNA 
targeting Renilla luciferase was used as negative control. After 
the transfection period, cells were cultured for an additional 96 
h in DMEM containing 0.5% FCS supplemented with 2 mM L-glu-
tamine and 50 U/L penicillin/streptomycin to ensure elimination 
of the spectrin proteins, as they are relatively long-lived pro-
teins. Efficiency of knockdown was subsequently determined by 
means of qPCR and immunofluorescence. For cell adhesion, cell 
spreading and YAP translocation studies, cells were reseeded 
on fibronectin-functionalized polyacrylamide gels for 24 h. Cell 
spreading was determined by measuring cell surface area with 





















fying the number of cells in 25 FOVs. YAP translocation was meas-
ured by means of immunofluorescence.
For myofibroblast differentiation experiments and the wound 
healing assay, the trypsinized cells were reseeded on polysty-
rene culture wells (for mRNA measurements or wound healing) 
or slides (for immunostaining), and cultured in DMEM containing 
0.5% FCS, 2 mM L-glutamine, 50 U/L penicillin/streptomycin and 
0.17 mmol/L ascorbic acid (A8960; Sigma-Aldrich), and supple-
mented with or without TGFβ1 (10 ng/mL) for 72 h. For the wound 
healing assay, IBIDI inserts were removed after 48 h, leaving an-
other 24 h for the cells to repopulate the wound area.
 
FIBRONECTIN-FUNCTIONALIZED POLYACRYLAMIDE HYDROGELS
To determine the role of spectrins in cell adhesion and spread-
ing, cells were seeded on fibronectin-functionalized polyacryla-
mide hydrogels with an elastic modulus of either 2 or 50 kPa. Po-
lyacrylamide hydrogels were prepared as described previously 
(Wouters et al., 2016). In brief, gels were prepared between a 
chemically modified glass plate and coverslip. The glass plate 
was cleaned by immersion in 99.9% ethanol for 15 minutes and 
treated with dichlorodimethylsilane to avoid polyacrylamide in-
teractions. Glass coverslips were treated with 0.5% trimethoxy-
propylmethacrylate in 99.9% ethanol, which was activated using 
3% glacial acetic acid to facilitate covalent adhesion of poly-
acrylamide hydrogels. Differences in stiffness (elastic modulus) 
were obtained by varying the ratio between acrylamide and bi-
sacrylamide and the Young’s modulus was validated by means 
of Atomic Force Microscopy (AFM). Hydrogel polymerization was 
initiated with TEMED and APS. To functionalize the surface of the 
hydrogels they were overlaid with 2 mg/ml L-DOPA (in 10 mM 
Tris), and incubated for 30 minutes. Next, L-DOPA was washed 
off and hydrogels were functionalized with 20 µg/mL plasma fi-
bronectin for 2 h at 37°C.
RNA ISOLATION, CDNA SYNTHESIS AND QRT-PCR
To obtain total RNA, the FavorPrep Tissue Total RNA Purification 
Mini Kit (Favorgen Biotech Corp., Taiwan) was used in accord-





















purity were determined by UV spectrophotometry (NanoDrop 
Technologies, Wilmington, NC). To assess gene expression, the 
RNA was reverse transcribed using the First Strand cDNA synthe-
sis kit (Thermo Fisher Scientific) using random hexamer primers in 
accordance to the manufacturer’s instructions. Gene expression 
quantification was performed using qRT-PCR analysis and SYBR 
Green Supermix (Roche, Basel, Switzerland). The thermal cycling 
conditions were 2 minutes at 95°C (enzyme activation), followed 
by 15 seconds at 95°C, 30 seconds at 60°C, and 30 seconds at 
72°C (40 cycles). All qPCRs were performed with a ViiA™ 7 Re-
al-Time PCR System (Applied Biosystems, CA, USA). Melting curve 
analysis was performed to verify the absence of primer dimers. 
Analysis of the data was performed using ViiA7 Real-Time PCR 
System Software v1.2.4 (Applied Biosystems, CA, USA). Primer se-
quences are provided in Table 1.
 
IMMUNOFLUORESCENCE
For spectrin immunofluorescence, PFA-fixated cells cultured for 
7 days were incubated with 10% goat serum for 1 h. Primary an-
tibodies were incubated in PBS + 2.2% BSA at room temperature 
(RT) for 2 h. For YAP immunofluorescence, cells were permeabi-
lized with 0.5% Triton X-100, and subsequently incubated with PBS 
10% goat serum RT for 1 h. Primary antibodies were incubated in 
PBS + 0.1% Triton X-100 and 2.2% BSA at 4°C for 16 h. For α-smooth 
muscle actin and collagen immunofluorescence, methanol/ac-
etone (1:1) fixed cells were incubated with 10% goat serum for 
1 h, and primary antibodies were incubated in PBS + 2.2% BSA 
at RT for 2 h. For all immunofluorescence, secondary antibodies 
were diluted in PBS + 2.2% BSA at RT for 1 h, and subsequently 
incubated with Alexa647-labeled streptavidin in PBS containing 
4’,6-diamidino-2-phenylindole (DAPI, 1:5000, 10236276001, Ro-
che, Basel, Switzerland) for 30 min. Actin was visualized by in-
cubation with TRITC labeled-Phalloidin in PBS for 30 minutes. Be-
tween incubations, cells were washed thrice with PBS containing 
0.5% Tween-20. Slides were mounted in Citifluor (Agar Scientific) 






















All data are represented as means ± SD of at least three inde-
pendent experiments and were analyzed by GraphPad Prism 
Version 6.01 for Windows (GraphPad Software, Inc., La Jolla, CA, 
USA) by either one-way or two-way ANOVA followed by Bonfer-
roni post hoc analysis.
RESULTS
αII- AND βII-SPECTRIN DO NOT INFLUENCE CELL ADHESION
In order to elucidate the role of spectrins on fibroblast behavior, 
we performed siRNA mediated knockdown. We found that both 
αII and βII-spectrin have a long half-life; we only observed >90% 
gene expression knockdown 168 h (7 days) after transfection 
(Figure 1A), and also observed knockdown at the protein level 
(Figure 1B). Interestingly, βII-spectrin siRNA knockdown also de-
creased the expression of αII-spectrin about two-fold. Next, we 
investigated whether αII and βII-spectrin have an effect on cell 
adhesion (Figure 2A) by seeding cells on either 2 kPa or 50 kPa 
fibronectin-coated substrates of different stiffness. Cell adhesion 
did not differ between 2 kPa and 50 kPa in either the control cells 
or the αII-spectrin and βII-spectrin deficient cells. 
CELL SPREADING ON SOFT AND STIFF SUBSTRATES IS INDEPENDENT 
OF αII- AND βII-SPECTRIN
The morphological and cytoskeletal changes of fibroblasts are 
well documented for cells cultured on fibronectin-coated surfac-
es with stiffness ranging from 2 to 55 kPa. When grown in sparse 
culture with no cell-cell contacts, fibroblasts show an abrupt 
change in spread area that occurs at a stiffness range above 3 
kPa (Yeung et al., 2005). We indeed observed major differences 
in cell size (spreading) between 2 kPa and 50 kPa gels: cells cul-
tured on 2 kPa were markedly smaller than cells cultured on 50 
kPa (Figure 2B-C). This was the case both for control cells as for

























αII-spectrin or βII-spectrin deficient cells, but we observed no 
significant differences in cell size between the spectrin-deficient 
cells and the control group. These data suggest that αII- and 
βII-spectrins do not affect the stiffness-dependent changes in 
cell size of dermal fibroblasts.
αII- AND βII-SPECTRIN DO NOT REGULATE YAP LOCALIZATION
YAP is a mechanosensitive transcriptional co-activator that has 
been shown to govern the phenotypical switch to myofibroblasts 
and accumulates in the nucleus on increased stiffness of the ECM 
(Piersma et al., 2015; Szeto et al., 2016). 
Fig 1. αII-spectrin and βII-spectrin knockdown with esiRNA.  (A) mRNA expression of αII-spectrin 
(SPTAN1) and βII-spectrin (SPTBN1) 7 days after esiRNA transfection. One-way ANOVA; * p<0.05 (B) 
Representative immunofluorescent images of αII-spectrin and βII-spectrin 7 days after esiRNA trans-





















One of the mechanisms of YAP nuclear accumulation involves 
polymerization of actin monomers into stress fibers (Aragona et 
al., 2013; Das et al., 2016; Dupont et al., 2011). Recently, αII- and 
βII-spectrin were shown to regulate cytoplasmic retention of YAP 
in stretched epithelial cells, by interacting with and activating 
Hippo signaling at the plasma membrane (Fletcher et al., 2015). 
Because fibroblasts and myofibroblasts rely heavily on their con-
tractile cytoskeleton and are known for their ability to spread over 
great distances, we investigated the effects of substrate stiffness 
and presence of αII- and βII-spectrin on YAP localization. We ob-
Fig 2. Cell adhesion and cell morphology. (A) Cell adhesion on 2 kPa and 50 kPa polyacrylamide 
hydrogels. (B) Effect of hydrogel stiffness on cell morphology and cell spreading. Two-way ANOVA; 
*** p<0.001 (C) F-actin (phalloidin) and nucleus (DAPI) staining to visualize cell size and cell ad-






















served major differences in YAP localization between 2 and 50 
kPa hydrogels (Figure 3): on 2 kPa all cells displayed cytoplasmic 
retention of YAP, while on 50 kPa all cells showed both nuclear 
and cytoplasmic localization of YAP. However, we observed no 
differences in YAP localization between spectrin-deficient cells 
and the control cells, suggesting that spectrins are not primarily 
involved in fibroblast stiffness-dependent YAP localization.
αII- AND βII-SPECTRIN DO NOT REGULATE FIBROBLAST MIGRATION 
AND WOUND HEALING
Others showed βH-spectrin to be involved in epithelial cell mi-
gration in Sophophora (Urwyler et al., 2012). Therefore, we asked 
whether spectrins are necessary for fibroblasts wound closure in 
vitro. We mimicked wound closure by means of IBIDI inserts, and 
found that no differences in wound repopulation in fibroblasts 
stimulated with or without TGFβ1 (Figure 4). Moreover, knockdown 
of spectrins did not affect the population rate of the wound area 
(Figure 4). 
Fig 3. Effect on YAP translocation. Yes-associated protein 1 (YAP; green) translocation in spectrin KD 
fibroblasts cultured on either 2 kPa or 50 kPa polyacrylamide hydrogels. Nuclei are stained with DAPI. 





















Fig 4. IBIDI Wound healing assay. Cells seeded at high density were left to repopulate the wound 






















αII- AND βII-SPECTRIN DO NOT AFFECT THE MYOFIBROBLAST PHENO-
TYPE
Myofibroblasts play an important role in both regular wound 
healing as well as dysregulated wound healing, the latter result-
ing in fibrosis. αSMA stress fiber formation is an important hall-
mark of the myofibroblast phenotype, which can be induced by 
TGFβ1. We indeed observed an increase in ACTA2 mRNA levels 
(Figure 5A). This was reflected in the number of αSMA-positive 
cells between fibroblasts cultured with or without TGFβ1 (Figure 
5B). However, we observed no differences in the percentage 
of αSMA-positive cells between spectrin-deficient and control 
cells, indicating that spectrins are not involved in the TGFβ1-in-
duced formation of αSMA stress fibers. This was also reflected in 
the mRNA levels of ACTA2 between spectrin-deficient and con-
trol cells, although knockdown of βII-spectrin resulted in slightly 
lower ACTA2 mRNA levels in TGFβ1-stimulated cells. Interestingly, 
knockdown of αII-spectrin had a significant effect on ACTA2 ex-
pression in non-stimulated cells: the mRNA level was markedly 
lower (Figure 5A). 
COLLAGEN DEPOSITION: THE SECOND HALLMARK OF FIBROSIS
To determine if another hallmark function of myofibroblasts, 
namely the increased synthesis of collagen type I, is regulated by 
spectrins, we determined mRNA levels and collagen deposition. 
We indeed observed large differences between cells stimulated 
with or without TGFβ1. The increase in COL1A1 mRNA levels (Fig-
ure 6A) was accompanied by an increase in collagen deposi-
tion (Figure 6B). However, αII- and βII-spectrin knockdown did not 
affect mRNA levels of COL1A1 in TGFβ1-stimulated cells (Figure 
6A) or the deposition of collagen type I (Figure 6B). Interestingly, 
knockdown of SPTAN1 had a major effect on COL1A1 expression 






















Fig 5. Formation of α-smooth muscle actin stress fibers. (A) mRNA expression of ACTA2 (αSMA) after 
4 days of stimulation with TGFβ1 on αII-spectrin (SPTAN1) and βII-spectrin (SPTBN1) KD cells. Two-way 
ANOVA; ** p<0.01. (B) Representative immunofluorescent images of α smooth muscle actin stress 
fiber formation on αII-spectrin (SPTAN1) and βII-spectrin (SPTBN1) KD cells. Nuclei are stained with 
DAPI. Original magnification 200×. αSMA, α smooth muscle actin; DAPI, 4',6-diamidino-2-phenylin-
dole; TGF, transforming growth factor. 
αII- AND βII-SPECTRIN ARE NOT NECESSARY FOR FOCAL ADHESION 
ASSEMBLY
We determined the formation of focal adhesions by means of 
vinculin staining as a function of TGFβ1. As expected, a major 





















 TGFβ1 (Figure 7). However, we did not observe any differences 
in focal adhesion formation between spectrin deficient and con-
trol cells.
Fig 6. Collagen type expression after spectrin KD. (A) mRNA expression of COL1A1 after 4 days of 
stimulation with TGFβ1 on αII-spectrin (SPTAN1) and βII-spectrin (SPTBN1) KD cells. Two-way ANOVA; * 
p<0.05, *** p<0.001. (B) Representative immunofluorescent images of collagen type I deposition on 
αII-spectrin (SPTAN1) and βII-spectrin (SPTBN1) KD cells. Nuclei are stained with DAPI. Original mag-






















TGFΒ1 ATTENUATES SPTAN1 AND SPTBN1 EXPRESSION
Since we did not observe differences in myofibroblast param-
eters between control and cells KD for spectrins, we wondered 
what happens with endogenous SPTAN1 and SPTBN1 mRNA levels 
when cells are stimulated with TGFβ1. Interestingly, TGFβ1 stimu-
lation had a direct negative effect on SPTAN1 and SPTBN1 gene 
expression, as incubation with TGFβ1 resulted in significantly low-
er mRNA levels of SPTAN1 and SPTBN1 (Figure 8). The effect of 
TGFβ1 on SPTBN1 was more pronounced than for SPTAN1. 
Fig 7. Effect of spectrin knockdown on focal adhesion formation. Representative immunofluorescent 
images of vinculin after 4 days of stimulation with TGFβ1 on αII-spectrin (SPTAN1) and βII-spectrin 
(SPTBN1) KD cells. Original magnification 200×. DAPI, 4',6-diamidino-2-phenylindole; TGF, transform-
ing growth factor.
Fig 8. TGFβ1 stimulation decreases αII-spectrin (SPTAN1) and βII-spectrin (SPTBN1) gene expression. 
mRNA expression of αII-spectrin (SPTAN1) and βII-spectrin (SPTBN1) after TGFβ1 stimulation. Two-way 






















Although much is known about the function of spectrins in eryth-
rocytes, less detailed information is available regarding the func-
tion of spectrins in non-erythroid cells. In fact, hardly any infor-
mation is available on the role of spectrins in fibroblasts. Since 
spectrins regulate cell morphology and are potential mech-
anosensors, we investigated whether αII- and βII-spectrin are 
required for the phenotypic properties of adult human dermal 
(myo)fibroblasts. 
We first determined the effect αII- and βII-spectrin on cell ad-
hesion and cell spreading on 2 kPa and 50 kPa gels, and no-
ticed that αII- and βII-spectrin do not regulate the adhesion or 
spreading of adult dermal fibroblasts, nor did we find morpho-
logical differences. This is of interest, as knockdown of spectrins 
results in major changes in shell shape in a variety of cell types 
(Liu et al., 2015). Mouse embryonic fibroblasts devoid of SPTBN1 
obtained at E14.5 showed an impaired cell spreading, and had 
a more rounded and spiky appearance. In addition, a reduction 
in cell proliferation was observed (Stankewich et al., 2011). Unfor-
tunately, SPTBN1 null mice are embryonic lethal, so the functions 
of βII-spectrin in adult fibroblasts are not known. The discrepancy 
between our data obtained with adult cells compared with the 
above mentioned embryonic cells points toward the direction 
that there could be age-related differences regarding the role 
of spectrins in cell shape of a specific cell type. This is also sub-
stantiated by the observation that no changes in cell shape or 
morphology were observed in embryonic epithelial cells of SPT-
BN1 knockdown mice (Stankewich et al., 2011), whereas major 
cell shape differences were observed in adult epithelial cells of 
humans (Kizhatil et al., 2007).
Next we determined whether αII- and βII-spectrin have an effect 
on the translocation of YAP as a function of stiffness and cell 
spreading. We mimicked cell spreading by sparsely culturing the 
fibroblasts on 2 and 50 kPa gels. As expected, YAP was largely 
localized in the cytoplasm in cells cultured at 2 kPa, and was 





















Deficiency of αII- or βII-spectrin did not change the translocation 
pattern of YAP. It has been shown that αII-spectrin and βII-spec-
trin have a mechanosensory function in the Hippo pathway in 
epithelial cells (Fletcher et al., 2015). This pathway is activated in 
densely confluent epithelial cell cultures and inactivated when 
cell density is sparse allowing cells to spread across the substrate. 
In these situations the transcriptional activator YAP is mainly lo-
cated in the cytoplasm or nucleus, respectively (Aragona et al., 
2013; Zhao et al., 2007). Knockdown of αII-spectrin and βII-spec-
trin prevents retention of YAP in the cytoplasm in high density cul-
tures (Fletcher et al., 2015). Since knockdown of αII- and βII-spec-
trin did not have an effect on the localization of YAP under our 
conditions (sparse cell density on a soft or stiff substrate), we pos-
tulate that under these conditions the localization of YAP is main-
ly regulated by Hippo-independent mechanisms, including actin 
polymerization and Smad3 shuttling (Dupont et al., 2011; Zhao et 
al., 2007). Our data indicate that spectrins are, in contrast to their 
crucial role in the Hippo pathway to regulate YAP, not required 
to regulate YAP in the mechanotransduction pathway that acts 
parallel to the Hippo pathway.
Fibroblasts, and more specifically myofibroblasts, are at the heart 
of fibrosis (Hinz, 2010). Fibroblasts undergo major morphological 
changes when are they activated into myofibroblasts by e.g. 
TGFβ, and changes occur in tissue stiffening during the fibrotic 
process (Chia et al., 2012; Hinz, 2009; Huang et al., 2012). We 
therefore wondered whether spectrins play a role in the myofi-
broblast phenotypical switch. We found that knockdown of spec-
trins did not affect myofibroblast formation, nor did we observe 
changes in the organization of αSMA stress fibers. Additionally, 
we found that focal adhesion assembly was unaffected by spec-
trin deficiency. The finding that the function of myofibroblasts 
without αII- and βII-spectrin seems unchanged, is illustrated by 
the observation that collagen type I mRNA expression and pro-
tein deposition are unaffected, together with unaffected wound 
closure. These results were unexpected, because it has been 
shown that knockdown of βII-spectrin leads to the disruption of 
TGFβ-signaling as mediated by SMAD proteins (Kitisin et al., 2007; 





















signaling via SMAD proteins is key for the induction of the myo- 
fibroblast phenotypical shift and collagen production. Howev-
er, these studies primarily focused on the epithelial lineage and 
mainly in the context of embryonic mouse development (Kitisin 
et al., 2007; Lim et al., 2014; Munoz et al., 2014; Thenappan et al., 
2011). Since we were puzzled by our observations, we also inves-
tigated endogenous gene expression of SPTBN1 when fibroblasts 
were stimulated with TGFβ1, and noted a four-fold reduction in 
SPBTN1 mRNA levels. This suggests that in adult human myofibro-
blasts, βII-spectrin does not interfere with SMAD-mediated gene 
expression, which is confirmed by our siRNA data, where SPTBN1 
levels are reduced more than 20-fold in combination with TGFβ 
without seeing an effect on collagen production or αSMA forma-
tion. The latter suggests that in fibroblasts, downregulation of αII- 
and βII-spectrin is pre-requisite for the myofibroblast phenotype 
switch.
In conclusion, αII- and βII-spectrin do not regulate cell adhesion, 
cell size and YAP localization in human dermal fibroblasts, and 
are not required for the myofibroblast phenotypical switch. Tak-
en together, despite the diverse roles of spectrins in a variety of 
other cells, they do not seem to be suitable candidates to inter-
fere in fibrotic processes. 
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L-ascorbic acid (AA), generally known as vitamin C, is a crucial 
co-factor for a variety of enzymatic reactions, including pro-
lyl-3-hydroxylase (P3H), prolyl-4-hydroxylase (P4H), and lysyl hy-
droxylase (LH)-mediated collagen maturation. Here, we investi-
gated whether AA has additional functions in the regulation of 
the myofibroblast phenotype, besides its function in collagen 
biosynthesis. We found that AA positively influences TGFβ1-in-
duced expression of COL1A1, ACTA2, FN1, and COL41A. More-
over, we demonstrated that AA promotes αSMA stress fiber for-
mation as well as the synthesis and deposition of collagens type 
I and IV. Additionally, AA amplified the contractile phenotype 
of the myofibroblasts, as seen by increased contraction of a 3D 
collagen lattice. Moreover, AA increased the expression of sev-
eral TGFβ1-induced genes, including DDR1 and CCN2. Finally, 























L-ascorbic acid (AA), generally known as vitamin C, is a wa-
ter-soluble vitamin with antioxidant properties [1]. Unlike most an-
imal species, humans are unable to synthesize AA due to a mu-
tation in the enzyme L-gulono-1,4-lactone oxidase and therefore 
depend on uptake from the diet [2,3]. The world’s first clinical 
trial by James Lind revealed that AA supplementation through 
fruits and vegetables is an effective treatment for scurvy, a con-
nective tissue disorder often found in sailors of the 17th and 18th 
century [3,4]. The anti-scorbutic action of AA is ascribed to its 
function as co-factor for three enzyme families involved in the 
biosynthesis of collagens, namely prolyl-3-hydroxylases (P3H), 
prolyl-4-hydroxylases (P4H), and lysyl hydroxylases (LH) [3]. These 
α-ketoglutarate-dependent non-heme iron dioxygenases are re-
sponsible for the hydroxylation of proline and lysine residues in 
the assembly of the collagen triple helix [5–9]. For these enzymes, 
AA acts as an electron donor in the catalytic cycle by reducing 
the highly reactive iron species (Fe4+ and Fe3+) into the catalyt-
ically active Fe2+ [3,10]. The formation of hydroxyproline (Hyp) 
is required for the stability of the triple helix [11,12]; an unstable 
triple helix is prone to intracellular degradation [13,14]. Because 
of its role in collagen biosynthesis, AA has been implicated in 
the pathophysiology of fibrosis, a chronic pathology character-
ized by excessive extracellular matrix (ECM) accumulation and 
cross-linking [15]. 
Although it is known for a long time that AA is required as culture 
medium supplement to enable collagen deposition by human 
fibroblasts [16], many studies have overlooked this fact, which 
may have led to unreliable conclusions. For example, exposure 
of human fibroblasts to conditioned medium from fetal or adult 
stem cells results in decreased collagen levels when AA is present 
in the medium thus showing an anti-fibrotic effect of stem cell 
conditioned medium [17], whereas the opposite is seen when 
AA is absent [18,19]. That the latter conclusion is incorrect, is il-
lustrated by rodent fibroblasts that react to conditioned medium 
of stem cells in the same way as AA-exposed human fibroblasts, 





















[20]. In contrast to human fibroblasts, rodent fibroblasts are able 
to synthesize AA themselves. 
The myofibroblast is the key cell in the pathophysiology of fibrosis 
and it is specialized in the synthesis of ECM components. Chronic 
organ injury activates effector cells such as fibroblasts and peri-
cytes to adopt a myofibroblast phenotype, under the influence 
of the pro-fibrotic cytokine transforming growth factor (TGF)β1 
[21,22]. We asked whether TGFβ1 and AA act in synergy with re-
spect to collagen deposition, and whether AA is involved in the 
TGFβ1-induced phenotype switch from fibroblasts to myofibro-
blasts. Our results indicate that AA works in synergy with actions 
of TGFβ1 both with respect to collagen deposition and in reg-
ulating a signature myofibroblast expression profile. We further 
elucidated that the involved mechanism of the latter is probably 
independent of canonical Smad signaling.
METHODS
CELL CULTURE
Human dermal fibroblasts were purchased from ATCC (CCD-
1093Sk (ATCC® CRL-2115™), Wesel, Germany), and subcultures 
were maintained in Eagle’s minimal essential medium (EMEM, 
Lonza, Basel, Switzerland) supplemented with 2 mM L-glutamine, 
1% penicillin/ streptomycin (complete growth medium) and 10% 
heat inactivated fetal bovine serum (FBS). For all experiments, 
cells were seeded at 15,000 cells/cm2 in complete growth me-
dium, and left to adhere for 24 hours before serum starvation. 
In brief, cells were starved in complete growth medium supple-
mented with 0.5% FBS (bare medium). After 18 hours, cells were 
stimulated with either 0.17 mmol/L AA (A8960, L-ascorbic acid 
2-phosphate sesquimagnesium hydrate; Sigma-Aldrich, Zwijndre-
cht, the Netherlands), 10 ng/mL TGFβ1 (100-21C; PeproTech Ltd, 
London, United Kingdom), or both, for up to 6 days and medium 
was refreshed daily.
RNA EXTRACTION AND QUANTITATIVE REAL-TIME PCR
For gene expression analysis, total RNA was isolated at day 2 and 
day 6 using the Tissue Total RNA mini kit (Favorgen Biotech Corp., 





















trophotometry (NanoDrop Technologies, Wilmington, USA). RNA 
was reverse transcribed using the RevertAid First Strand cDNA 
synthesis Kit (ThermoFisher Scientific, Landsmeer, the Nether-
lands), according to manufacturer’s instructions. Real-time PCR 
was performed with SYBR green PCR master mix (Roche, Basel, 
Switzerland) using a VIIA7 thermal cycling system (Applied Bio-
systems, Carlsbad, USA). The thermal cycling conditions were 2 
minutes at 95°C, followed by 15 seconds at 95°C, 30 seconds at 
60°C, and 30 seconds at 72°C, for a total of 40 cycles. Primers 
were designed and tested to have a calculated 95–105% reac-
tion efficiency. mRNA expression levels of genes from the col-
lagen biosynthesis pathway and other ECM components were 
analyzed with a custom made microfluidic card-based low den-
sity array (Applied Biosystems) and a VIIA7 thermal cycling sys-
tem, as described previously [23]. 
IMMUNOFLUORESCENCE
For immunofluorescence of Smad2, cells were washed twice 
with PBS and fixed with 2% paraformaldehyde (Sigma-Aldrich) for 
10 minutes. For immunofluorescence of smooth muscle α-actin 
(αSMA), collagen type I, procollagen type I, and collagen type 
IV, cells were washed twice in PBS and fixed with ice-cold meth-
anol/acetone (1:1) for 10 minutes at -20°C. Methanol/acetone 
fixed cells were first dried and later rehydrated with PBS before 
use. For all immunofluorescent stainings except collagen type I 
and IV, fixed cells were permeabilized with 0.5% Triton X-100 in 
PBS for 10 minutes, and incubated with 2.2% bovine serum albu-
min (BSA) for 30 minutes. Next, cells were incubated for 1h with 
primary antibodies: mouse monoclonal to αSMA (Clone 1A4, 0.28 
µg/mL; Dako, Glosstrup, Denmark), mouse monoclonal to colla-
gen type I (ab90395, 1 µg/mL; Abcam, Cambridge, United King-
dom), goat polyclonal to pro-collagen type I (sc-8782, 2 µg/mL; 
Santa Cruz Biotechnology, Dallas, TX, USA), or mouse monoclonal 
to Smad2 (L16D3, 0.5 µg/mL; Cell Signaling Technologies, Leiden, 
the Netherlands) in PBS containing 2.2% BSA. After three washes 























Cells were lyzed with RIPA buffer (ThermoFisher Scientific) supple-
mented with protease inhibitor cocktail (Sigma-Aldrich) and son-
icated. The DC protein assay (Bio-Rad, Hercules, CA, USA) was 
used to quantify protein concentrations and equal amounts of 
protein (20 µg/lane) were subjected to SDS gel electrophoresis on 
stain free TGX mini-PROTEAN pre-cast gels. Before protein trans-
fer, hydrogels were put under UV to activate stain free trihalo 
components in the gel, and gel images were taken for total pro-
tein quantification and normalization as described before [24]. 
After activation, protein transfer to a nitrocellulose membrane 
was performed using the semidry Transblot Turbo system (Bio-
Rad). Membranes were blocked in 5% skimmed milk in Tris-buff-
ered saline + 0.1% Tween 20 and incubated overnight with pri-
mary antibodies: mouse monoclonal to αSMA (Clone 1A4, 0.28 
µg/mL; Dako) and goat polyclonal to collagen type I (sc-8783, 
2 µg/mL; Santa Cruz Biotechnology). Next day, after three wash-
es with TBST, membranes were incubated with goat-anti-mouse 
HRP (P0447, 1 µg/mL; Dako) or rabbit-anti-goat HRP (P0049, 0.5 
µg/mL; Dako) for 1 hour at RT. Protein bands were visualized with 
chemiluminescence (ECL, ThermoFisher Scientific) and a Chem-
iDoc imaging system (Bio-Rad). Image analysis was performed 
with ImageJ version 5.1 [25].
COLLAGEN LATTICE CONTRACTION ASSAY
After three days of stimulation, dermal fibroblasts were seeded in 
collagen lattices with a final concentration of 2.4 mg/mL rat tail 
collagen type I (354249; BD, San Jose, CA, USA), 1x PBS, 20 mM 
HEPES, 5.8 mM NaOH, 50% EMEM complete growth medium, and 
5% FBS. Cells were seeded at a concentration of 2x105/mL gel. 
Cells were allowed to pre-stress the collagen lattice 3 days prior 
to detachment, while continuing stimulation with either or both 
TGF-β1 and AA. At time point t = 0 min, gels were released from 
the well rim and allowed to contract. Well plates were scanned 
at multiple time points on a flatbed scanner. Collagen lattice 
contraction was calculated using ImageJ version 5.1. 
TRANSIENT TRANSFECTION AND LUCIFERASE ASSAY





















were transfected with 2 µg plasmid DNA containing four copies of 
a Smad-binding element (SBE4-luc, Addgene #16495) [26] using 
Lipofectamine LTX and PLUS reagent (ThermoFisher Scientfic) in 
bare EMEM. After 24 hours, cells were starved for 4 hours in EMEM 
with 0.5% FBS (bare medium) and subsequently stimulated with 
either bare medium, TGF-β1, AA, or both for 18 hours. Cells were 
lyzed and luciferase activity was detected using a luciferase as-
say system (E1500; Promega, Leiden, the Netherlands) according 
to the manufacturer’s instructions. The average fold-change was 
calculated from three independent experiments and normalized 
against total protein concentration.    
STATISTICS
All data were tested with one-way ANOVA combined with Bon-
ferroni post hoc testing using GraphPad Prism version 7.01 for 
Windows (Graphpad, La Jolla, CA, USA).
RESULTS
ASCORBIC ACID AND TGFΒ1 WORK IN SYNERGY WITH RESPECT TO 
(PRO)COLLAGEN TYPE I DEPOSITION
To determine whether AA affects mRNA expression levels of CO-
L1A1, we cultured human dermal fibroblasts in the presence or 
absence of AA and/or TGFβ1 for 2 and 6 days. No changes were 
seen in COL1A1 mRNA levels at day 2 when either AA or TGFβ1 
are added, whereas at day 6 an increase was seen for AA (but 
not for TGFβ1 alone). In contrast, higher mRNA levels of COL1A1 
were seen at day 2 and especially at day 6 when AA and TGF-β1 
were added together (Figure 1A). Another extracellular matrix 
molecule, fibronectin (FN1), was—in contrast to (pro)collagen 
type I—not affected by AA (Figure 1A). We next investigated the 
presence of procollagen by means of immunofluorescence with 
an antibody that recognizes to the α1(I) N-propeptide. Intracel-
lular procollagen was present under all conditions, whereas ex-
tracellular procollagen was only seen at day 2 and 6 when AA 
or AA+TGFβ1 was present (Figure 1B). Staining with an antibody 
that recognizes native (triple helical) but not denatured (pro)col-
lagen showed the absence of triple helical (pro)collagen in the 
absence of AA, whereas both intra- and extracellular triple heli-





















at day 2 and 6 when AA + TGFβ1 was present (Figure 1B). The im-
munofluorescence data regarding the amount of (pro)collagen 
confirm that AA and TGFβ1 work in synergy. The immunofluores-
cence data were verified with immunoblotting using an antibody 
recognizing both the native and denatured triple helical part of 
the procollagen α1(I) chain (tropo-collagen). It indeed shows 
the presence of procollagen under all culture conditions, and 
furthermore a prominent presence of collagen at day 6 when AA 
or AA + TGFβ1 were present (Figure 1C).
 
ASCORBIC ACID FACILITATES THE TGFΒ1-INDUCED DIFFERENTIATION 
OF FIBROBLASTS INTO MYOFIBROBLASTS
We wondered, since AA and TGFβ1 work in synergy with respect 
Figure 1. Ascorbic acid synergizes with TGFβ1 to govern collagen production. (A) Relative mRNA 
expression of COL1A1, ACTA2, and FN1. Cells were exposed to bare medium or TGFβ1 for 2 or 6 days 
with or without addition of AA. (B) Representative immunofluorescent confocal photomicrographs 
of procollagen type 1 and collagen type 1α1 staining on day 2 and 6. Original magnification 630x; 
scale bar = 100 µm (C) Immunoblot on complete cell lysates for pro-collagen type 1, tropo-collagen 
type 1α1 after 2 and 6 days. Data are represented as mean ± SD. Two-way ANOVA with Bonferroni 
post-test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001. AA, ascorbic acid; kD, kilo Dalton; TGFβ1, 





















to mRNA levels of COL1A1 and protein levels of procollagen and 
collagen, whether AA is also involved in TGFβ1-induced myofi-
broblast formation. A marker of myofibroblasts is the presence of 
αSMA stress fibers, which are absent in quiescent fibroblasts [27]. 
We first measured mRNA (ACTA2) and protein levels of ̈SMA, 
and found that AA or TGFβ1 alone did not significantly increase 
ACTA2 mRNA levels, but that the combination AA + TGFβ1 does 
result in a major increase (Figure 2A). Staining for αSMA showed 
a modest formation of stress fibers at day 6 under the influence 
of TGFβ1, whereas an abundance of stress fibers was observed 
with the combination AA + TGFβ1 (Figure 2B). Incubation with AA 
alone did not result in the formation of stress fibers. Immunoblots 
showed elevated levels of αSMA at day 2 and 6 in the presence 
of TGFβ1 or AA + TGFβ1, but not with AA alone (Figure 2C). These 
data show that AA facilitates the TGFβ1-induced myofibroblast 
formation. Since αSMA stress fibers contribute to myofibroblast 
contractility [28–30], we assessed the impact of AA combined 
with TGFβ1 on myofibroblast contractility with a collagen lattice 
contraction assay. Combined stimulation with AA and TGFβ1 in-
deed resulted in increased contraction in a 3D collagen lattice 
(Figure 3A, B). 
Figure 2. Ascorbic acid amplifies TGFβ1-induced αSMA expression. (A) Relative mRNA expression of 
ACTA2. Cells were exposed to bare medium or TGFβ1 for 2 or 6 days with or without addition of AA. 
(B) Representative immunofluorescent confocal photomicrographs of αSMA staining on day 2 and 
6. Nuclei are visualized with DAPI. Original magnification 630x; scale bar = 100 µm. (C) Immunoblot 
on complete cell lysates for αSMA after 2 and 6 days. Data are represented as mean ± SD. Two-way 
ANOVA with Bonferroni post-test. ** p<0.01; **** p<0.0001. AA, ascorbic acid; kD, kilo Dalton; αSMA, 





















AA ENHANCES THE EXPRESSION OF COL4A1, CCN2 AND DDR1    
Since AA seems to be involved in the TGFβ1-induced myofibro-
blast phenotype, we investigated whether AA is involved in the 
expression of other genes known to be upregulated in myofibro-
blasts. We analyzed the expression of genes coding for various 
ECM components together with proteins and enzymes involved 
in collagen synthesis and degradation. Microfluidic card-based 
low density array analysis revealed that compared to bare me-
dium or AA alone, TGFβ1 increases the expression of multiple 
genes, including COL4A1, P4HA2, P4HA3, and COL5A1 (Figure 
4A). Moreover, combined stimulation with TGFβ1 and AA lead 
to further upregulation of COL4A1 (Figure 4A, B). The pro-fibrotic 
gene CCN2 showed a similar upregulation when AA and TGFβ1 
are combined (Figure 4B). These data suggest that AA increases 
the expression of some but not all TGFβ1-responsive genes. Im-
munofluorescence analysis confirmed the increase of collagen 
type IV after TGFβ1 stimulation and that AA enhances the syn-
thesis of collagen type IV compared to TGFβ1 alone (Figure 4C). 
An example of a gene that is non-responsive towards TGFβ1 but 
that is expressed on AA exposure is the collagen receptor DDR1 
(Figure 4A, B).    
Figure 3. Ascorbic acid promotes TGFβ1-induced collagen contraction. (A) representative photo 
scan of a 24-well plate containing a myofibroblast-populated collagen lattice, exposed to TGFβ1 
and stimulated with or without AA for 72 h. (B) Quantification of panel A. Data are represented as 
mean ± SD. Two-way ANOVA with Bonferroni post-test. *** p<0.001; **** p<0.0001. AA, ascorbic acid; 





















   
ASCORBIC ACID MEDIATED MYOFIBROBLAST PHENOTYPE SWITCH IS 
SMAD2/3 INDEPENDENT
Smad2, together with Smad3, are the major transcriptional ef-
fectors of the canonical TGFβ1 signaling cascade, and have 
been shown to govern the expression of several collagens and 
αSMA [31–33]. To investigate the relationship between AA and 
Smad2/3 transcriptional activity, we transiently transfected fibro-
Figure 4. Ascorbic acid synergizes with TGFβ1 to mediate expression of ECM components. (A) Heat 
map of a microfluidic card-based low density array-based mRNA expression. Cells were exposed to 
bare medium or TGFβ1 for 2 or 6 days with or without addition of AA. Heat map shows fold induction 
over bare treatment (-AA -TGFβ1). (B) Relative mRNA expression of COL4A1, CCN2, and DDR1. (C) 
Representative immunofluorescent confocal photomicrographs of collagen type IV staining. Orig-
inal magnification 630x; scale bar = 50 µm. Data are represented as mean ± SD. Two-way ANOVA 
with Bonferroni post-test. * p<0.05; *** p<0.001; **** p<0.0001. AA, ascorbic acid; TGFβ1, transforming 





















blasts with a SBE4-luc promotor construct containing four copies 
of a Smad-binding element in front of a luciferase reporter gene. 
TGFβ1 alone increased the transcriptional activity of Smad2/3 
compared to bare medium and AA alone (Figure 5A). However, 
combined stimulation of TGFβ1 and AA did not further enhance 
luciferase activity significantly. Moreover, immunofluorescence 
analysis revealed that AA addition does not enhance the nucle-
ar accumulation of Smad2 compared to TGFβ1 alone (Figure 5B). 
These data suggest that the effects of AA on the expression of 
signature myofibroblast genes are independent of Smad2, and 
probably Smad3 signaling.
DISCUSSION
We investigated the effect of AA in the presence or absence 
of TGFβ1 on collagen deposition at day 2 and 6 into more de-
tail by means of quantitative RT-PCR and with antibodies direct-
ed toward the N-propeptide of procollagen type I, the native 
(triple helical) structure of the collagenous part of procollagen 
type I (thus recognizing only native collagen and procollagen), 
and an antibody recognizing procollagen and collagen type I 
in both its native and denatured state. This resulted in some un-
expected findings. First, AA alone does not change mRNA levels 
of COL1A1 on day 2, but does increase COL1A1 expression on 
day 6, although not significantly. Similarly, AA resulted in a major 
Figure 5. Ascorbic acid does not affect Smad2/3 signaling. (A) Smad binding element (SBE) promot-
er activity luciferase assay. (B) Representative confocal immunofluorescent photomicrographs of 
Smad2 staining. Original magnification 630x; scale bar = 50 µm. Data are represented as mean ± SD. 
Two-way ANOVA with Bonferroni post-test. ** p<0.01. AA, ascorbic acid; AU, arbitrary units; TGFβ1, 





















increase of COL1A1 mRNA levels at day 6 in combination with 
TGFβ1, whereas this was not seen at day 2. Second, procolla-
gen was observed in all experimental conditions (bare medium; 
TGFβ1; AA; AA + TGFβ1) intracellularly, whereas extracellular pro-
collagen was observed only in the presence of AA. Third, native 
procollagen (or native collagen) was barely observable under 
control or TGFβ1 conditions, but was clearly seen in the presence 
of AA. The presence of extracellular procollagen or extracellu-
lar native collagen/procollagen was most obvious when AA was 
combined with TGFβ1. 
From the protein data one can conclude that, although procol-
lagen is present in all conditions, the procollagen is only present 
in its triple helical form when AA is present. We did not observe 
extracellular procollagen in the absence of AA, indicating that 
the non-native procollagen is not excreted by the cell and/or is 
immediately degraded in the extracellular space. The immunob-
lot revealed, that at day 6 the non-native procollagen was not 
processed into collagen (i.e. the N-propeptides and C-propep-
tides were not cleaved off), whereas tropo-collagen was seen in 
the presence of AA. Indeed, cleavage of the N-propeptides oc-
curs only when the procollagen is in its native state [11,12] . The 
native state is facilitated by the presence of Hyp [34]. Absence 
of AA results in a severe underhydroxylation of proline residues, 
since AA is a co-factor for prolyl hydroxylase [26].
 
It should be stressed that most antibodies towards collagen type 
I react with both native and denatured collagen proteins. Stud-
ies carried out with human fibroblasts in the absence of AA will 
detect collagen with such antibodies, but by far the majority of 
this “collagen” actually represents non-native procollagen. Not 
knowing this will clearly lead to unreliable conclusions, and this 
can unfortunately be readily observed in the existing literature.
It is well-known that TGFβ1 promotes the differentiation of fibro-
blasts into myofibroblasts [10,35–37]. Much to our surprise, we 
observed that this process is facilitated by AA, as shown by the 
dramatically increased ACTA2 mRNA levels when TGFβ1 was 
combined with AA. mRNA levels of ACTA2 were not increased in 





















AA and TGFβ1. This was also obvious at the protein level: staining 
for αSMA stress fibers revealed much more myofibroblasts at day 
6 compared to AA or TGFβ1 alone, which indeed resulted in an 
increased contraction of a 3D collagen lattice. Thus, AA works 
in synergy with TGFβ1, facilitating the pro-fibrotic properties of 
TGFβ1. However, not all TGFβ1-responsive genes were addition-
ally upregulated by AA, indicating that the action of AA is not 
regulated via Smad2/3, being the canonical TGFβ1 pathway. In-
deed, we observed that AA did not enhance the nuclear trans-
location of Smad2, and no increased activity was observed with 
a luciferase reporter containing four copies of a Smad-binding 
element. 
The heat map shows that the addition of AA alone results in a 
change in the expression pattern of only a few genes, but that 
AA in combination with TGFβ1 is involved in the general enhance-
ment of the myofibroblast expression profile in dermal fibroblasts. 
However, how exactly AA amplifies the TGFβ1-induced myofibro-
blast phenotype remains elusive. We speculate that this is likely 
due to the function of AA in epigenetics. Several studies highlight-
ed that AA is involved in the process of active demethylation of 
cytosine (5mC), mediated by the ten-eleven translocation (Tet) 
methylcytosine dioxygenases enzymes Tet1, Tet2 and Tet3 [37]. 
Conventionally, 5mC is regarded as mark for the transcriptionally 
repressed chromatin, and DNA methylation of lineage-specific 
loci govern cellular differentiation programs [38,39]. Similar to 
the prolyl hydroxylases P3H and P4H, AA acts as electron donor 
for Tets and reduces Fe3+ to Fe2+. Moreover, it is thought that 
AA also acts as cofactor for the Jumonji C-domain containing 
histone demethylases (jmjC) [40]. Methylation of histones is de-
scribed as another tier of chromatin remodeling, which is associ-
ated with either activation of repression of transcription [41]. The 
importance of AA in determining the epigenetic landscape has 
also emerged in the reprogramming of induced pluripotent stem 
cells, which are unable to be fully reprogrammed in the absence 
of AA [41].
In conclusion, we have not only shown why AA is crucial in the 





















TGFβ1-induced adoption of a myofibroblast phenotype. Thus, 
AA is involved in fibrotic processes at multiple levels. Finally, we 
speculate that AA induces epigenetic changes, thereby regulat-
ing expression of multiple myofibroblast-related genes. 
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The recognition that cells are mechanosensitive and respond to 
changes in stiffness has led to new insights into cell-biomaterial 
interactions[1–5]. Mesenchymal stem cell fate can be directed 
solely by stiffness[6–8], myocytes optimally differentiate on sub-
strate with tissue-like stiffness[9–11], while fibroblasts gain a con-
tractile, myofibroblasts-like phenotype on substrates with higher 
stiffness[12–15]. Although mesenchymal mechanosensing has 
been studied in great detail, not much is known about mechano-
sensing in macrophages. Macrophages are master regulators of 
a wide range of intricate processes, and play an important role 
in host-defense and wound healing. This thesis investigated the 
effect of stiffness (Young’s modulus) on macrophage polarization 
and multinucleation, and studied fibroblast behavior in wound 
healing and fibrosis.
MECHANOBIOLOGY: ON THE VERGE OF BIOLOGY 
AND ENGINEERING
For decades’ biomaterials – materials engineered to interact 
with(in) biological systems for medical purposes – are used to 
mimic or augment specific tissues in vivo, and are used on a daily 
basis in the clinic. However, upon implantation of foreign body 
materials, our body will elicit a material-dependent inflammatory 
response[16]. This response is aptly named the foreign body re-
sponse. (FBR). The biomaterials’ chemical composition and me-
chanical properties play an important role in the onset of the 
FBR[17]. Much effort is put into tuning the biomaterial composi-
tion and properties to facilitate optimal host-biomaterial com-
patibility and to attenuate the material-dependent inflammato-
ry response[18–20]. During the FBR, proteins form a cohesive layer 
over the biomaterial, enabling macrophages to densely popu-
late the surface in an effort to degrade the biomaterial. If suc-
cessful, the biomaterial will be fully degraded and the FBR will not 
endure. However, if the biomaterial cannot be degraded, then 
chronic inflammation will lead to macrophage fusion, forming 
multinucleated giant cells. In a later stage of the FBR, fibroblasts 
encapsulate the biomaterial, effectively trapping macrophages 




















Monocytes in the bloodstream attracted by chemokines extrav-
asate into the site of injury during wound repair. During diapedes-
is monocytes extravasate from the bloodstream into the affect-
ed tissue and start producing macrophage colony stimulating 
factor (M-CSF) under the influence of granulocyte macrophage 
colony-stimulating factor, tumor necrosis factor alpha and inter-
feron gamma[21].  Once inside the affected tissue, monocytes 
differentiate into CD68+ mature macrophages and are in direct 
contact with the affected tissue. Macrophages are highly dy-
namic plastic cells[22] and have two main activation states: in 
vitro they polarize into either an inflammatory (M1) phenotype, 
or in a wound healing/homeostatic (M2) phenotype[23–25]. The 
function and role of macrophages in tissue is mainly determined 
by acquisition of either a M1 or M2 phenotype. Macrophages 
instruct fibroblasts to proliferate and produce extracellular ma-
trix (ECM) components[22] and are known to be influenced by 
cytokines and pathogen-associated molecular patterns (PAMPs) 
during wound healing[22]. Macrophages exposed to interfer-
on-gamma (IFNγ) and/or lipopolysaccharide (LPS) display a M1 
phenotype, whereas macrophages exposed to the interleukins 
IL4 and/or IL13 display a M2 phenotype[24].  It is of crucial im-
portance to understand that the phenotypic properties of mac-
rophages form part of a continuum; therefore, many interme-
diates exist between M1 and M2 in vivo. Although the effect of 
cytokines and solubles on macrophage polarization and behav-
ior have been studied in great detail, the effect of stiffness on 
macrophage biology has remained elusive. 
POLYACRYLAMIDE: A SUITABLE IN VITRO MODEL?
 In order to study the effect of stiffness on macrophage and fibro-
blast behavior, we developed a 2D polyacrylamide (PAAM) in 
vitro culture model in Chapter 2. Polyacrylamide hydrogels with 
a pre-tunable stiffness offer chemical, mechanical and optical 
advantages for studying cell mechanosensing in vitro, but due to 
their biologically inert surface macrophages and fibroblasts do 
not adhere. In order to functionalize such polyacrylamide hydro-
gels for 2D cell culture, we used 3,4-dihydroxy-L-phenylalanine 


















byssus adhesion[26–29]. L-DOPA was found to be able to crosslink 
a thin layer of extracellular matrix (ECM) to the inert PAAM sur-
face[30]. We compared our results with sulfo-SANPAH, the gold-
en standard used in polyacrylamide mechanosensing studies, 
and found more homogeneous adherence of ECM to the PAAM 
surface when using L-DOPA. Fibroblasts responded to differences 
in PAAMs stiffness; morphology, cell size and protein localization 
were all affected as expected and in accordance with literature 
where other cross-linkers were used. Our novel model developed 
in Chapter 2 was used in Chapters 3, 4, 5 and 6 to study mac-
rophage and fibroblast mechanosensing and mechanotrans-
duction. 
MACROPHAGE MECHANOSENSITIVITY AND POLARIZATION STATUS
In order to study the effect of stiffness on macrophage behavior 
we differentiated monocytes cultured on polyacrylamide hydro-
gels functionalized with collagen type I to CD68+ positive mac-
rophages. Only two other recent studies have shown the effect 
of stiffness on human macrophage behavior[31,32]. Irwin et al. 
used a THP-1 non-adherent monocytic cell line which they acti-
vated by means of phorbol myristate acetate (PMA). In this study 
they used hydrogels with a stiffness of 1.4, 6.0, 9.9 and 348 kPa, 
and all hydrogels were functionalized with a peptide containing 
the Arg-Gly-Asp (RGD) motif. No effect was observed for TNFα 
secretion, while IL-8 demonstrated a biphasic response (low at 
1.4, 6.0 and 348 kPa, a 2 to 3 fold increase on 9.9 kPa)[31]. PMA 
however, triggers the rapid hydrolysis of inositol phospholipids 
to diacylglycerol and inositol phosphates by phospholipase C 
(PLC). Diacylglycerol functions as an allosteric activator of pro-
tein kinase C (PKC) activation, which trigger calcium ion release 
and leads to a cascade of cellular signaling[33]. As calcium ions 
play a pivotal role in a wide range of cell signaling pathways, 
this study cannot directly be compared to our M-CSF stimulated 
macrophages derived from primary monocytes. In a separate 
study by Patel et al., human U937 macrophages (cell line) were 
cultured on PAAMs with a stiffness range of 0.3 to 76.8 kPa and 
stimulated with PMA to form macrophages. Patel et al. found a 
slight decrease in TNFα production as a function of stiffness. We 


















cells (not cell lines) and M-CSF (not PMA) to obtain macrophag-
es. 
Two other studies did observe an effect of stiffness on mouse 
macrophages, but the stiffness at which an effect sorted often 
far exceeded the biophysical range[34,35]. Previtera & Sengup-
ta (2016) obtained mouse bone marrow monocytes and differ-
entiated them to macrophages with high dosage M-CSF (20-40 
ng/mL for a total of 6-7 days). In comparison, we only used 10 ng/
mL M-CSF and only treated our cells for 3 days to obtain fully ma-
ture CD68+ macrophages. Next, mouse macrophages were stim-
ulated with M1 inducing lipopolysaccharide (LPS) and cultured 
on collagen-coated PAAMs with a stiffness ranging from 0.3 to 
230 kPa. TNFα, NO, and IL1β mRNA synthesis were only increased 
when macrophages were cultured on PAAMs with a stiffness high-
er than 120 kPa, far exceeding the physiological range (Chap-
ter 1). Only IL6 production already increased at an intermediate 
stiffness of 47 kPa. We did observe a slight biphasic response in 
IL-6 mRNA synthesis on 12 kPa and glass (>70GPa). However, we 
did not observe any induction of IL-6 by stiffness alone.
Blakney et al. (2012) showed, in a similar experimental setup, an 
increase of IL1β, IL6 and IL10 expression at 840 kPa compared to 
130 kPa; no such effect was seen for TNFα. Again, these stiffness 
moduli far exceed the physiological range. Furthermore, a study 
conducted by Martinez et al. clearly demonstrated that mouse 
macrophages are phenotypically and genotypically completely 
different from their human counterparts[36]. 
While other studies have focused on  the effect of stiffness on the 
macrophage cytoskeleton[37–40], they did not study the effect 
of stiffness on macrophage polarization status, nor did they study 
whether stiffness in the biophysical range had an effect on the 
activation status of human macrophages when stimulated with 
M1 (LPS/IFNγ ) or M2 (IL4/IL13) inducing cytokines. A study from a 
different group (using rat alveolar macrophages) also reported 
no differences in cell size between intermediate (40 kPa) and stiff 
(160 kPa) hydrogels. However, if stiffness was reduced to 0.1 kPa 
(epithelial cell layer) a reduction in cell size and cell height was 


















observed with mesenchymal cells. 
In our study, monocytes isolated from human donors were seed-
ed in high density on polyacrylamide hydrogels with 4 different 
stiffness, and functionalized with collagen type I (Chapter 3). The 
polyacrylamide stiffness ranged from internal organs/skin (4 kPa) 
up to severe fibrotic tissue (92 kPa). All adherent monocytes dif-
ferentiated into mature CD68+ macrophages within three days 
of MCS-F stimulation (both on protein and mRNA level).  We did 
not observe any effect of stiffness on macrophage polarization 
capacity when induced by M1 or M2 cytokines, and observed 
no effect of stiffness alone on macrophage polarization: CD68+ 
macrophages stimulated with LPS/IFNy obtained an M1 pheno-
type as observed by the RNA expression of CD40, IL1B, CCL5 and 
IL6. Cells stimulated with IL4/IL13 obtained a M2 phenotype as 
observed by the RNA expression of CD209, CD1B, MRC1 (CD206), 
CLEC10A (CD301 or MGL) and CCL18. Also, stiffness as a param-
eter on its own did not induce either M1 or M2 phenotype. Clear-
ly, substrate stiffness, when functionalized with collagen type I 
does not seem to have an effect on macrophage polarization. 
This however, does not mean macrophages are not mechano-
sensitive. Stiffness can induce changes in attachment[41], mor-
phology[37–39], migration[42] and even direct macrophage 
function, such as phagocytosis[39,43,44].
MACROPHAGE FUSION: A STIFFNESS AND ECM-DEPENDENT 
MECHANISM
Biomaterials transplanted in the body display a wide variety of 
different characteristics such as chemical composition, surface 
roughness/topography and stiffness, which come in direct con-
tact with macrophages extravasating from the bloodstream into 
the area of injury. Macrophages are one of the first responders 
and are in direct contact with the foreign body material. The en-
suing foreign body reaction is divided into three phases: the onset 
phase, the progression phase and the resolution phase. The onset 
phase starts directly after implantation of the biomaterial when 
proteins (such as fibronectin) adsorb to the biomaterial surface. 
Infiltrating macrophages and leukocytes come in direct contact 


















characteristics, will try to invade and/or degrade it. Transitioning 
into the progression phase, acute inflammation turns into chron-
ic inflammation, which include activated macrophages and the 
formation of foreign body giant cells (FBGC). Macrophages and 
their fused counterparts, FBGCs,  secrete factors that attract and 
activate resident fibroblasts. These fibroblasts form a fibrous cap-
sule around the implant, effectively trapping macrophages and 
foreign body giant cells at the biomaterial surface. During the 
resolution phase macrophages and FBGC often persist on the 
biomaterial surface during the entire lifetime of an implant, trying 
to degrade and invade the foreign body material.
To study the effect of stiffnes on the foreign body response, we 
changed the ECM type to plasma fibronectin in Chapter 4 and 
stumbled upon enhanced ECM and stiffness-dependent giant 
cell formation. Although macrophage polarization into M1 or M2 
phenotypes did not seem to be influenced or directed by stiff-
ness, changing the ECM type from collagen type I (Chapter 3) 
to fibronectin (Chapter 4) led to an enormous increase in the 
amount of giant cells. Fibronectin has been associated with an 
increase in multinucleation in other studies as well[45,46], but to 
our knowledge, no studies exists which focus on the effect of stiff-
ness on macrophage multinucleation. 
We used freshly isolated CD14+ human monocytes and differ-
entiated the cells towards macrophages by M-CSF stimulation 
on fibronectin functionalized 4, 12, 26 and 92 kPa PAAMs, similar 
to the protocol used in Chapter 3. We observed small multinu-
cleated cells on 12 and 26 kPa hydrogels, whereas only mono-
nucleated macrophages were observed at lower (4 kPa) and 
higher (92 kPa) stiffness. Evidently, this shows that certain stiff-
ness values can induce macrophage fusion. Macrophages were 
subsequently left unstimulated or were stimulated with IL4/IL13, 
cytokines known to induce the formation of FBGC[46–50]. After 
only 24 hours of stimulation, we observed large multinuclear gi-
ant cells on 12 and 26 kPa, independent of IL4/IL13 stimulation.
In comparison, it usually takes at least 7 days to obtain foreign 
body giant cells[51], while we already observed giant cells after 


















To unravel the mechanism behind this enhanced macrophage 
multinucleation, we performed gene expression analysis. Inter-
estingly, none of the markers described in literature as giant cell 
markers seemed to be upregulated when comparing different 
hydrogels (Chapter 4). To determine if this effect was similar on 
protein level, we stained for both DC-STAMP and CD44, two well 
described fusion markers[52–57], and did not observe any differ-
ence in protein expression between different hydrogels or be-
tween multinucleated giant cells and non-fused macrophages. 
We did not unravel which marker facilitated this enhanced mult-
inucleation.
CD44 IN MACROPHAGE FUSION
In Chapter 5 we investigated whether the CD44 pathway is in-
volved  in our fusion-related findings in Chapter 4.  CD44 is a 
cell-surface glycoprotein involved in cell-cell interactions, 
cell-surface adhesion and migration, and can directly regu-
late RAC1. RAC1 is a pleiotropic regulator actively involved in 
cytoskeletal remodeling, and macrophage fusion is accom-
panied by cytoskeletal reorganizations[50,58].  Cellular pro-
trusions called lamellipodia are observed before macrophage 
fusion[59,60], and CD44-RAC1 are regulators of lamellipodia for-
mation[59,61,62]. CD44 is described as a giant cell marker[55,57], 
and knockdown of the intracellular part of CD44 greatly attenu-
ates giant cell formation[56]. RAC1 has been described in mac-
rophage fusion, and is necessary for the formation of osteoclasts 
and foreign body giant cells via MMP14 (MMP-MT1)[60]. Howev-
er, we did not observe any difference in CD44 expression (both 
RNA and protein level), or gene expression downstream of RAC1 
(POR1, ARP2/3, PAK1, CDC42, ROCK, RhoA). In fact, in most in-
stances gene expression was higher on the glass+DOPA+FN con-
trol, while no giant cells were observed under this condition. In 
conclusion, although CD44 is considered a plausible candidate 
in macrophage mechanosensing-based fusion, we observed no 
differences in CD44 expression between macrophages cultured 
on different stiffness, and downstream genes had similar expres-




















In Chapter 6 we investigated the role of αII- and βII-spectrin in 
fibroblasts, two major cytoskeletal proteins that line the intracel-
lular side of the plasma membrane and are tethered to the cy-
toskeleton[63]. Spectrins play an import role in maintaining cellu-
lar morphology and integrity[64]. In this chapter we investigated 
the role of spectrins in fibroblast mechanosensing and myofibro-
blasts formation. Spectrins have been linked to migration[65], cell 
spreading[66–68], cell adherence and Yes-associated protein 
(YAP) localization[69–71] in cells other than fibroblasts. YAP acts 
as a transcriptional regulator of genes involved in proliferation 
and suppression of apoptotic genes and is regulated by both 
Hippo and  TGFβ1 signaling [12,72]. YAP is a proline-rich phos-
phoprotein involved in mechanotransduction. YAP, also known 
as YAP65, was discovered as it binds to the SH3 domain of the 
Yes proto-oncogene product[73–75]. Spectrins also display this 
specific SH3 domain[66], which participates in RAC activation 
(Chapter 5).  In Chapter 2 we observed stiffness induced translo-
cation of YAP to the nucleus, and we wondered  whether spec-
trins could act as stiffness-specific rheostats, enabling mesenchy-
mal cells to sense differences in substrate stiffness. 
We found that spectrin deficiency in adult dermal fibroblasts did 
not affect cell adhesion, cell spreading or migration: cell num-
bers and size were similar between KD cells and controls, and in 
vitro wound repopulation was equally efficient. Furthermore, an 
equal amount of supermature focal adhesions were observed 
between controls and spectrin knockdown, which means spec-
trin knockdown had no effect on focal adhesion formation[68]. 
YAP was sequestered to the cytoplasm when fibroblasts where 
cultured on low stiffness hydrogels (2kPa) and translocated to 
the nucleus on higher stiffness. Although βII-spectrin is reported 
to regulate SMAD signaling[76,77] in mesenchymal cells, spectrin 
deficiency did not seem to abrogate TGFβ1-induced canonical 
SMAD signaling in our cells, as observed by a significant upregu-
lation of αSMA stress fibers and collagen type I in fibroblasts stim-
ulated with TGβ1 after αII-spectrin and βII-spectrin siRNA induced 
knockdown.
Since spectrin knockdown did not seem to have any adverse 


















ditions the localization of YAP is mainly regulated by Hippo-inde-
pendent mechanisms. These mechanisms include actin polym-
erization and Smad3 shuttling[12,73,78]. Our data indicate that 
spectrins are, in contrast to their crucial role in the Hippo path-
way to regulate YAP, not required to regulate YAP in the mech-
anotransduction pathway.
In fact, upon further inspection, TGFβ1 reduced αII-spectrin 
(SPTAN1) gene expression two-fold, and βII-spectrin (SPTBN1) 
gene expression four-fold. This again indicates that in adult hu-
man myofibroblasts both αII-spectrin and βII-spectrin do not in-
terfere with SMAD signaling. Despite diverse roles in other cell 
types, we observed no significant changes in human adult der-
mal fibroblast morphology or function after spectrin knockdown.
ASCORBIC ACID
In Chapter 7 we investigated the role of ascorbic acid on human 
adult dermal fibroblast to myofibroblasts differentiation. Most an-
imal studies on wound healing are performed with rodents, while 
rodents are – unlike humans – able to synthezise ascorbic acid. Hu-
mans are therefore dependent on dietary ascorbic acid intake. 
In 1757 James Lind was the first who discovered that scurvy could 
be treated and prevented with citrus fruit dietary intake[79]. It 
would take until 1932 before the anti-scorbutic agent hexuronic 
acid, first isolated by Hungarian biochemist Szent-Györgyi, was 
proven to treat scurvy[80]. After these experiments hexuronic 
acid was renamed to ascorbic acid[80].
In Chapter 7 we observed that, although procollagen is present 
in all conditions, it is only present in its triple helical form when 
ascorbic acid is present. When human adult fibroblasts were 
stimulated with TGFβ1 alone, no maturation of pro-collagen type 
I to collagen type I was observed, which is in accordance with lit-
erature[81]. Furthermore, ascorbic acid synergistically amplified 
the TGFβ1-mediated effect on collagen type I mRNA expression. 
αSMA stress fibers are a hallmark of myofibroblasts formation 
where fibroblasts gain a more contractile phenotype and pro-
duce large quantities of collagen type I. As fibrosis is charac-


















whether ascorbic acid could regulate fibroblast to myofibroblasts 
differentiation. Interestingly, the formation of αSMA stress fibers 
was, much like collagen type I, under direct control of TGFβ1 and 
ascorbic acid. Although TGFβ1 alone induced αSMA stress fibers, 
this stimulation was much less pronounced when compared to 
TGFβ1 combined with ascorbic acid. Ascorbic acid treatment 
alone did not induce any stress fiber formation, further outlin-
ing the synergy between TGFβ1 and ascorbic acid. Our findings 
clearly illustrate the crucial role ascorbic acid plays in wound 
healing and fibrosis in dermal tissue.
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Mechanosensing beschrijft de respons van cellen op mechanis-
che stimuli. De wondhelingscellen (fibroblasten) in ons lichaam 
reageren sterk op mechanische stimuli, en toch wordt al jaren 
vrijwel alle experimenten uitgevoerd op polystyreen, een be-
paald soort plastic met een stijfheid die ver boven het fysiolo-
gische bereikrange ligt. Tijdens gestoorde wondheling (fibrose) 
veranderen fibroblasten in myofibroblasten (myo = spier). Dit 
houdt in dat de fibroblast contraherende eigenschappen krijgt 
vanwege de expressie van cytoskelet eiwitten, zoals het α-glad-
de spier-actine. Tevens produceren myofibroblasten grote hoev-
eelheden gecrosslinked collagen, hetgeen aanleiding geeft tot 
een stijver weefsel, waardoor weer meer myofibroblasten ont-
staan tijdens het fibrose proces (terugkoppelingsreactie ofwel 
feedback loop).
Het doel van dit proefschrift was het ontwerpen van een nieuw in 
vitro kweekmodel waarbij cellen op fysiologische stijfheid en op 
verschillende extracellulaire matrix (ECM) eiwitten (= de eiwitten 
die normaal om cellen heen liggen) gekweekt kunnen worden. 
Dit model bestaat uit verschillende lagen. Voor de onderste laag 
is gebruik gemaakt van een organisch acrylaatpolymeer, waar-
bij de verhouding acrylamide en bisacrylamide de uiteindelijke 
stijfheid bepaald. De volgende laag bestaat uit L-DOPA, een 
stof welke de mossel een sterke aanhechting geeft aan organ-
ische en anorganische ondergronden. Deze stof is als ‘lijm’ ge-
bruikt voor binding van de derde laag, de ECM-eiwitten. Deze 
methode is beschreven in hoofdstuk 2, waarbij er ook direct een 
vergelijking is gemaakt met het tot op heden gebruikte model 
(sulfo-SANPAH). Hieruit kwam duidelijk naar voren dat L-DOPA de 
ECM aanmerkelijk beter en heterogener aan de gels met ver-
schillende stijfheid kan koppelen. Hierdoor vindt er geen convo-
lutie plaats van ECM-dichtheid en stijfheid, waardoor beter het 










Macrofaag, bestaande uit de woorden macro (=groot) en faag 
(=eter) is een ontstekingscel betrokken bij het opruimen van 
dode resten van cellen en het klaren van micro-organismen en 
anorganische inerte deeltjes. Macrofagen zijn onderdeel van het 
aangeboren immuunsysteem en spelen o.a. tijdens wondheling 
een zeer belangrijke rol.
Bij wondheling zijn macrofagen het meest talrijk tijdens de chro-
nische ontstekingsfase. De macrofaag helpt bij het opruimen en 
instrueert o.a. de fibroblast. Macrofagen kennen twee uitersten 
in een glijdende schaal: de M1 en de M2 macrofaag. De M1 of 
klassiek geactiveerde macrofaag is een pro-inflammatoire mac-
rofaag: d.w.z. dat de M1 zorgt voor meer ontsteking. De M2 of 
alternatief geactiveerde macrofaag is een anti-inflammatoire 
macrofaag welke betrokken is bij weefsel herstel en homeostase. 
Het doel van hoofdstuk 3 was te kijken in hoeverre de polarisatie 
van humane macrofagen gereguleerd kan worden door stijfheid. 
Dit is belangrijk omdat er een strikte balans moet zijn tussen pro 
en anti-inflammatoire om een juiste wondheling te faciliteren.
 In dit hoofdstuk zijn de gels gecoat met collageen type I, het 
meest voorkomende ECM type tijdens de wondhelingsrespons, 
en zijn humane monocyten tot macrofaag gestimuleerd met 
behulp van macrophage colony stimulating factor (M-CSF). Na 
3 dagen M-CSF zijn de macrofagen verdeeld in 3 groepen: (1) 
M1, gestimuleerd met LPS en interferon gamma, (2) M2, gestimu-
leerde met interleukine 4 en 13 of (3) ongestimuleerde of naïeve 
macrofagen, gekweekt met alleen gecomplementeerd medi-
um. Vooral de derde groep was in deze erg interessant, om te 
kijken of stijfheid aanzette tot een bepaald fenotype. De con-
clusie van dit hoofdstuk is dat stijfheid geen effect lijkt te hebben 
op macrofaag polarisatie; polarisatie capaciteit was even hoog 
onafhankelijk van de stijfheid en stijfheid an sich zette niet aan 
tot een bepaald genotype.
DE VREEMDLICHAAMSREACTIE
Als voorwerpen in het lichaam worden geplaatst, zorgt dit voor 
een zogenaamde vreemdlichaamsreactie. Tijdens deze vreem-
dlichaamsreactie ontstaat een ontstekingsreactie waarbij het 








ten. De macrofaag en de fibroblast spelen hierbij een hoofdrol. 
Macrofagen binden aan het oppervlak van het (bio)materiaal 
en proberen binnen te dringen en het materiaal te degraderen. 
Vaak zijn de materialen te groot voor macrofagen om te degra-
deren, wat leidt tot “gefrustreerde fagocytose”. Dit leidt uitein-
delijk tot macrofaag fusie: een grote cel met vaak tientallen tot 
honderden kernen.  In hoofdstuk 4 hebben wij gekeken naar het 
effect van stijfheid gecombineerd met een andere ECM-compo-
nent, fibronectine, op macrofaag fusie. Fibronectine, en vooral 
de aminozuurvolgorde arginine-glycine-asparaginezuur (het 
tripeptide RGD) in fibronectine is beschreven als induceerder 
van macrofaag fusie. In dit hoofdstuk zagen wij een stijfheid en 
ECM-geïnduceerd effect op macrofaag fusie. Bijzonder gegeven 
was dat er geen verschil zat tussen onze resultaten ten aanzien 
van fusie en de beschreven fusie genen: geen van de genen kon 
gerelateerd worden aan het wel of niet optreden van fusie.
CD44 
Om een verklaring te geven hoe stijfheid en fibronectine fusie 
kunnen faciliteren is in hoofdstuk 5 gekeken naar de CD44 / Small 
GTPase pathway. CD44 is een membraaneiwit dat gevonden 
wordt in vrijwel alle ontstekingscellen, inclusief macrofagen. 
CD44 is beschreven als een macrofaag fusie marker, waarbij 
het intracellulaire domein afsplitst, en zorgt voor activatie van 
zogenaamde Small GTPases; eiwitten die o.a. betrokken zijn bij 
cytoskelet modificaties. Het is bekend dat er cytoskelet modifi-
caties plaatsvinden vlak voor en tijdens fusie. We hebben geen 
verschillen gevonden in CD44 expressie tussen “gewone” mac-
rofagen en macrofagen die gefuseerd waren. Verder is er geen 
verschil geobserveerd in CD44 expressie tussen de verschillende 
stijfheden. Hierop hebben we gekeken naar genexpressie van 
CD44 en genen die (indirect) gereguleerd worden door CD44. 
Helaas waren er weinig verschillen te vinden in de genen die 
aangezet worden door activatie van CD44.
SPECTRINS
In dit hoofdstuk lag de focus op de wondhelingscellen, de fibro-
blasten. In hoofdstuk 6 is gekeken naar spectrins in fibroblasten, 








witten bestaande uit 2 subunits: αII- en βII-spectrin. Deze lang-
vormige, rekbare eiwitten binden enerzijds het actine cytoskelet 
en anderzijds de binnenzijde van het celmembraan. Spectrins 
zijn beschreven als eiwitten die betrokken zijn bij cel uitspreiding 
en migratie, en bij regulatie van Yes-associated protein (YAP). 
YAP is een goed bestudeerd mechanosensing eiwit betrokken bij 
celdeling en cel differentiatie. Hoewel er veel bekend is over de 
rol van spectrin in verschillende soorten cellen, is er nooit gekek-
en wat de rol is van deze eiwitten in fibroblasten. Daarom heb-
ben we fibroblasten gekweekt op verschillende stijfheden, en 
hebben we gekeken naar een knockdown van beide genen. Tot 
onze verrassing had spectrin knockdown geen effect op wond 
heling, migratie en/of differentiatie van fibroblasten in myofibro-
blasten.
VITAMINE C
In dit hoofdstuk lag de focus op de wondhelingscellen, de fibro-
blasten. In hoofdstuk 7 is gekeken naar het effect van vitamine 
C op fibroblast functie, en differentiatie van fibroblasten in my-
ofibroblasten. Vitamine C lijkt naast een (bekend) effect op col-
lageen type I, ook een groot effect uit te oefenen op myofibro-
blast formatie. Dit gebeurde alleen als vitamine C gecombineerd 
werd met transforming growth factor β1 (TGF β1) stimulatie. Vita-










αSMA  Alpha smooth muscle actin
AA   Ascorbic acid
AFM   Atomic force microscopy
ANOVA  Analysis of variance
APS   Ammonium Persulfate
BSA   Bovine serum albumin
CCL2   Chemokine (C-C motif) ligand 2 (monocyte  
   chemoattractant protein 1)
CCL3   Chemokine (C-C motif) ligand 3    
   (monocyte chemoattractant protein 1α)
CCL7   Chemokine (C-C motif) ligand 7    
   (monocyte chemoattractant protein 3)
CD   Cluster of differentiation
CLEC10A  C-type lectin domain family 10 member A  
   (MGL-1)
Col I   Collagen type I
Col1a1  Collagen type 1A1
DAPI   4;6-diamino-2-phenylindole
DC-SIGN   (Dendritic Cell-Specific Intercellular adhesion  
   molecule-3-Grabbing Non-integrin (CD209)
DC-STAMP  Dendritic cell-specific transmembrane protein
ECM   Extracellular matrix
EMEM   Eagle’s minimum essential medium
FAK   Focal adhesion kinase
FBGC   Foreign body giant cell
FBR   Foreign body response
FBS   Fetal Bovine Serum
FN   Fibronectin
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase
HEPES  4-(2-hydroxyethyl)-1-piperazineethane   
   sulfonic acid
HRP   Horse Radish Peroixdase
IFNy   Interferon gamma
IL   Interleukin
KD   Knockdown









LPS   Lipopolysaccharide
M1   Classically activated macrophages
M2   Alternatively activated macrophages
MEMα  Minimal essential medium α
MMPs  Metalloproteinases
MRC1  Mannose receptor, C type 1 (CD206)
PAAMs  Polyacrylamide hydrogels
PBMCs  Peripheral Blood Mononuclear cells
PBS   Phosphate buffered saline
PDMS   Polydimethylsiloxane
Sulfo-SANPAH Sulfosuccinimidyl 6-(4’-azido-2’-nitro 
   phenylamino)hexanoate
TGFβ1  Transforming Growth factor β1
Vin   Vinculin
YWHAZ  Tyrosine 3-Monooxygenase/Tryptophan 

















De auteur van dit proefschrift is geboren op 27 November 1987 in 
het Prinsengracht ziekenhuis te Amsterdam. De auteur is de jong-
ste in de familie met één oudere broer (Axel) en twee oudere 
zussen (Fanny en Laura). Hij is getrouwd met Chantal Bosma en 
trotse vader van een drie-enéénhalf jarige dochter (Faylice) en 
een maand oude zoon (Finley). 
De interesse en nieuwsgierigheid voor biologie zat er van jongs af 
aan in en deze nieuwsgierigheid werd mede gestimuleerd door 
zijn beide ouders, Harm en Loes Wouters. Verwondering voor de 
natuur speelde in zijn opvoeding een grote rol. 
De auteur is na het basisonderwijs op het Da Vinci college in Pur-
merend terecht gekomen. Hier heeft hij zowel het VMBO als de 
HAVO doorlopen, met een focus op exacte vakken. Na de HAVO 
heeft hij zijn ingenieurstitel behaald op de Hanze Hogeschool te 
Groningen in Biologie en Medisch Laboratoriumonderzoek, met 
een specialisatie in research. Na het behalen van het HBO diplo-
ma is hij gestart met een overbruggingsprogramma aan de RUG, 
om zichzelf te kwalificeren voor de master Biomedical Sciences.
Na het behalen van het felbegeerde master diploma en de doc-
torandus titel is de auteur als PhD-student een promotie traject 
gestart bij TiGeR (Tissue Generation and Repair) onder leiding 
van Prof. dr. R.A. Bank. Later is deze naam veranderd in MATRIX 
(Matrix Accumulation, Tissue Regeneration and Inflammation). 
Deze groep focust zich op macrofagen en fibroblasten in het 
(gestoorde) wondhelingsproces. Bij deze groep kreeg de auteur 
de mogelijkheid zich zowel breed als in de diepte te ontwikkelen 
op het front tussen cel biologie en biomechanica, wat uitein-
delijk geleidt heeft tot dit proefschrift.
Momenteel werkt de auteur als docent moleculaire biologie aan 











3,4-Dihydroxy-L-phenylanaline as a novel covalent linker of ECM 
to polyacrylamide hydrogels with a tunable stiffness. 
Olaf Y. Wouters, Diana T.A. Ploeger, Sander M. van Putten, and 
Ruud A. Bank, Tissue Engineering part C: 2016 February; 22(2): 
91:101.
Substrate elastic modulus regulates the morphology, focal adhe-
sions, and alpha-smooth muscle actin expression of retinal muller 
cells. 
Bu, S-C., Kuijer, R., van der Worp, R. J., van Putten, S. M., Wouters, 
O., Li, X-R., Hooymans, J. M. M. & Los, L. I. 2015 In : Investigative 
ophthalmology & visual science. 56, 10, p. 5974-5982
SUBMITTED FOR PUBLICATION
Polarization of human macrophages into M1 and M2 phenotypes 
is stiffness independent 
Olaf Y. Wouters, Diana T.A. Ploeger, Pytrick P.G. Jellema, Saskia 
de Rond, Ruud A. Bank   
Fusion of macrophages: formation of foreign body giant cells is 
stiffness dependent, irrespective of IL4/IL13 stimulation.
Olaf Y. Wouters, Diana T.A. Ploeger, Saskia de Rond, 
Ruud A. Bank   
   
αII-spectrin and βII-spectrin do not  affect fibroblast mechano-
sensing and TGFβ1-induced myofibroblast differentiation. 
Olaf Y. Wouters, Bram Piersma, Ruud A. Bank  
Ascorbic acid promotes a TGFβ1-induced myofibroblast pheno-
type Switch.
Bram Piersma, Olaf Y. Wouters, Saskia de Rond, Miriam Boersema, 









Dit is het moment terug te kijken op 3 jaar, waarin in relatief ko-
rte tijd veel is gebeurd. Ik zou hierbij graag een aantal mensen 
willen bedanken voor hun directe of indirecte bijdrage aan dit 
proefschrift.
Ten eerste mijn promotor, Prof. dr. Ruud Bank.
Beste Ruud, 
Vier jaar geleden gaf jij aan dat er een plek voor mij was bin-
nen jullie groep, die toen nog Tissue Generation and Repair (Ti-
GeR) heette. Ruud, bedankt voor de kansen die je me niet alleen 
toen, maar ook zeker gedurende het traject hebt geboden om 
mij verder te kunnen ontwikkelen. Niet alleen binnen het onder-
zoek, maar ook in het onderwijs, waar – achteraf terugkijkend - 
mijn hart ligt. Je hebt mij tijdens een aantal moeilijke jaren daar 
waar nodig goed ondersteund en aangestuurd binnen project-
en. Ik heb ontzettend veel van je geleerd, vaak in combinatie 
met een goede dosis humor. Ik heb mijn passie en kennis voor 
onderwijs verder kunnen ontwikkelen met het behalen van ver-
scheidene certificaten van gerenommeerde universiteiten met 
jouw steun. Daarnaast heb ik ieder jaar studenten mogen bege-
leiden tijdens de bachelor course Ontwikkelingsbiologie en Re-
generative Medicine (OBRM), wat mij heeft geleerd studenten 
niet alleen op theoretisch maar ook op praktisch niveau te be-
geleiden. Bedankt voor alles!
Ten tweede wil ik mijn tweede promotor, Marco Harmsen bedank-
en. Marco, bedankt voor de kansen die jij mij hebt geboden 
om als ‘onervaren’ docent mee te draaien binnen jouw curric-
ulum. Ik heb ontzettend genoten van het samen lesgeven en 
veel geleerd tijdens het ‘flip-the-classroom’ concept tijdens de 
master course Stem Cells and Regenerative Medicine. Jouw en-
thousiasme voor onderwijs is de start geweest voor mijn carriére 
als docent en zal mij altijd bijblijven. Daarnaast wil ik je graag 
bedanken voor alle gesprekken die wij nadien hebben gehad 
over mijn bewuste keuze om het onderwijs in te gaan.








Prof. dr. Jan-Luuk Hillebrands en Prof. dr. ir. Henk Busscher wil ik 
bedanken voor het lezen en goedkeuren van dit proefschrift.
Een dankwoord voor mijn vrouw en eerste paranimf, Chan-
tal Wouters. Lieve Chantal, bedankt voor alle steun, liefde en 
geduld de afgelopen jaren. We hebben het vooral in het eerste 
levensjaar van onze dochter niet altijd gemakkelijk gehad, maar 
samen staan wij sterk. Ik ben ontzettend dankbaar voor jou en 
ons gezin, en zonder jou was dit proefschrift niet mogelijk gewe-
est.
Een speciaal plekje in het dank woord is gereserveerd voor mijn 
tweede paranimf en collega, Diana Ploeger. Vanaf mijn tweede 
jaar hebben wij veel samengewerkt, aan zowel de DOPA pa-
per als de macrofaag/giant cell stukken aangezien we beide 
geïnteresseerd waren in humane biologie van de macrofaag. Dit 
ging niet altijd van een leien dakje. Toch heeft het combineren 
van jouw macrofaag- en mijn biomechanica kennis ons veel ge-
bracht. Hopelijk worden onze stukken (te lezen in hoofdstuk 3 en 
4) snel geaccepteerd. Jouw (vaak enorme) opzet van experi-
menten, Groningse nuchterheid en gezelligheid blijven mij bij. En 
hoewel de vraag blijft of een optimist slechts een slecht geïnfor-
meerde pessimist is of juist andersom, ben ik erg dankbaar voor 
de samenwerking die wij hebben gehad.
Ik wil mij graag richten tot mijn directe collega’s, want het werk 
was niet hetzelfde geweest zonder jullie. Ten eerste de collega’s 
die direct of indirect betrokken zijn geweest bij het tot stand 
komen van dit proefschrift.
Sander, in het eerste jaar heb jij mij op zowel theoretisch als prak-
tisch vlak enorm veel geleerd, bedankt daarvoor. Daarnaast 
heb jij gefaciliteerd dat ik met de juiste mensen in gesprek kwam, 
waardoor ik onder andere low level compression testing (LLCT) 
en atomic force microscopy (AFM) heb geleerd bij de afdeling 
Biomedical Engineering. Dit heeft mij in staat gesteld de stijfheid 
van de polyacrylamide gels te meten wat aan de basis staat van 
tenminste 4 hoofdstukken. Daarnaast wil ik je uiteraard bedank-








onder fluorescentie microscopie, de TISSUEFAXS en confocaal 
microscopie. De vele gezellig lunchpauzes, werkbesprekingen 
en onze reis naar Toronto (Canada) en Santa Fe (VS) zal ik niet 
snel vergeten! Daarnaast onze andere twee postdocs, Miriam 
Boersema en Marike van der Beuge, bedankt voor het delen van 
jullie kennis en de vele gesprekken die wij (vaak onder lunchtijd) 
hebben gehad. 
Bram, in hoofdstuk 6 en 7 hebben wij samengewerkt aan twee 
papers. Ik wil je ten eerste bedanken voor alle feedback en stur-
ing die jij aan deze projecten hebt gegeven. Daarnaast wil ik je 
bedanken voor alle gezelligheid. Je grappen (zoals lab-dances) 
zal ik niet snel vergeten!
Rutger, ik heb een ontzettende bewondering voor jouw doorzet-
tingsvermogen en alle uren die jij in jouw promotietraject hebt 
gestoken. Het heeft je veel gebracht en ik hoop dat de kennis en 
ervaring die jij hebt opgedaan je nog veel verder zal brengen.  
Daarnaast wil ik graag onze fantastische analisten, Pytrick en 
Saskia, bedanken voor alle steun die jullie geleverd hebben bij 
alle projecten. Zonder jullie was dit resultaat niet mogelijk gewe-
est. Nataly, althoughI’ve only seen you in the first few months of 
your PhD we had some great laughs. De overige (oud)-matrix 
leden: Masum Mia, Evert Jan ten Dam, Jelena Popov en Jurjen 
Zandstra, bedankt voor alle gezelligheid. Jullie maakten TiGeR/
MATRIX tot een gezellige groep!
Ik wil graag alle collega’s van de Medische Biologie bedanken 
voor de gezelligheid en behulpzaamheid, met name Anita, Hen-
riëtte, Jelleke, Linda, Henk, Theo, Peter, Marja, Wendy, Rianne, 
Guido, Janette, Hans, Ee Soo, Marousjka,  Byambaa, Monika, 
Marloes, Genaro, David, Ditmer, Joris, Joseé, Julio, Vincenzo, Uil-
ke, Annet, Susan, Carolien en ‘the face’: Marcel.
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